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This dissertation describes the development and clinical use of a novel stereotactic neurosurgical
system, the Cape Town Stereotactic Pointer (CTSP). This system has four main components;
a halo containing three fiducials also serves as the platform for a tripod pointing device which
is set with the aid of a 3D phantom or a printed setting diagram, and software which enables
transformation of imaging space into patient space.
Laboratory tests indicated an application accuracy of 1.9 +/- 0.6mm using the 3D phantom to set
the tripod. From the first clinical application, the system underwent a series of iterations which
could broadly be divided into four successive phases of refinement. This took place over a six
year period, encompassing one hundred patients who underwent 115 stereotactic procedures.
Indications for surgery included biopsy (62.6%), aspiration (15.7%) and cannulation (21.7%)
and the surgical objective was realized in 101/109 cases (92.7%). Given the fact that six of the
eight failures represented errors of surgical judgment that could not be ascribed to the device,
and each of two system errors resulted in a significant modification to the system, the CTSP
demonstrated a satisfactory level of accuracy in the clinical setting.
This was accomplished at an acceptable complication rate, with one death five days after surgery
attributable to a stereotactic procedure (mortality 0.9%) and major morbidity in two cases (1.7%);
thirteen patients experienced minor complications, all of which proved to be transient (11.3%).
A simple protocol for use of the CTSP evolved over the course of this study, making it easier
for neurosurgeons from varying backgrounds to introduce stereotaxis into their practice with the
help of this system. In addition to satisfactory levels of clinical reliability and safety, the system
was versatile and also well tolerated by patients. It is hoped that the CTSP provides a cost-
effective alternative for neurosurgeons working in under-resourced settings. Sixty units of the
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Finding your way to an unseen destination depends on recognition of known landmarks- reliance
on navigation is likely as old as vision itself. In the same way, the neurosurgeon needs to be
able to find his or her way to lesions hidden within the depths of brain, reliably and safely. The
conceptual framework that makes this possible is stereotaxis, a word derived from the Greek
words stereo ("three-dimensional") and taxis ("arrangement").
This term was coined a century ago by Robert Clarke as he and Sir Victor Horsley developed a
method for accurately passing probes into the brains of various experimental animals [Clarke].
A Cartesian co-ordinate system of section planes in three dimensions, sagittal, frontal and
horizontal, was superimposed on the brain, dividing the intracranial space into eight segments
(Figure 1.1). This hidden world was then explored with the help of a frame mounted outside the
head, which was able to direct an instrument to a specific point in the brain defined in terms of
these three dimensions [Horsley].
Figure 1.1: The Cartesian co-ordinate system comprises three planes intersecting at right angles,
mathematically these are expressed as X-, Y- and Z-axes with each individual point having a
unique set of X-, Y- and Z-co-ordinates. (from [Friedman_1992], permission requested from Wiley
Interscience)
Stereotaxis has always been guided by images. Those used in the laboratory were derived from
anatomical atlases and it took four decades before neurosurgeons were able to plot internal











The pioneers in the field defined themselves as "stereotactic surgeons"; with remarkable
ingenuity, they led the way in developing the first subspecialty in neurosurgery to be defined by a
technology and not a disease [Bakay]. First guided by the shadows of pneumoencephalography
and later by contrast ventriculography, they introduced a range of new techniques for exploring
and modulating brain function.
It was however the ever-sharper outline of the brain revealed by computerized imaging that truly
brought stereotaxis to the fore, to the extent that stereotactic guidance is now indispensable
to the modern practice of neurosurgery. As one of the leading thinkers in the field has written,
"stereotactic surgery has moved beyond a subspecialty, so that every neurosurgeon might
benefit from using stereotactic techniques...." [Gildenberg_2000i]. There is no better example of
this than the extent to which modern navigation technology has found its way into the Operating
Theatre. Not only is image space mapped onto patient space, as with traditional stereotactic
surgery, but patient space in turn can now be mapped back onto image space, extending the
safe reach of the neurosurgeon.
No neurosurgeon who looks at a CT scan showing a lesion deep within the brain, whether an
abscess to be tapped, a tumour to biopsy or a cyst to drain, should have to undertake this today
without having the option of using a stereotactic instrument to guide his or her hand, using the
so-called "freehand" approach.
While this may be true in the developed world, the "sad fact", to use the late Professor
Ramamurthi's term, is that this is simply not the case in those parts of Africa, Asia and South
America which have not enjoyed the benefits of this neurosurgical progress [Ramamurthi 2004].
Meagre investment by governments in healthcare, together with inadequate access to training
for aspiring neurosurgeons and a perception that this is only for rich countries have limited the
growth of our specialty in developing countries. The reality though is that neurosurgery does
have much to offer in these countries, but will never gain a foothold without the "appropriate
technology" that Ramamurthi sought.
Modern neurosurgical technology in the shape of operating microscopes, neuroendoscopes,
stereotactic frames and navigation doesn't come cheap. Although increasing competition should
help to drive prices down, this is still a niche market dominated by a few big companies and new
applications and "add-ons" mean steadily increasing cost. Faced with our own lack of access to
stereotaxis in Cape Town in the early 1990's, we were well aware of the limitations and hazards











This thesis will describe the development and use of a novel stereotactic system, the Cape Town
Stereotactic Pointer (CTSP), which emerged from fruitful collaboration between land surveyors,
biomedical engineers and neurosurgeons. Key considerations that informed this process were
simplicity and cost; we sought to develop a stereotactic system that could readily be used by
general neurosurgeons and was also relatively inexpensive, in order to encourage wider access
to this fundamental technique. Achieving patient acceptance through considering their comfort
was a concern but ultimately, accuracy would be of paramount importance.
As the essence of stereotaxis is the ability to locate the unseen target in the brain with the help
of visible external landmarks, three components are required to ensure the surgical instrument
finds the correct destination:
i. a "visible" reference framework, external to the brain
ii. an imaging system that will "see" both the reference system and the target within the
brain
iii. a mechanical device that will enable one to reach that target, based on the external
reference system.
After reviewing the history of stereotactic neurosurgery over the past century in Chapter 2, the
evolution of the CTSP to meet these three requirements will be described in Chapter 3. As with
all prototypes, the system went through various iterations before a clinically useful methodology
emerged. As accuracy and precision are the hallmarks of stereotaxis, the various laboratory
studies that underpinned the translation of this concept into the clinical arena will be reviewed in
Chapter 4.
Chapter 5 describes the first one hundred patients who underwent 115 operations with this system
over a 6 year period. As the development of the CTSP was of necessity also the development of
stereotactic neurosurgery in Cape Town, the lessons learnt in developing the system as well as
learning the principles of stereotaxis will be reviewed in detail.
Individual chapters will review specific applications. Stereotactic brain biopsy was overwhelmingly
the most common procedure performed and this experience is covered in Chapter 6. Specific
challenges will be addressed and the results obtained will be compared with the published
literature with respect to diagnostic yield and complications.











will be discussed in Chapter 7, where the method of stereotactic implantation of the catheter in
the specific case of cystic craniopharyngioma will be examined, together with the results of this
treatment strategy.
Chapter 8 encompasses a range of other applications, such as the use of the CTSP in children,
insertion of shunts for treating hydrocephalus, aspiration of abscesses, biopsy in the setting
of HIV, which is so relevant to South Africa and will conclude with a method of performing
stereotactic craniotomy with the aid of the CTSP.
This thesis will conclude with an evaluation of the strengths and weaknesses of the CTSP in
Chapter 9. One of our main goals in undertaking this project was to produce a system that
was cost-effective and therefore available to a wider group of neurosurgeons, and the chapter
will reflect on challenges in trying to meet this need. Modifications introduced by newer users,
suggesting that this system is not only simple and easy to use but also versatile, will be described
and future developments considered.
Appendices will cover the patient data and relevant forms, present a concise protocol detailing














When surgeons first crossed the frontier into the human body, they were guided by a constellation
of symptoms and signs pointing to a particular organ as the seat of the patient's trouble. The
brain presented a particular challenge- not only was it protected by the rigid skull, but there were
few clues to guide early surgeons until the pioneering work of 19 91 century neurologists such
as Paul Broca and Hughlings Jackson led to an appreciation that different areas of the brain
subserved specific and highly specialized functions.
In 1876, Broca was the first surgeon able to use a patient's neurological findings to localize an
intracranial lesion, in this case an extradural abscess in the speech area, and treat it by a direct
surgical approach [Green]. In a sense, modern neurosurgery was ushered in by an operation
at the National Hospital for Nervous Disorders in London 125 years ago. A patient with focal
seizures and a left hemiparesis was thought by his neurologist Alexander Hughes Bennett to
have a tumour in the motor cortex on the right side of the brain. Bennett persuaded the surgeon
Rickman Godlee that trephination in the right parietal area would allow resection and he produced
a localization diagram in order to guide him; a tumour was indeed found just below the surface
of the brain [Green]. This was perhaps the first instance ever of a neurosurgeon benefiting from
navigation assistance!
Anatomists in the 19th century devised various instruments for guiding intracranial procedures,
both in experimental animals and patients [Redfern]. Dittmar, working in Germany, reported
using an instrument to guide probes into the medulla oblongata of experimental animals in 1873
and Zernov, Professor of Anatomy in Moscow, reported the use of an instrument called the
"encephalometer" which was designed to identify cerebral convolutions and sulci for surgical
procedures in 1889 [Kandel]. This was subsequently used on at least three occasions, one
of which was to drain a brain abscess [Al-Rhodhan]. Another ingenious device for removal of
missiles from the brain based on orthogonal X-rays was reported in a magazine called L'illustration
[Benabid].
This era was also remarkable for the burgeoning interest in experimental neurophysiology with











neurologists were soon supplemented by the new technique of X-ray radiography, which showed
bone very well but was not at that stage able to reveal the anatomy of the brain. As will be seen,
first neurophysiology and then neuroradiology would serve as springboards for the development
of stereotactic neurosurgery.
2.2 Physiologists: Horsley and Clarke
Sir Victor Horsley (1857-1916), godson and namesake of Queen Victoria, was an extraordinary
polymath (Figure 2.1). In addition to being a leading surgeon, intellectual and social activist,
he was also a pioneering experimental neurophysiologist [Sachs]. He wished to elucidate the
functions of the cerebellum by placing lesions in the deep cerebellar nuclei of Macaque monkeys
and frustrated by his inability to do this accurately using a freehand approach, he enlisted the help
of a surgical colleague, Robert Henry Clarke (1850-1921). Clarke solved this problem through
combining two old concepts, a three-dimensional positioning apparatus and a Cartesian co-
ordinate system [Pereira_2008i]. As already noted, a number of instruments had been utilized to
guide various probes into the brain, but coupling such a device to a Cartesian coordinate system
may truly have been an original concept [Kelly_2000i].
Clarke and Horsley divided the brain into eight segments by section planes in three dimensions-
sagittal, frontal and horizontal, each of which was further divided at one millimeter intervals.
Based on a series of meticulously taken sections at intervals of 2mm, they produced an atlas
of the monkey brain in which each 1mm cube had a unique set of coordinates in these 3 planes
[Clarke].
With this, they designed a "mechanical contrivance" capable of directing an electrode to any
desired target within this coordinate system. This consisted of a brass frame, which could be
affixed to the skull of an experimental animal by means of rods inserted into the external auditory
meati. A headpiece was then attached to the frame; this contained an instrument carrier such
as a micromanipulator and translational movement allowed calibration in each of the three axes
[Dagi]. Their first such device, manufactured in 1905 by the London instrument maker Messrs Swift
and Son, now resides in the Wellcome Collection at the Science Museum in London (Figure 2.1).
They also devised various instruments for making electrolytic lesions in experimental animals
and in applying their "combined method", were able to explore function in various regions of the
brain. Their brief article in the British Medical Journal in 1906 was followed by a detailed report











Clarke coined the term "stereotaxis" which was a hybrid derived from the Greek terms for "three
dimensional" (stereo) and "arrangement" (taxis) [Dagi]. He was convinced that this device could
be used on humans and predicted that with the use of this apparatus, "through a 5mm trephine
hole, brain tumours might be treated by electrical means or by the placement of radium, relief of
pain by coagulation of intracerebral tracts, and direct application of drugs and pharmaceuticals
into the CNS" [Jensen]
It is puzzling that Horsley appears to have dismissed this possibility, leading to an acrimonious
breakdown in their relationship. It has been suggested that a contributing factor may have been
Clarke's envy of Horsley's position as the King's surgeon and he is reputed to have accused
him of being a "self-seeking political wire-puller"! [Al-Rhodan]. Although Clarke subsequently
became a general practitioner [Pereira 2008i], he remained interested in the field he had
nurtured, continuing to work on various modifications of the device. He obtained a patent in 1912
and published a stereotactic atlas consisting of serial brain sections on which a co-ordinate grid
was superimposed in 1920. It appears that he only published four papers, all of them concerned
with stereotaxis [Kelly_1991].
A Canadian neurophysiologist, Aubrey Mussen was particularly impressed with the Horsley-
Clarke apparatus, so much so that he purchased a model in 1906 for $100! [Olivier]. He had
another frame built in London in 1918, modified for human use by calibrating it to external
calvarial landmarks [Dagi], but was unable to persuade his surgical colleagues at the Montreal











2.3 Clinicians: Spiegel and Wycis
The major problem in the transfer of this technology from monkeys to patients was the much
greater variability in the shape and size of the human cranium, together with considerable
variation in the contours of the brain, particularly in the presence of atrophy or other cerebral
pathology. Landmarks were required within the brain itself. The solution lay in technology already
available- Roentgen's discovery of X-rays in 1895 was followed by Walter Dandy's introduction
of air ventriculography in 1920, which for the first time allowed visualization of the living brain,
even if only partially. Perhaps it is surprising that it took half a century for roentgenograms to find
their way into the stereotactic operating room, but the impetus for this finally happening has been
ascribed to the technological advances of the Second World War [Kelly_2000i]. This conflict
stimulated the migration of stereotaxis from the laboratory into the operating theatre in various
ways.
Ernst Spiegel, a Viennese neurologist born in 1895, was appointed professor of experimental
neurology at Temple Medical School in Philadelphia in 1933. His interest in stereotaxis stemmed
from a desire to find a less invasive alternative for the widely practiced procedure of pre-frontal
lobotomy which necessitated a craniotomy and was replete with complications. He was also
concerned with the treatment of movement disorders and before Clarke's death in 1926, he
looked into having a stereotactic device manufactured by Swift, but the cost (£300) dissuaded
him [Kelly_1991].
Spiegel established a remarkably productive collaboration with the neurosurgeon Henry Wycis,
which culminated in the first human stereotactic operation, reported in Science in 1947 [Spiegel].
Their patient had Huntington's chorea and alcohol was injected into both the globus pallidus and
the dorsomedial nucleus of the thalamus, with sustained benefit. Wycis verified the location of
the lesion by performing an autopsy when the patient died 15 years later and then paid for his
funeral! [Nashold 2004]
The frame used for this operation was similar to the Horsley-Clarke apparatus and was
mounted on a ring suspended from a plaster cap made individually for each patient. After
applying the headring with the base parallel to the Frankfurt plane, the patient was subjected to
pneumoencephalography in order to identify the intraventricular landmarks which would be used
to locate the target with the aid of a stereotactic atlas of the human brain which they had created.
As the large volume of intraventricular air invariably made the patient acutely ill, the frame was











The important point is that, for the first time, internal landmarks were used to tailor these
operations to the patient's own anatomy, with intraventricular air serving as the first radiographic
contrast medium. Spiegel and Wycis termed the new discipline "stereoencephalotomy." The key
step was linking the patient's anatomy to one of several stereotactic atlases of the human brain
which were developed over the years, such as that produced by Schaltenbrand and Bailey. The
major problem was that there was still significant variability, which was not always adequately
corrected by using ventricular landmarks.
Spiegel was productive throughout his career. He founded a journal in 1939 which was to
serve as an important vehicle for the development of the nascent field of stereotaxis. The title,
Confinia Neurologica, was true to his belief that he was working at the borderland of neurological
understanding and he edited this journal until Gildenberg took over in 1975, renaming it Applied
Neurophysiology. With the advent of image-guided surgery, the name of the journal was to
change again a decade later, this time to Stereotactic and Functional Neurosurgery. Spiegel's
final major contribution to the field was the book "Guided Brain Surgery" published in 1982, at
the age of 87! [Gildenberg_2004].
2.4 The rise and fall of stereotaxis
A succession of neurosurgeons from around the world visited Philadelphia and in turn developed
their own techniques, a feature of which was often a novel stereotactic frame, largely because no
system had been produced commercially [Kelly_1991]. The market was still small and commercial
viability was diminished by constant refinement of the various prototypes in response to new
problems- the early stereotacticians certainly needed to be very innovative.
Among these enterprising pioneers, Lars Leksell (Stockholm), Jean Talairach and Jean Bertrand
(Paris), Traugott Riechert (Freiberg), Hirotaro Narabayashi (Tokyo), Robert Rand (Los Angeles)
and Ron Tasker (Toronto) were particularly prominent in stimulating the growth of stereotaxis
around the world.
Lars Leksell (1907-1986) succeeded Herbert Olivecrona as Professor of Neurosurgery at
the Karolinska Institute in Sweden. Although Leksell was determined to attempt stereotactic
techniques wherever possible, he remained however committed to the notion of technical
excellence in neurosurgery, believing that "the best stereotactic neurosurgeon is one who is also











Leksell is a giant in the history of stereotaxis, having first developed the cuboidal target-centered
frame which bears his name [Leksell 1949], he later consummated the marriage of stereotaxis
and radiotherapy with the development of stereotactic radiosurgery, which is now one of the
major applications of the stereotactic concept worldwide. He made his mark not only through the
instruments he developed, but also in mentoring leaders of the next generation of stereotactic
neurosurgery [Lunsford_1997].
Jean Talairach (1911-1993) had a somewhat different background, training initially as a neurologist
and psychiatrist under Professor Marcel David at Ste. Anne. Like Spiegel and Wycis, he sought
an alternative to frontal lobotomy and in the late forties designed his own stereotactic system
with a double grid and relocatable cranial fixation system [Kelly 2004i]. He and Sabbaton also
devised a system for collimated biplane teleradiography which improved accuracy by reducing
magnification. There is no doubt that Talairach was an original thinker and Bertrand recollects a
spat at the 1949 World Congress of Neurology between Spiegel and Wycis on the one side and
David and Talairach over who had priority in the development of a human stereotactic apparatus!
[Bertrand].
Patrick Kelly describes from first-hand experience how Talairach's group devised a process
(repérage) whereby multiple data sources including ventriculography, stereoscopic angiography,
serial biopsy and stereo-EEG were combined in scale drawings (les dessins) to provide a
navigational chart of the patient's brain [Kelly_2004i]. It is noteworthy that they were able to
perform tumour biopsies based on this painstaking process and also pioneer the use of interstitial
irradiation where radionuclides such as iridium-192 were inserted into defined tumour volumes.
Kelly later championed the role of stereotactic "volumetric" resection of tumours, crediting
Talairach with teaching him that a stereotactic target was not necessarily a single point, but is
also a volume in space.
It is interesting to reflect on the fact that an important driver in early stereotactic neurosurgery
was the quest for improved psychosurgery. It wasn't long before other indications became more
prominent, most notably movement disorders, pain and epilepsy. As is usually the case, this new
discipline culminated in an international society with the International Society for Research in
Stereoencephalotomy established in 1961. This was renamed the World Society for Stereotactic
and Functional Neurosurgery (WSSFN) at the meeting held in Tokyo in 1971; it is also worth
noting the decision at that meeting to replace the term stereotaxic with stereotactic ("to touch") to











Although Spiegel and Wycis had pointed to these wider applications, such as aspiration of tumour
cysts in their 1947 article, virtually all operations done in the early days were for movement
disorders such as Parkinson's Disease. The advent of an effective medical treatment in the
form of I-dopa in 1967 led to a dramatic fall in the number of stereotactic operations over the
next decade (Figure 2.2) [Gildenberg 1987]. Kelly credits Spiegel's protégé, Philip Gildenberg,
with keeping "the torch of American stereotaxy burning through the post I-dopa dark ages"!
[Kelly 2004i]
Figure 2.2: Variation in the levels of activity in stereotactic and non-stereotactic functional
neurosurgery from the time of Spiegel and Wycis first stereotactic surgery in 1946, graphically
showing the decline in stereotactic surgery following the introduction of I-dopa, followed by a
second upsurge of interest in the 1970s (from [Gildenberg_1987], with permission from Williams
and Wilkins).
Two developments were to bring a new dawn for stereotaxis. It wasn't long before the shortcomings
of long-term I-dopa treatment became apparent, with many patients developing troublesome
side-effects, but more importantly, computerized tomographic scanning was about to make its
entrance.
2.5 Tomography and the resurrection
Human stereotactic surgery and computers are age -mates, with the first electronic calculator










computers on this field was to be enormous; the history of stereotaxis offers an excellent example
of the migration of technology into neurosurgery, and indeed into the practice of medicine as a
whole [Dagi]. Spiegel and Wycis had taken advantage of post-war advancements in plane film
radiology but it was really the advent of computerized axial tomography, also known as computed
tomography (CT) that launched stereotaxis into the mainstream of neurosurgery.
The Nobel Prize in Physiology or Medicine for 1979 was awarded to Allan MacLeod Cormack and
Godfrey Hounsfield in recognition of their work in the development of computerized tomography.
While working as a physicist in the Radiotherapy department at Groote Schuur Hospital in the
1950's, Cormack was required to calculate the radiation doses given to patients. In his Nobel
Prize citation, Professor Greitz noted that the methods in use at the time had been imprecise
and Cormack devised a mathematical solution for obtaining precise values for the tissue-density
distribution within the body, which he realized could also be used to produce X-ray images of
cross-sectional slices of the body [Vaughan]. Unfortunately, performing the calculations required
was beyond the capacity of most computers of the day.
Hounsfield came to this field from a very different direction; he hit on the idea of CT while
contemplating the potential of automatic pattern recognition in clinical practice [Petrik]. At the
ti me, he was working for Electrical and Music Industries (EMI), and he was fortunate in finding
an ally in the neuroradiologist at Atkinson Morley's Hospital in London, Dr James Ambrose.
Ambrose, a South African who had found himself in the UK as a Spitfire pilot, immediately saw
the clinical potential of this concept, a prototype was installed at his hospital and the first patient
was duly scanned on 1 October 1971.
The most obvious advance signified by CT was the ability to directly visualize intracranial
structures other than just the ventricles and vessels. Normal anatomical structures such as the
white matter and basal ganglia could now be visualized, as could a wide array of pathological
entities such as haematomas, abscesses and tumours. Equally important though was the fact
that this new imaging medium was also an accurate 3D measuring device as it was spatially
accurate, using a measuring system based on a Cartesian co-ordinate system. Although CT
reduced the problems of parallax, magnification and proportion which plagued teleradiography,
some new technical challenges arose, such the need to include frame fiducials for purposes of
co-ordinate mapping while avoiding large metallic artifacts. Initially it was laborious to get the
coordinates off the CT slice as each slice had to be "transferred" onto stereo X-rays, but various











Bergstrom and Greitz reported adapting the Leksell frame for CT as early as 1976 [Bergstrom], but
this required a thermoplastic head cast and was soon abandoned [Dagi]. One of the challenges
was to find a way of registering the z co-ordinate on each image. Theodore Roberts, Professor
of Neurosurgery at the University of Utah encouraged a medical student, Robert Brown, to tackle
this problem [Cosman]. His simple but elegant technique incorporated the localizing device into
the stereotactic apparatus itself, with three diagonal rods in an "N" shaped array generating
fiducials on each CT scan slice [Brown]. This was incorporated into a number of other systems.
Perry and co-workers at Pfizer independently developed an artifact-free frame along similar lines
[Perry]. Leksell himself devised a solution [Leksell_1980], as did Gildenberg, in which the CT
slice was related to a lateral X-ray film in the operating room [Gildenberg_1982].
2.6 Proliferation
There was a remarkable proliferation of stereotactic systems- this reflected not only the ingenuity
of the early stereotactic surgeons, but also the reality that the field had to develop before
commercial vendors would consider it viable to produce these instruments.
Devising a widely quoted classification, Gildenberg noted that each stereotactic apparatus fell
into one of four different groups, depending on how the electrode carrier was mounted:
1. Translational systems, such as Horsley-Clarke and Spiegel-Wycis, and the Talairach
system.
2. Arc or polar coordinate system, employing an electrode carrier fitted to an arc such
that it always points to the centre of the frame- this was the novel contribution of
Leksell. Other arc systems include the Todd-Wells and Riechert-Mundinger.
3. Burr- hole mounted systems consist of a fulcrum attached to a burr-hole, to which
is fixed an electrode carrier with angular adjustments to point to the target and a
microdrive to advance the electrode- the McKinley and Patil systems are examples.
4. Early in the era of CT scanning, the availability of computers made possible some
rather complex systems consisting of multiple interlocking arcs, such as the Brown-












Figure 2.3: The four basic types of stereotactic apparatus. A: Translational system. B: Arc
system. C: Burr-hole mounted. D: Interlocking arcs (from [Gildenberg_1987], with permission
from Williams and Wilkins)
One of the more helpful innovations was Mundinger's use of a phantom target device to
mechanically set the stereotactic frame to the correct trajectory and depth, with the phantom
replicating the "patient space". The evolution of the BRW into the CRW arc-centered system is an
excellent example of how a surgical apparatus improves as new challenges are met [Pell_1994i].
The successful systems did very well- over 2,500 Todd-Wells frames were sold and up to a
decade ago, approximately 2,000 BRW frames, 2,500 CRW frames and 1,500 Leksell frames
had been produced [Apuzzo 1999].
2.7 Attempts to simplify stereotaxis
With the advent of CT, a number of simple stereotactic systems were introduced. Some were
based on the "plane-of-target" concept which required that the device be aligned in the CT
scanner such that the entry point is on the same image slice as the target, but this severely
limited the range of safe trajectories [Friedman 1988]. Various techniques for scalp marking











In an attempt to broaden access to stereotaxis, Carol introduced a simple skull-mounted
stereotactic system (the Pelorus Frame) which employed a skull set consisting of a series of
discs, the first of which was attached with two self-tapping screws; the patient was secured to the
CT table via a table mount attached to the skull mount [Carol 1985]. A novel three-dimensional
phantom (the "Gyrantom") was used to simulate the relationship between the intracranial target,
the entry point and the skull and efficacy was demonstrated in a clinical series [Carol 1987].
A number of non-invasive stereotactic systems have been introduced, most notably the
Multipurpose Stereoadaptor [Laitinen_1987], which was shown to be effective and efficient in a
series of 18 patients [Hariz] and the Gill-Thomas relocatable frame from Queen's Square [Gill]
which is particularly applicable to stereotactic radiotherapy. A group in Australia described the
use of stereolithography to create a solid plastic model (a "biomodel") which facilitated planning
of surgery which was guided by a three-legged frame containing a ball-and-socket instrument
guide [d'Urso].
The high cost of the instrumentation was a major obstacle to neurosurgeons introducing
stereotaxis in developing countries; in China, Dr Jian-Ping Xu and Dr Da-Jie Jian both designed
their own systems of necessity [Sun] and Dr Arjun Sehgal played a very important role in the
development of stereotaxis in India through the introduction of a new stereotactic apparatus
[Ramamurthi_2000].
2.8 The new challenge: MRI
Magnetic Resonance Imaging was introduced into clinical practice within a decade of CT and the
first report of its use for stereotactic neurosurgery appeared in 1983 [Thomas 1983]. Clinicians
immediately appreciated the advantages of this new imaging technology, the most striking of
which was the ability to now obtain images in all three planes (corona) and sagittal in addition
to the axial images rendered by CT). The ever-improving differentiation of soft tissues such as
brain produced exquisite images of the central nervous system, including the spine and contrast
enhancement with gadolinium delineated pathology with greater clarity than CT.
Early disadvantages included long scan times, enormous cost and the absolute proscription of
any ferromagnetic metals, which necessitated the development of a new generation of MRI-
compatible stereotactic frames. Despite the obvious superior quality of the images produced,
reservations arose concerning possible geometric distortion which would compromise the











MR imaging uses a strong, constant magnetic field (BO) and three pulsed linear magnetic
field gradients (magnetic fields that change in a linear fashion over distance) to localize and
to image points in an object. Geometric distortions occur when the constant field and the
gradient field are perturbed from their ideal character; causes include gradient field non-
li nearities and resonance offsets due to chemical shifts or due to magnetic field inhomogeneities
[Sumanaweera]. Of these, the two most important are gradient field non-linearities and magnetic
field inhomogeneities induced by the imaged object. An early solution was to modify the frame
so the patient could undergo both CT and MRI [Lunsford_1986], leading to the development of
"image-fusion" techniques, where the accuracy of CT was wedded to the superior images of
MRI. A comprehensive study reported a difference of 2mm between stereotactic co-ordinates
determined by CT and MRI [Kondziolka_1992], but current MRI technology appears to have
addressed most of these problems and many neurosurgeons now use this imaging modality
alone.
2.9 From frameless to robots
Although a frame had become almost synonymous with stereotactic surgery, this was simply
a means to an end, with the essential feature being defining a co-ordinate system based upon
the patient's image and the patient's anatomy [Bakay]. Once that had been accomplished,
transformation and co-registration of these two co-ordinate systems allowed a point in imaging
space to be related to anatomical space (and, as we shall see, vice versa).
Although stereotactic frames provided a stable and redundant frame of reference as well as a
stable aiming arc, they had disadvantages, including restriction of the operative field, bulk and
complexity. Furthermore, the frame was always temporary and there was no real-time updating
after the initial scan [Maciunas_1993]. A number of centres described innovative approaches
to utilizing stereotactic guidance without need of a frame, such as the "Neuronavigator", a
stereotactic articulated arm from Tokyo [Watanabe] and integration of the microscope in Lebanon,
NH [Roberts], where the term "frameless stereotaxy" appears to have originated. Likening the
ongoing usage of this term to that of "horseless carriage" to refer to the automobile, Maciunas
later argued for the adoption of the term "interactive image-guided surgery" [Maciunas_1993].
In extending the analogy, he cogently reasoned that the engine driving this new technology was
the digital computer.
As most surgical interventions are preceded by imaging of some kind, one could argue that











quantitatively- in other words, their spatial parameters carry equal or greater weight than their
grey-scale parameters [Galloway_2001]. A detailed review of the evolution of this metamorphosis
in stereotaxis would be out of place here, but this technology has really placed stereotactic
methodology squarely in the midst of mainstream neurosurgery in the form of surgical navigation.
Today, it would be unusual to find a neurosurgical department in any developed country that
didn't have access to at least one BrainLab® or StealthStation®. While the appeal of navigation is
clearly apparent in open surgery, some authors have even suggested that such approaches are
superior to frame-based approaches for closed procedures such as biopsies [Dorward_2002];
this argument does, however, need to take into account the long-established track record of
frame-based approaches, which have set a benchmark [Lunsford 2008]. The culmination of the
quest for real-time co-registration of patient space and image space is utilization of intraoperative
imaging such as ultrasound [Unsgaard] or even MRI [Sutherland]; perhaps robotic assistance is
the next step in this continuum [Louw, DF].
2.10 Functional Stereotactic Neurosurgery
The advent of sectional imaging, first CT and then MRI, opened up a whole new spectrum
of so-called "morphological" indications for stereotactic neurosurgery, many of which were
diagnostic in nature. The core interest of the discipline however has always been investigating
and modulating the physiology of the central nervous system, in treating "functional" conditions
such as movement disorders and pain. As the purpose of the CTSP was to meet the needs of the
general neurosurgeon confronted with diagnosing and treating a lesion found on a scan, space
does not permit a detailed review of the fascinating history of functional stereotactic surgery.
Although no CT-based stereotactic surgery was being performed in Cape Town when this work
commenced, a number of functional cases had been performed some years previously by the
first Helen and Morris Mauerberger Professor of Neurosurgery, JC "Kay" de Villiers. He had been
trained in this field at Atkinson Morley's Hospital in London and was assisted in his endeavours
by Dr Peter Keet [de Villiers JC, personal communication].
Early surgical interventions were predominantly ablations targeting a wide array of brain regions;
although these were primarily guided by imaging such as ventriculography, microelectrode
recordings were often used as well. Although thalamotomy became a popular procedure for
controlling tremor, this fell from favour following the introduction of I-dopa [Gildenberg_1987].











by Laitinen's group [Laitinen 1992] led to a rebirth of surgery for Parkinson's Disease
[Gildenberg 2005].
A reversible alternative for these patients became available with introduction of deep brain
stimulation, largely through the pioneering work of Alim Benabid. Although the mechanism of
action is still not fully understood, electrodes placed in the ventral intermediate nucleus of the
thalamus markedly improve tremor, while those in the internal segment of the globus pallidus
or the subthalamic nucleus substantially improve bradykinesia, rigidity and tremor [Perlmutter].
This is currently a vibrant area of research with a bewildering array of brain regions now targeted
for conditions ranging from dystonia and pain through to depression and other psychiatric
conditions.
2.11 What is Stereotactic Neurosurgery today?
The literature pertaining to the development of stereotactic surgery is vast; although there has
been a concerted attempt to cover this adequately, it must be mentioned that to a great extent
only the English-language literature has been accessible to the author. This is an unfortunate
li mitation in that much of the innovation in this field has originated in Europe, but it may be safe
to assume that most of the important information has permeated across barriers of language.
For the General Neurosurgeon, a stereotactic system remains simply a surgical guidance device
and although the mechanics of this have evolved dramatically over a century, the underlying
concept remains unchanged. The challenge is figuring out where to point this device and that is
where modern imaging has had such a dramatic impact.
During the century since Horsley and Clarke introduced the concept of stereotaxis, enormous
technical strides have enabled neurosurgery to evolve rapidly. It is clear from this review that
many of the new methodologies that have been adopted throughout neurosurgery, such as frame-
based and frameless procedures for biopsy of lesions, neuronavigation during open surgery and
radiosurgery, have their origins in this concept.
Within this context, the European Society for Stereotactic and Functional Neurosurgery (ESSFN)
and the WSSFN have published a consensus definition of contemporary Stereotactic and
Functional Neurosurgery [WSSFN]:











structural and functional neuroimaging to identify and target discrete areas of the brain and
to perform specific interventions (for example ablation, neurostimulation, neuromodulation,
neurotransplantation, and others) using dedicated instruments and machinery in order to relieve
a variety of symptoms of neurological and other disorders and to improve function of both the
structurally normal and abnormal nervous system."
As with all branches of modern neurosurgery, Stereotactic Neurosurgery has quite clearly evolved
into a highly specialized field. This process of refinement has invariably been accompanied
by increasing technical sophistication, which inevitably comes at a greater cost. This creates
a difficult tension for neurosurgeons practicing in under-resourced regions of the world, torn
between knowing they could be doing a better job, and the reality of the patients needing treatment












Development of the Cape Town Stereotactic Pointer
3.1 Overview of the CTSP
All stereotactic frames share the common purpose of establishing a rigid relationship between
the outside of the patient's head and the brain inside in order to provide a mechanical outside
space guidance system [Adams 1998].
For a stereotactic system, the essential requirements are:
i. an external constellation of visible fiducials
ii. a computer program that enables one to transform the three-dimensional space of
the visible fiducials into the three dimensional space of the invisible brain.
iii. a construct which replicates the patient's own three dimensional space
iv. a surgical guidance device
In the specific case of the CTSP, these requirements are fulfilled by the following components:
i. a halo incorporating three ball bearings; these serve as the fiducials which are visible
both externally and on imaging with a CT scanner
ii. computer software developed by Adams and van Geems and licensed to Fibretek
iii. a three dimensional phantom
iv. a three-legged or tripod stool with a swivel head
Figure 3.1: The first production version of the CTSP, showing the full set of components required











There are four discrete steps in the use of the CTSP:
As with any other stereotactic system, one also requires:
• an imaging system which will show both the fiducials and the area of surgical interest
(typically a CT scanner)
• various surgical tools such as biopsy cannulae, catheters an electrodes.
This chapter will examine the concept underlying the Cape Town Stereotactic Pointer, which was
rooted in the discipline of photogrammetry. From its origins as a proton beam placement method,
this concept then evolved through various surgical iterations, undergoing a metamorphosis from
a rather complex stereophotogrammetric-controlled surgical pointing device to a simple and
effective neurosurgical apparatus.
3.2 Beacons in the Brain
Few people have driven past a land surveyor busy with his or her theodolite and not wondered
what exactly they were up to. When performing a boundary survey on a property, they are
required to locate the original property beacons, some of which are "lost", with reference to
the existing integrated survey system which already exists, based on a network of visible
trigonometric beacons. Prior to the advent of the Global Positioning System (GPS), the cadastral











As Adams [1999] has written, "the "lost" beacon was located by setting up a theodolite in the
vicinity, observing a round of angles to three or more trigonometric pillars, undertaking a resection
calculation and a transformation of coordinates of a local origin system into the integrated system,
turning off a pre-computed angle, taping a pre-computed distance, digging a hole and revealing
a rusty old iron pin or angle iron that had been hidden from sight for numerous years". Sounds a
bit like neurosurgery doesn't it?
This project arose out of a discussion between Professor Jonathan Peter, at the time the
newly appointed Chair of Neurosurgery at the University of Cape Town (UCT), and Emeritus
Professor Laurie Adams, who had taken up a research position in the Department of Biomedical
Engineering after retiring from the Chair of Land Surveying at UCT. Professor Peter and two of
his registrars, Dr Graham Fieggen (the author) and Dr Allan Taylor, were looking to develop a
stereotactic system to locate targets in the brain, with a particular interest in finding a way to insert
shunt catheters accurately in the ventricle. Professor Adams saw this as a straightforward land
surveying problem, entirely analogous to the "lost" boundary beacon situation and he enlisted
the help of one of his postgraduate students Ms Barbara van Geems, who tackled this as a PhD
project [van Geems].
Adams had previously considered the problem of locating anatomical points using X-rays, in this
case X-ray stereoscopic pairs [Adams1 981]. In mathematical terms, an X-ray picture represents
the mapping of space upon a plane which is a special case of a central projection; in other
words, an X-ray picture represents the projection of 3-D space onto 2-D film. It is therefore not
possible to recreate the position in space of objects imaged on an X-ray picture by using a single
picture, but if two pictures are taken of the same object from slightly different points of view,











measurement in X-ray photographs is known as X-ray photogrammetry and is primarily used for
determining geometrical data such as the size, position and shape of objects.
Adams described a method using stereophotogrammetric techniques that enabled one to locate
an "intracranial" target located within a polyurethane model head [Adams 1981]. Although this
system was highly accurate, with vector displacement errors of less than 1mm between calculated
and control co-ordinates, it was limited by the fact that the target could only be reached along
a trajectory that was orthogonal to the surface (i.e., there was only one possible trajectory).
Furthermore, all marker coordination was done using stereo X-rays and stereophotogrammetry
which is very labour intensive and time-consuming and therefore unsuitable for routine clinical
practice [van Geems].
It is of interest to note that the theory of stereophotogrammetry was first postulated by the French-
born scholar HG Fourcade in a paper read before the South African Philosophical Society
in Cape Town in 1901. Following publication of this method [Fourcade], he produced the first
recorded topographic map using stereoscopic measurements [Adams_2001]. In a remarkable
co-incidence in relation to the work covered in this thesis, the map he produced depicted Devil's
Peak in Cape Town, on whose slopes the Medical School of the University of Cape Town was
founded in 1912 [Louw, JH].
3.3 Radiosurgical Roots
The advent of stereotactic radiosurgery has already been mentioned, with various stereotactic
systems being modified to guide the delivery of radiation. The CTSP may well be the only
stereotactic system where the reverse occurred.
Radiotherapy can be administered using either photons or protons. Both modalities are very
effective at killing tumour cells but are limited by the damage done to healthy surrounding tissue,
which is particularly relevant in the brain. As was mentioned in the profile of Lars Leksell, one
of his many brilliant contributions was the concept of using the precise guidance of stereotaxis
to direct single high doses of radiation to various loci in the brain [Leksell_1951]. This become
known as stereotactic radiosurgery and may be accomplished with two different techniques:
• Multiple X-ray beams (photons) converging to a single point











Photon based therapy is exemplified by two different systems, the Linear accelerator (LINAC)
and Gamma Knife and has achieved much wider application than Proton therapy, which requires
an extremely costly cyclotron. The South African National Accelerator Centre was commissioned
at Faure in the Western Cape in 1986; the cyclotron at this facility, 35 km from downtown Cape
Town, was designed to produce high-energy particles for nuclear physics research, radioisotope
production and radiation therapy with either neutrons or protons. The latter function made it
the only heavy particle facility in the Southern hemisphere, servicing patients referred through
Groote Schuur, Red Cross Children's Hospital and Tygerberg Hospital; this facility is now known
as iThemba Laboratories.
The main accelerator is a variable-energy separated-sector cyclotron capable of producing a
200MeV horizontal beam [Jones]. Protons have a similar biological effect to conventional RT and
are attractive for treating lesions in the brain due to their dose-distribution with a low dose at the
surface, a peak at a predictable depth and an abrupt distal drop-off (the Bragg peak). As it is not
possible to "bend" a proton beam which is therefore in a fixed location, the tumour is placed in
the correct location by translating and rotating the patient [Adams_1999].
Adams and Ruther of the Departments of Surveying and Geodetic Engineering and of Mechanical
Engineering of the University of Cape Town devised a unique stereophotogrammetric patient
positioning system [Adams_ 1989]. The system they devised not only moved the patient into the
correct position, but also monitored for any unwanted movement using multiple charge-coupled
device (CCD) cameras.
The basic principal of the stereophotogrammetric positioning system is that the 3-D co-ordinates
of an invisible point may be described by its position in space based on fixed and visible
landmarks. In the case of a lesion in the brain, these landmarks could be located either on the
scalp or housed in a frame firmly attached to the head and this orthogonal 3-D coordinate system
was established most easily through CT scan or MRI. A patient referred for proton therapy would
undergo a planning CT scan wearing a snug custom-made mask, which contained a number
of 1mm radio-opaque targets or fiducials. Following the scan, retroflective markers are fixed to
the mask exactly over the fiducials. The mask was then fixed to the specially designed chair in
which the patient sat for proton therapy; this chair has 5 degrees of freedom (three translations
and two rotations), enabling precise placement of the tumour in the path of the fixed horizontal
proton beam. This was surrounded by an array of 5-6 black and white CCD cameras connected
to a frame-grabber, capturing video images which were analyzed on a personal computer











patient movement after commencement of treatment so that the beam could be cut immediately
[Adams_1989].
This procedure, termed the "biostereometric method", was found to have a high degree of
accuracy with the mean displacement of the fiducials in the order of 1.0 mm [Levin].
3.4 Stereophotogrammetry in the Operating Theatre
If one thinks of the proton beam as a surgical instrument (as is implicit in the term "gamma knife"
for an equivalent photon beam), it is readily apparent that this methodology could also be used
to guide the surgeon's hand in locating invisible "targets".
Professor Laurie Adams presented his work to a meeting of senior academics in the Faculty of
Medicine at UCT in 1993. He suggested that this technique could be used much more widely and
encouraged clinicians to collaborate with him in developing a stereophotogrammetric-controlled
pointing device (SPD) for surgical use. Professor Jonathan Peter, newly appointed Chair of
Neurosurgery saw a potential application of this concept in guiding the insertion of ventriculo-
peritoneal shunts for treating hydrocephalus. The proximal catheter, which is inserted into the
ventricle, must not only enter the ventricle, but must also follow the correct trajectory so that the
tip is correctly located; this is therefore a vector which can be described in terms of proximal and
distal points.
A project to devise a SPD method that would guide the neurosurgeon in placing shunts optimally
was commenced; an additional aim was to be able to correct for any patient movement during
the planning CT scan. The reason for this was most of the patients for whom this system was











The Proton therapy system required a number of modifications as a mask was clearly impractical
for surgery; four fiducials were therefore attached to the scalp around the region of shunt insertion.
Two CCD cameras were mounted on a portable trolley, which also had a frame grabber, PC and
electronic laser-pointing device. This low power laser was able to demonstrate the vector from
the surface towards the intracranial target, thus guiding insertion of the shunt catheter in the
correct trajectory.
Before surgery, the cameras had to be calibrated using a surveyed control framework [van
Geems]. While this was not a great obstacle, having the fiducials in the operative field certainly
was, particularly with shunt surgery where sterility is paramount. Furthermore, the laser presented
logistic and space disadvantages in the Operating Room. The solution to these challenges was
a simple, small manual pointing aid in the form of a tripod, which could be preset outside the
Operating Room. The first prototype, the "J1" was a particularly small three-legged device, which
was very unstable and clearly unsuitable; although the system was conceptually elegant and
a subsequent iteration (Figure 3.3) was more promising [Adams_1995], this system was never
used clinically.
Figure 3.4: An early version of the Pointer ("J3") mounted on the phantom head used for various
accuracy trials. The tip of the probe is co-incident with the target "intracranial lesion".
An important consequence of this phase of the project however was the realization that the CCD
cameras were in fact no longer required. Adams labeled this development somewhat paradoxically
as "photogrammetry without cameras" and the stage was now set for the emergence of a system











3.5 The principles of the Cape Town Stereotactic Pointer
The mathematical concept
The CTSP is based on the same principle outlined above, namely that the known three
dimensional coordinates of a point in space obtained from one coordinate system (X,Y,Z) can be
described in terms of a second coordinate system (x,y,z) provided that the spatial relationship
between the two systems is known [Adams 1998].
This relationship can be obtained by using markers that can be visualized and co-ordinated
in both systems, for example, radio-opaque targets such as the ball bearings attached to the
patient's head. Using an imaging system such as a CT scanner, one can co-ordinate the invisible
intracranial target with these visible external markers or fiducials in three dimensions (X, Y, and
Z).
The "equivalent" external fiducials (the three foot points of the tripod) can also be co-ordinated in
the second system (x, y, z), which has been previously calibrated. In the case of the CTSP tripod,
this calibration was undertaken using a reflex microscope, a highly accurate instrument with a
measuring precision of +/- 4 micrometers in all three axes [Scott, PJ].
The co-ordinates of the intracranial target, which have been obtained from the CT image, can
readily be transformed mathematically into the CTSP system [Adams_1999], using a centre of
gravity relationship of common points by the matrix relationship:
Where
X, Y, Z' = the three dimensional co-ordinates of a point in system A
X, Y, Z = the three dimensional co-ordinates of a point in system B












The surgical guidance device is a tripod which defines two parallel planes intersected by a vector
(Figure 3.5).
A plane is defined by any three points in 3D space which are not collinear and for this device,
the three footpoints constitute one plane (the distal plane) while the other is swept out by rotation
of the horizontal arm containing the surgical instrument guidance device (the proximal plane),
which is parallel to the distal plane. As these planes are a fixed distance apart, this distance is
known.
A vector, that has an initial and a terminal point, has both magnitude (length) and direction. If a
burr hole has been drilled in order to reach an intracranial target, the line passing from defined
target to the burrhole constitutes a vector.
For the CTSP tripod, this surgical vector can be continued out into space to intersect the two
planes defined by the footpoints and the instrument guide. As will be described, the points at
which this vector intersects both of these planes are the basis of the scaled graphical plot which
is used to set the tripod to the correct trajectory to locate this intracranial target [Adams 1999].
Figure 3.5: An early cartoon showing the design principles of the CTSP, with two parallel planes
described by the footpoints and the horizontal arm, intersected by a vector described by the
instrument carrier. This vector is defined by the trajectory through two points, namely the











3.6 The components of the CTSP
As mentioned at the start of this chapter, the CTSP comprises the following components:
■ a halo incorporating three ball bearings; these serve as the fiducials which are visible
both externally and on imaging with a CT scanner
• computer software developed by Adams and van Geems, now licensed to Fibretek®
■ a three dimensional phantom
■ a three-legged or tripod stool with a swivel head
Before describing the role and development of each of the four specific components, it is worth
considering the central role played by the CT scanner, correct use of which is fundamental to
obtaining a homogenous and therefore accurate set of spatial co-ordinates for the fiducials and
the intracranial target.
3.6.1 The scanners
For all the scanners used in this study, the axial image reflected the X and Y axes, with the X
axis running in the corona! plane (i.e. from side to side) and the Y axis running in the sagittal
plane (i.e. front to back/ back to front). The origin of the axes (i.e. X=0; Y=0) was in the centre
of the screen and it is absolutely crucial not to shift the image in relation to this, or to alter the
position of the co-ordinate grid. The X and Y co-ordinates to an accuracy of 0.1 mm for any
discrete point on the axial image could readily be obtained by activating the screen cursor and
manually positioning this on the selected target, with an accuracy of 0.1mm. Movement of the
table is along the Z axis which runs in the axial plane caudally (i.e. from head to foot) and the
table position, which is displayed on each axial slice to the nearest 1.0 mm, is used as the Z co-
ordinate. The CT imaging plane must be parallel to the XY plane and it is absolutely imperative
that the gantry of the scanner not be tilted.
As will be discussed later, slice width is an important contributor to accuracy and this varies
depending on the technical specifications of the scanner. When this project commenced, the











All Groote Schuur patients (effectively all the adults in this study) were scanned on the CT
scanner in the Radiotherapy department, manufactured by Picker (Model No. 174203). This will
be referred to as the GSH scanner; there were several reasons for using this particular scanner:
■ This was the scanner used to develop the radiosurgery system; hence the biomedical
engineers were familiar with the set-up (and the radiographers were accustomed to the
biomedical engineers!)
■ At the time, this was the most accurate scanner in the hospital. The two scanners in the
Radiology department were not only rather antiquated, but also in constant use for all
emergency and elective clinical work and totally over-loaded; hence any research activity
was out of the question.
Figure 3.6: The CT control room for the GSH scanner; two radiographers are seated at the scanner
console while Dr Allan Taylor enters the stereotactic co-ordinates into the laptop computer (a). A
typical CT surview from this scanner; the level at which the scan was taken is demonstrated by












CT technology has evolved very rapidly and patients scanned at Red Cross Children's Hospital
were scanned on two different scanners (Figure 3.5) with vastly different technical capabilities:
■ From 1994 to 1998, an Elscint model 2400 was used (RXH1)
• From 1998 to 2000, a General Electric ProSpeed S, an early model helical scanner was
used (RXH2)
Figure 3.7: The CT control room for the RXH scanner; two radiographers are seated at the
scanner console while Dr Tony Figaji selects the appropriate image (a). A series of images from
this scanner showing the axial slices and the relevant surviews; the level at which each scan was
taken is demonstrated by a line while the numerical value for the table position, and each X- and
Y- co-ordinate for the selected target on the axial slices, is shown at the top right corner of the
screen (b).
Before doing a clinical case at Red Cross Children's Hospital, a trial phantom was scanned
using the Elscint scanner and the data obtained was quite clearly incorrect. Further investigation
revealed that manufacturers of the early scanners used either "right hand" or "left hand"
configurations for their Cartesian co-ordinate systems as this was not standardized, and the
GSH and RXH scanners were different in this respect. The software was therefore re-written to











3.6.2 Fiducials: from donuts to halo
Stainless steel ball bearings make an ideal fiducial as they are easily visible to the human eye
but also highly radiopaque hence can be identified readily on an X-ray or CT scan. Ball bearings
served as the fiducials throughout this project, and the first method used was direct application
onto the scalp using donut-shaped adhesive discs 18 mm in diameter with a small central
perforation, just large enough to hold the 2mm ball bearing snugly.
The first step was to decide where the optimal site for the burr-hole was; this was considered the
"entry point". There were two reasons for doing this:
a. the safest and simplest trajectory to the intracranial target must be planned, based on an
intuitive understanding of the location of the lesion.
b. the initial planning software generated a printed "setting diagram", the first version of
which was absolutely dependent on having a defined "entry point".
Once the burr-hole site had been selected, this "entry point" was marked with a disc containing
a ball bearing. The setting jig, a three-legged template conforming exactly to the dimensions of
the three legs of the tripod stool which would be used for the surgical procedure, was then placed
against the scalp and a small patch of hair shaved in the region of the footpoint of each leg to
facilitate attachment of the disc to the scalp. The undersurface of each disc was sprayed with
Dow Corning Medical Adhesive B TM , an aerosol silicone adhesive, before being applied with firm
pressure and then numbered to facilitate later identification.
Once the discs were securely attached, the ball bearings were inserted into the perforation.
Attachment of the discs had to be done with great care as misplacement or dislodgement of even
a single disc or its ball bearing would render the whole exercise void and one would have to start
again, but remarkably this never occurred. The patient was then taken to the CT scanner and
positioned with the array of three discs uppermost. A typical arrangement is seen in Figure 3.8











Figure 3.8: Scalp-mounted ball bearings as fiducials. The setting jig (a) and the patient with 4
fiducials attached, one for each of the 3 legs and a central fiducial indicating the proposed entry
point (b). This patient had a larger area shaved as a craniotomy was planned should the smear
have disclosed a high grade tumour. Stereotactic CT scan showing the selected intracranial
target (top left image) and the 4 fiducials (lower 4 images) (c).
Upon completion of the scan, the ball bearing was removed as the three vacated perforations
then served as receptacles for the three feet of the tripod stool. Care had to be taken not to
dissolve the adhesive when prepping the scalp with chlorhexidine/ alcohol; once this had dried,
a sterile adhesive plastic drape was placed over the surgical site.
An alternative strategy was to remove the ball bearings and mark the central holes of each of
the three discs with an indelible pen, after which they were peeled away. The legs would then
be placed directly onto these marks and held in position by an assistant during the surgical
procedure, but this was considered much less reliable.
This system of adhesive discs was used for 30 patients and although no case had to be
terminated because of a problem related to this system, it was not very robust and one was
always concerned that one of the discs might come adrift.
One solution was to place sharp tacks into the outer layer of the skull; the head of each tack
served as the fiducial (Figure 3.9) and the concave upper surface served as a receptacle for
the footpoint of the tripod. There are some ideas that you only try once; although a compact
tapper was manufactured to facilitate controlled placement, it was extremely unappealing to be











Figure 3.9: Tacks as fiducials. Stereotactic CT scan showing a tack serving as the fiducial, with
the head of the tack serving as the centroid.
The solution was very elegant indeed: Dr Allan Taylor suggested that the fiducials be implanted
into a halo, which could be secured onto the patient's head. This had the added advantage of
serving as a stable platform onto which the tripod stool could be mounted. A lightweight halo
was manufactured out of polycarbonate, which was transparent, making the three ball bearings
contained inside easily visible. Although the ball bearings were no longer positioned exactly
where the feet of the stool were, they continued to be referred to as "leg 1", "leg 2" and "leg 3".
The halo was 10 cm in diameter and was able to sit securely on the convexity of the skull, but the
only problem was- how to attach the halo to the scalp?
There were two options- either scalp or cranial fixation. Cranial fixation with self-tapping screws
placed in the outer table of the skull did however provide secure fixation (Figure 3.10) and this
was used in eight patients. Stainless steel surgical screws 2 mm in diameter were sourced and a
hand-held power tool used to drill the hole in the skull. A depth stop was used to prevent plunging
and the screw was securely inserted using the power tool. Two screws didn't provide any greater
stability than one as there was still the possibility of the halo rocking unless it was fixed at three
points or more.
The halo was affixed to the scalp with adhesive medical tape for five cases; but this was bulky
and wasn't considered reliable enough. A hybrid system was also tried, where one screw was











Figure 3.10: Skull-mounted halo, attached with screws. CT surview showing the halo secured
with two screws (a); these had been placed using a hand-held power tool with a depth stop to
prevent plunging (b). Insertion of the screws resulted in secure cranial fixation of the halo (c).
When the solution finally occurred to us, it was somewhat embarrassing that as surgeons we
hadn't thought of it earlier- sutures! In adults the halo was almost invariably applied in the ward;
after prepping the scalp and infiltrating local anaesthetic, four or five 2/0 silk sutures provided
very stable fixation (Figure 3.11). Younger children were anaesthetized before applying the halo
in the Operating Theatre.
Figure 3.11: Scalp-mounted halo, attached with sutures. CT scan showing the target and the 3
fiducials clearly seen within the halo (a) and a different patient with the halo sutured in place and











The prototype halo was manufactured from polycarbonate and therefore could not be autoclaved.
After each case, the halo was cleaned and gas sterilized so that it was sterile at the time of
attachment to the next patient. Although the exact orientation of the fiducials was not of any
importance, as a convention the halo was always positioned with "leg 2" closest to the midline,
in order to facilitate identification on the CT scan.
If one considers the different strategies for mounting the fiducials, the development of the project
went through three sequential phases, with a fourth phase entered when the production system
was introduced:
Phase 1 scalp-mounted adhesive fiducials, with different strategies to prevent loss of
these
Phase 2 fiducials housed in the prototype halo
■ skull-mounted with one or two screws
■ scalp-mounted with adhesive tape
■ hybrid fixation (one screw and tape)
Phase 3 fiducials housed in the prototype halo, scalp-mounted with sutures.











Figure 3.12: Fiducials used for the 115 cases
Phase 1: adhesive fiducials
Phase 2: prototype halo skull-mounted with screws scalp-mounted with tape
Phase 3: prototype halo, scalp-mounted with sutures











3.6.3 A surgical guidance device: The Tripod
This is the effector of the system and served as the interface between the surgeon with a tool
such as a biopsy needle and the patient with a lesion.
As described in Chapter 3.5, the device comprised the following (Figure 3.13):
• A base with three feet, the tips of which defined a lower or distal plane
• An upright post which had an aperture through which slides a radial arm, rotation of
which defined an upper or proximal plane; this radial arm could be locked firmly in place
by a nut mounted at the top of the post
• A swivel head attached to the end of the radial arm via a ball-and-socket connection; this
contained a hollow instrument guidance cannula which could be locked firmly in position,
defining a specified trajectory
Figure 3.13: The prototype tripod Pointer, the J6, with a isosceles triangle configuration to the
legs.
The three legs tapered at the tips and these footpoints fitted snugly into three small holes on the
upper surface of the halo.
The instrument carrier was calibrated by tightening a ball-and-socket joint. The swivel head
comprised two annular plates, which were clamped into position by tightening two screws with
an Allen key, one on the upper surface and one on the lower surface. The outer surface of
the instrument guidance cannula had a spherical construct, serving as a ball-and-socket joint
with the annular plates on either side. This mechanism locked the instrument guidance cannula











A versatile aspect of the CTSP was that various different diameter instruments could be used
through simply changing the guidance cannula in the swivel head as these had differing diameters
and lengths to accommodate instruments varying from biopsy needles to shunt catheters.
As the tripod determined the trajectory of the instrument passed into the brain, it was vitally
important that this should be set correctly. The first prototype tripod stool that was used clinically
was the "J5" which had the three legs arranged as an equilateral triangle. A problem recognized
only at the time of surgery in one of the early cases (Case 4) was a trajectory that quite clearly
was grossly incorrect, hence the biopsy had to be performed freehand. Upon review of the data
later it was apparent that two of the legs had been transposed, but this had not been detected
on the setting diagram, due to the fact that the configuration of the legs (and therefore the
fiducials) described an equilateral triangle, which was aesthetically pleasing but made it possible
to position the frame three different ways, two of which would be incorrect.
The solution was to move legs one and three closer together to describe a isosceles triangle.
The new model was called the "J6" and the problem did not recur.




As the co-ordinates entered into the program were derived from the CT scan, it was crucial that
this was performed correctly.
The patient was positioned comfortably on the CT table, with the head positioned in the standard
head holder; no specific holder was required. Ideally the patient was positioned as they would
be during surgery, with particular care taken to ensure there was no scalp deformation. Ensuring
the patient is comfortable and understands the importance of not moving their head during the
scan is very important; applying soft padding between the patient's head and the head holder,
together with a strip of masking tape gently applied across the head further reduces the chances











A decision was made as to whether intravenous contrast was required; if this would facilitate
target selection, 50m1 of Omnipaque® was administered by the neurosurgeon. Often it was
helpful for the neurosurgeon to gown up and stay in the CT room in order to reassure the patient.
The scanning protocol varied with different scanners over the course of this project, but with the
GSH scanner, a surview was first performed, from which a series of 5mm slices was planned
through the region where the target was located. The optimal table position was noted, then
a series of 2mm scans was done through each of the three or four fiducials, moving the table
manually and determining the optimal position with the help of the low-power laser mounted
in the gantry. The sequence followed was to scan from caudal to rostral, scan at the selected
table position for the target and then re- scan the first fiducial in order to establish that the head
position had not changed during the scan.
The screen cursor was then activated and the X- and Y-co ordinates of each of the 3 fiducials
were obtained. This was a crucial step as great care had to be taken to select the image on which
the fiducial was seen best and the cursor was then positioned at the centroid of the fiducial.
Following this, the images showing the lesion were carefully inspected to select the optimal
target and a second intracranial target was often chosen as well. All these X- and Y-values were
recorded together with the table position as the Z-co ordinate and the slice number. A pro forma
designed by Dr Taylor facilitated data logging and this is shown in Appendix III.
The x, y and z co-ordinates of the three fiducials and the intracranial target are then entered into
the laptop computer, using the software specially written for this purpose. This is a critical step
as an error in entering this data will have disastrous consequences. An optimal routine is to have
two people doing this- one reading out the values while the second enters them, and then these
must be checked before proceeding, as is required by Law for Land Surveyors [van Geems]!
Two different techniques were used to set the pointer. The first entailed generation of a printed
setting diagram, and the second utilized a simple three-dimensional phantom. Whichever
technique was used, the program was run immediately so that the data could be checked and
the trajectory ascertained to ensure it was intuitively correct prior to the patient leaving the CT













The software embodied the three-dimensional mathematical transformations of the co-ordinate
system of the CT scanner into the control system of the Pointer. A mouse driven menu ran
the various programs written in Turbo C while all other programs were written in True Basic
[van Geems], installed on a Compaq Contura/ Aero 4/25 laptop computer. As the biomedical
engineers working on the project also wrote the software, this was updated and amended
immediately a problem was recognized and this really facilitated the goal of making this interface
neurosurgeon-friendly. A "user guide" was written by Professor Adams to facilitate day-to-day
troubleshooting; this took the neurosurgeon through the menu which offered four programs:
1. CT Scan input
2. Stool plot
3. Recalculate entry point- on curved surface
4. Recalculate entry point- on plane
1. CT Scan input The x, y and z co-ordinates obtained from the scanner were entered in the
order: target, entry point, leg 1, leg 2, leg 3 and "played back" as X, Y and Z. If correct,
[Y] (yes) was entered and the program returned to the menu.
2. Stool plot A sequence of simple instructions generated a "setting plot" on the screen;
if this was suitable [PRINT SCREEN] was entered and the setting diagram printed (as
below).
3. Recalculating the entry point on a curved surface This program was to be used in the
operating room if it was necessary to select a new entry point during surgery.
4. Recalculating the entry point on the plane This procedure would be undertaken in the
CT scanner.
The software contained a vitally important accuracy check at this point, the "test of transformation
precision". Because the fiducials are mounted in a halo and therefore always the same distance
apart, it was a simple matter for the program to compute these distances from the co-ordinates
obtained from the CT scan and check how closely these matched the known distances.
As will be discussed later, the CTSP program provided with each system contained this calibration
data (which is identical for every halo as they are all manufactured in exactly the same way) as
well as a second unique set of data which relate to the exact measurements of the phantom and
tripod provided with that particular system. It is absolutely essential that the correct data set is












A number of modifications were made subsequently. One of the situations that had to be dealt
with was when the selected entry point proved unsuitable at the time of surgery. A method was
devised that allowed the neurosurgeon to select a new entry point and then generate a new
setting diagram. In order to do this, the following sequence was followed [van Geems]:
1. The tripod was set at 90° using the T-shaped perpendicular setting tool which was
removed after fastening the ball-and-socket joint and the tripod is then placed in the
surgical field with the feet located in the adhesive discs surrounding the new burr hole.
2. A probe was then passed through the instrument channel and the arm adjusted such
that the tip of this probe lay at the midpoint of the new burrhole. A depth stop is fastened
on the probe at the point where it exits the top of the instrument channel, allowing one to
measure the exact distance the burr hole lies below the tripod.
3. The tripod is then placed on the previously printed setting diagram and a probe used to
mark the position of the burr hole on the setting diagram.
4. The distances from the new burr hole to each of the three legs were easily measured
5. These four measurements (distances of the burr hole from the 3 legs and the distance
from the top of the tripod instrument channel) were entered into the program and a new
setting diagram could be generated in Theatre.
3.6.4.3 The setting diagram
The printed diagram used to set the pointer was the projection of the three footpoints and the
points where the vector intersected the proximal and distal planes onto a 2D plane. This setting
diagram displayed 6 points, with the option of a 7th:
• One for each leg, labeled "leg1, "leg 2" and "leg 3"
• One labeled "P" (proximal)
• One labeled "D" (distal)
• One labeled "T" (target)
• One labeled "E" (entry point) (optional)
A Canon Bubble Jet printer BJ-10SX was used to print the setting diagram. In order to ensure
that the printout was exactly to scale, scaling parameters for the X- and Y- co-ordinates were











Figure 3.14: (a) The setting diagram represents the vector passing from the intracranial target, T,
and continuing to intersect first with the lower plane (described by the three feet of the tripod)
at D, and then with the upper plane (described by the swivel arm) at P. (b) The tripod may be set
perpendicular if for example, should one require an orthogonal trajectory to define the intracranial
target or the entry point, by using the T-shaped perpendicular pointer.
To set the tripod using this diagram one first needed to ensure that the 3 nuts had been loosened
i.e. the nut which locked the sliding radial arm in place and the nuts on the superior and inferior
plates of the ball and socket joint which locked the swivel head in place.
Setting the tripod with the setting diagram required 4 simple steps:
1. The setting diagram was placed on a flat surface and the pointer positioned such that
each of the three legs was on the appropriate point, using the best optimum fit. As
mentioned previously, the configuration was changed from an equilateral triangle to an
isosceles triangle to eliminate the likelihood of mispositioning the pointer.
2. The second task was to align the instrument channel of the swivel head directly above
point P, i.e. the projection of the point where the vector intersects the proximal plane.
This was done by first inserting the T-shaped perpendicular setting tool in the instrument
channel, which kept the swivel head at 90°, and then tightening the ball and socket joint
clamp. The most efficient procedure was to tighten the inferior nut "finger-tight" and then
use the Allen key to tighten the superior nut. The nut securing the radial arm where it
traversed the vertical post was locked once the instrument carrier was in the correct











3. The third task was to define the vector from point P to point D (i.e. where it intersected
with the lower plane). This was done by loosening the nut on the superior plate of the ball
and socket joint, inserting a long straight stainless steel probe through the instrument
channel in the swivel head and then gently angling this until the tip rested exactly on point
D; the swivel head was now locked in position by again tightening the superior nut.
At this point, the trajectory of the tripod should clearly be in the direction of the intracranial
target.
4. The final task is to calibrate the depth to which the cannula was to be inserted into the
brain. The distance from the top of the instrument carrier to the intracranial target was
given on the printout and this was then set on the cannula by measuring this distance
from the tip with a ruler and then sliding a depth guide along the shaft, gently locking it in
place at the measured distance. Care had to be exercised in doing this as tightening the
screw too much would permanently damage it, leaving an indentation.
Figure 315: A depth stop is applied to the biopsy needle with gentle pressure after measuring the
required depth with a ruler.
The tripod was now placed on the patient's head and the trajectory checked to ensure that
it was intuitively correct. This was an absolutely vital step as the software was able to detect
errors in the co-ordinates of the fiducials but was not able to detect an error in the target co-
ordinates. A three dimensional phantom was designed as an extra check prior to surgery, but
to the neurosurgeons it seemed that this was a much easier method of setting the tripod and











3.6.4.4 The 3D phantom
The setting diagram presented a number of challenges. It was quite a fiddle to set the pointer
accurately and in order to do so in the operating theatre, the printout had to be placed under
a sterile sheet of transparent plastic as it wasn't sterile. This printout did in fact serve as a
permanent record, which was useful for documentation.
As the central concept was to replicate the three-dimensional space of the patient in order to set
the trajectory on the pointer, it was suggested that this could be done using a three-dimensional
phantom. The initial idea was to use this as a back up to check the trajectory determined by the
setting diagram, but as it was so simple to use the phantom, this soon became the preferred
technique.
The 3D phantom was made out of stainless steel and was therefore autoclavable. It consisted
of a flat surface containing three small holes corresponding to the legs of the pointer. The top
surface had a large opening and was mounted on four posts; one of these had a millimeter ruler
which served as the z-axis. The axis running parallel to the anterior aspect of the base (in the
corona) plane) was the x- axis and the y-axis was on the same axial plane but ran from front to
back (in the sagittal plane); each of these axes also had a stainless steel millimeter ruler.
A metal block served as the intracranial target with a 1mm wide hole on the upper surface giving
the exact location of the target. After calibrating the phantom for the z co-ordinate (depth below
the platform) and the x co-ordinate, the procedure was completed by sliding the target block
along the y-axis to the calculated co-ordinate value.
The software had needed to be modified to give the x, y and z values for the intracranial target so
that they could be set directly on the phantom. Each is set in turn by moving the marker shown












Figure 3.16: The printout giving readings for x-, y- and z- coordinates (a) to be set on each of the
axes of the 3D phantom (b); the prototype 3D phantom with the tripod set such that the instrument
passes through the burr hole indicator (c).
The tripod was then mounted on the platform with a long straight stainless steel pointer running
through the instrument carrier and resting in the target hole. The nut atop the vertical post was
tightened first, locking the sliding arm in place and then the swivel head was locked, securely
setting the trajectory.
One limitation of this arrangement was that the trajectory to the intracranial target had to pass
through the gap in the centre of the platform. This in fact was an advantage in real terms as
it avoided having a trajectory which was particularly angled and therefore more likely to be
inaccurate.
If the burr hole is not centered or the trajectory is angled, the position of the burr hole could be
replicated on the phantom using a small circular loop at the tip of an adjustable arm mounted
on the phantom. This was easily performed; after completing the burr hole, the swivel head was
set at 90° as described earlier and the tripod mounted on the halo. The steel probe was passed











depth stop. With the tripod then mounted on the phantom, the tip of the steel probe marks the
position of the burr hole. The small circular burr hole indicator is then positioned at the tip of
the probe and the trajectory of the tripod adjusted until the probe passes through the burr hole
indicator to the target.
It is important to emphasize that the software that accompanies each CTSP system contains
a set of calibration data which is unique to each system. This data represents a set of exact
measurements made of the tripod and phantom following manufacture; although these are all
machined in exactly the same way, there are small individual variations which may adversely












This data set is shown in Figure 3.17 and represents the following measurements:
1. The three sets of x-, y- and z- co-ordinates all relate to the halo, with "leg 1" as the
datum point. Z.0 for all as the legs are all on the same plane when measured.
2. The next three values relate to the tripod:
Sp1= the height from the tip of the tripod leg to the centre of the ball in the tripod
arm
Sp2= the proximal length of the biopsy guide tube (from the centre of the ball)
Sp3= the proximal length of the cutoff guide tube (from the centre of the ball)
3. The last three values relate to the 3D phantom.
4. Px, Py, Pz = the zero settings for the phantom when the target block sits directly
under leg 1.
3.6.5 The Operation
Once the neurosurgeon was satisfied that the planned trajectory of the tripod looked correct,
the patient was taken to the Operating Theatre, or to the ward if there was going to be a delay in
starting the case.
There was sufficient time to autoclave the tripod and the various peripherals such as biopsy
needles and depth stops, the ruler and the other peripheral instruments and attachments while
the anaesthetist took care of the patient. Anticonvulsants and steroids were administered if
there was an appropriate indication, and an intravenous dose of an antibiotic was given if the
neurosurgeon requested this.
The disc marking the entry point was removed and the scalp was prepped by the neurosurgeon
with chlorhexidine and alcohol in the usual fashion with particular care taken to ensure that the
other adhesive discs marking the footpoints were not dislodged. Once the halo was introduced
this was no longer an issue and the entry point was also no longer specified. A solution containing
long acting local anaesthetic and a vasoconstrictor (Marcaine® and Por-8 ®) was infiltrated with
care taken not to do this too close to the fiducials so as not to displace them. The surgical site
was then covered with an OpSite® adhesive drape, which was initially applied in the centre and












If the printed setting diagram was to be used to set the tripod, this was placed on the surface of
a table and covered with an OpSite® adhesive drape. Once the 3D Phantom was introduced, this
was no longer required as the phantom was autoclaved (Figure 3.18). It was always necessary to
re-set the tripod prior to surgery as all the clamps were loosened prior to autoclaving to prevent
damage due to the high temperatures.
The scalp incision was usually made in the centre of the halo and the edges held apart with a
small self-retaining retractor. The pericranium was gently scraped aside and the Hudson Brace
used to drill a 12 mm diameter burr hole. Prior to incising the dura, the tripod was set and
positioned to ascertain the trajectory; on rare occasions it was necessary to nibble the edge of
the burr hole with a Leksell rongeur if the trajectory was quite oblique. At this point the instrument
to be passed into the brain was also checked; if a biopsy was to be taken, the depth to which
the needle would be inserted was set by applying a depth stop to the shaft. The depth stop was
typically placed 5-10 mm short of the calculated depth as biopsy would not be taken from the tip
of the needle, but 5-10 mm proximal to the tip and this therefore needed to straddle the target.
Once the neurosurgeon was satisfied that the procedure could be performed, the dura was
incised, a small opening made in the pia with bipolar electrocautery and the procedure performed
Figure 3.18). Various different biopsy needles were used, as will be discussed in Chapter 6;
techniques for placing catheters in cysts, aspirating abscesses and performing stereotactic
craniotomies will be described elsewhere.
Figure 3.18: Surgery. The trajectory of the tripod is checked in the Operating Theatre prior to
performing the biopsy (a). The self-retaining retractor must be carefully positioned so as not to
displace the halo (b); the tripod is coupled to the halo and biopsy is taken by aspirating gently












The CTSP developed out of close collaboration between biomedical engineers and
neurosurgeons, with important input from colleagues including radiologists and radiographers
as well as theatre nurses. This process transformed a conceptually novel but unwieldy prototype
into a potentially useful neurosurgical device; the main features of this were the four sequential
phases for securing the fiducials, and the introduction of the 3D phantom.
The CTSP was well tolerated by patients as the halo was so small and light. The drawbacks of a
heavy conventional stereotactic frame have long been recognized [Austin]; a recent contribution
described the use of a lightweight customized (and presumably rather costly) miniature
stereotactic platform which also had a tripod configuration and was attached to three skull-
implanted fiducials [Fitzpatrick].
Furthermore, the four sequential steps for using the system were intuitive and simple, making
the CTSP attractive to busy neurosurgeons who were not specialists in the field of stereotaxis.
As accuracy was the most essential determinant of whether this system would be clinically
effective, this was rigorously evaluated in the laboratory prior to clinical application. This
laboratory accuracy data was an important component of Dr van Geems doctoral thesis, but the
salient findings will be summarized in the next chapter as this was critical in laying the foundation














"The purpose of incorporating stereotactic methodology into neurosurgical operations is to
achieve a consistently high degree of accuracy in localizing intracranial targets" [Maciunas 1994].
In view of this, the first question any neurosurgeon will ask when looking at a stereotactic system
is "What is the accuracy?"
In a landmark series of experiments at Vanderbilt University, Maciunias and Galloway rigorously
asked this question of four of the most commonly used stereotactic systems, having unambiguously
defined the appropriate terminology [Galloway 1991, Maciunas 1991, Maciunas 1994];
• Accuracy refers to the ability of the system to provide the true location of a point in
space; this encompasses both unbiasedness and precision
• A series of observations that have a minimum of spatial error and tend to the true value
are without skew or "unbiased"
• Precision reflects the variability of the system in repeatedly localizing the same point in
space Le. reproducibility or ability to return to the same location.
A system can be precise but still inaccurate if there is a large degree of bias in its measurements
[Benardete_2001].
Manufacturers readily claim sub-millimetric accuracy but what they are referring to is the
mechanical accuracy of the device; published performance specifications for stereotactic devices
call for submillimetric mechanical accuracy [Galloway 1991]. In manufacturing the production
version of the CTSP, the machinist has to be within tolerances in the order of 0.05- 0.10 mm
[Mundell PJ, personal communication]. Although this is an essential foundation for a clinically
reliable stereotactic system, accuracy in practice encompasses a much wider range of factors.
4.2 Application accuracy
While one cannot simulate all the actual operative factors in a laboratory experiment, an attempt











application performance or application accuracy by the Vanderbilt group [Maciunias 1991,
Maciunas_1994].
A multitude of factors may affect the accuracy of a stereotactic system; some will be specific to
the particular system used, but some are generic and apply to all stereotactic systems.
One of the more important of these generic factors is the scanning protocol, the impact of
which can be readily quantified using a phantom. The role of slice width was clearly shown in a
study where a phantom was scanned at slice thickness varying between 5.0 mm and 1.5 mm
with interscan spacing varying from 3.0mm to 0.5mm; mean error decreased by 23% as slice
width diminished and by 45% as interscan spacing diminished [Bucholz]. At a slice width of
1.0mm, the major stereotactic systems may still have an appreciable error, as shown in Table 4.1
[Maciunas 1994]. As imaging technology has continued to improve, slice width has fallen below
1 mm with contemporary scanners, some of which have a voxel size of around 0.5mm 3 .
Measurement BRW CRW Compass Leksell
(millimeters)
Mean 1.9 1.8 1.2 1.7
Standard deviation 1.0 1.1 0.6 1.0
Minimum value 0.1 0.0 0.3 0.2
Maximum value 5.0 4.9 3.2 4.9
95% CI 3.6 3.6 2.2 3.4
99.9% CI 5.0 5.2 3.1 4.8
Table 4.1: The application accuracy of four stereotactic frame systems when using a 1mm slice
width CT scan protocol (from Maciunas_1994]). The application accuracy fell markedly with either
angulation of the gantry or increasing the slice width.
Less easy to quantify is the accuracy of an actual surgical procedure, although it has been
suggested the position of the probe tip could theoretically be localized by radiography
[Kitchen 1993]. This group noted that postimaging brain distortion could be due either to
physiological or physical factors [Dorward_1998]; physiological factors included manipulation
of blood volume, use of diuretics and ventilation, while physical factors encompassed patient
positioning, gravity, withdrawal of CSF or other intracerebral tissue. The effect of gravity when











An elegant study using MRI demonstrated that changing from supine to prone resulted in a
registration error of around 2mm, leading the authors to recommend that patients should ideally
be scanned in the same position that will be used for surgery [Rohlfing].
Intraoperative brain shift during stereotactic brain biopsy may be observed utilizing intraoperative
MRI and the following classification has been proposed [Bernays]:
1. inward (due to atrophy) or outward (due to raised ICP) shift of the brain surface
2. shifting of the target, particularly with small firm lesions, or those with a firm capsule
3. midline shift occurred following decompression of cystic or necrotic masses
A simpler approach to verifying the intracranial position of the instrument is to implant a silicon
sphere which can be detected on the postoperative scan [Alesch]. One way to verify accuracy is
by comparison of the preoperative and postoperative scans as there is often a small gas locule
or dot of haemorrhage at the biopsy site, but this is difficult to do unless both scans are done in
the same fashion, ideally on the same scanner. This was seldom the case in this series, as the
stereotactic scan was only done on the same scanner as the preoperative scan in five paediatric
biopsies.
4.3 Laboratory testing of the CTSP
As outlined in Chapter 3.6, three different stereotactic methodologies were considered in the
evolution of the CTSP. These were the initial Stereophotogrammetric Pointing Device (SPD),
followed by the introduction of the tripod with the stereophotogrammetric system for backup, and
ultimately the CTSP as a stand-alone device. At each step of this process, laboratory tests were
conducted to assess the accuracy of the system and these have all been detailed in Barbara
van Geems doctoral thesis [van Geems]. As the data pertaining to the stand-alone CTSP is
considered highly relevant to this thesis, the results will be summarized here.
4.3.1 Accuracy of the CT Scanner
As the CT scanner was used as the measuring device for these tests, it was important to first
establish how accurate this is. All accuracy tests were performed on the previously described
Picker CT scanner (the "GSH scanner") which had a minimum slice thickness of 2.0 mm and a











It has been pointed out that there is a common misconception that if you have slice thickness
N, system accuracy cannot be better than N [Galloway 1991], and van Geems calculated the
measuring accuracy for this scanner to be 1.5mm using this protocol [van Geems, p91].
4.3.2 Phantom Head Study
The first experiment to establish application accuracy entailed scanning the black phantom head
which had been used for the development of the SPG system (Figure 3.2). This was secured on
the CT table and scanned, following which a setting diagram was generated, the tripod calibrated
and a needle inserted into the head. Van Geems concluded "from repeated phantom trials, the
pointer tip placement was in the range of 2mm" [van Geems, p96].
This experiment was conducted prior to the first clinical applications and although it was
reassuring, the phantom only had a single fixed target and a more comprehensive laboratory
accuracy test was requested by the neurosurgeons once the halo was introduced.
4.3.3 Ring Phantom Study
A test phantom was designed with a polycarbonate halo identical to the prototype used clinically;
this was rigidly mounted on three posts, above a platform which contained narrow twelve plastic
posts of different heights, each of which had a 2 mm ball bearing mounted on its summit (Figure
4.1). These targets were therefore distributed over a wide volume of "intracranial" space.
Figure 4.1: The ring phantom
An "error free" set of 3D co-ordinates for the 3 fiducials and the 12 targets could be obtained
using the reflex microscope which, as previously mentioned, has a measuring precision of 4











Van Geems describes the approach as follows: "Using the three leg markers as the common
points between the CT scan system and reflex microscope system, the 3D coordinates of the
12 lesion markers were transformed into the reflex microscope system, using the Rodrigues
transformation" [van Geems, p97].
These results are shown in table 4.1, and show the accuracy of the measuring system alone,
prior to testing the CTSP.
Marker Difference in X Difference in Y Difference in Z Vector difference
(mm) ( mm) (mm) (mm)
Fiducial 1 -0.7 -0.0 -0.3 0.7
Fiducial 2 +0.2 +0.0 +0.3 0.4





0.6 0.0 0.3 0.2
Target 1 -1.5 -1.4 -0.8 2.2
Target 2 -0.1 -0.3 -1.1 1.1
Target 3 +0.1 -0.7 -1.2 1.4
Target 4 -0.4 -0.9 -0.6 1.2
Target 5 +0.1 -1.3 -0.7 1.5
Target 6 +0.1 -1.0 -0.5 1.1
Target 7 +0.1 -0.9 -0.4 1.0
Target 8 -0.2 -0.9 -0.6 1.1
Target 9 -0.7 -1.6 -0.6 1.9
Target 10 -1.1 -0.2 -0.2 1.1
Target 11 +0.0 +0.2 -1.1 1.1
Target 12 -0.3 -1.6 -0.7 1.8
Mean values
-0.3 -0.9 -0.7 1.4
Standard deviations
0.5 0.6 0.3 0.4
Table 4.1: Precisions for the Rodrigues transformations for the three fiducials and the twelve











The X-, Y- and Z- coordinates for each target point were then entered into the computer and a
setting diagram produced for each target. The tripod was calibrated for each of these points
and coupled with the halo atop the ring phantom and a probe passed to the calculated depth. A
small blob of putty had been placed on top of each target and the exact position of the tip was
established by the indentation made in the putty. After this had been done for 11 of the targets
(the 12th could not be reached as it was behind a pillar), the phantom was examined in the
reflex microscope; the results are shown in Table 4.2 with the vector difference being the actual
distance between each target and the corresponding indentation. Van Geems highlighted the
fact that the mean values were similar to those found in the previous experiment (table 4.1), but
the standard deviations were larger. She concluded: "...the overall accuracy decreases from a
mean of 1.3 and a standard deviation of 0.4, to a mean of 1.8mm with a standard deviation of
0.3mm" [van Geems, p 99].
Marker Difference in X Difference in Y Difference in Z Vector difference
(mm) (mm) (mm) (mm)
Target 1 +0.8 -0.2 -1.7 1.9
Target 2 -0.7 +0.2 -1.6 1.7
Target 3 -0.4 +0.7 -0.8 1.2
Target 4 -0.9 +0.7 _0.6 1.3
Target 5 _0.8 -1.7 -0.3 1.9
Target 6 +1.2 -1.2 -0.5 1.7
Target 7 -0.2 -0.8 -1.0 1.4
Target 8 +0.1 -2.2 -1.8 2.8
Target 9 -0.6 -1.3 -1.3 2.0
Target 10 -0.4 -1.5 -0.0 1.6
Target 11 -0.6 +0.3 -2.3 2.3
Mean values
-0.2 -0.6 -1.1 1.8
Standard deviations
0.7 1.1 1.5 0.3
Table 4.2: Differences between the actual position of each target and the tip of the tripod, set for











Once the 3D phantom had been introduced into clinical practice as a back-up to calibrating the
tripod using the setting diagram, it became apparent that this could also be used to calibrate the
tripod. Prior to introducing this into clinical practice, it was necessary to ascertain the accuracy
of this method, using the same protocol used to check the accuracy of the setting diagram
method. The data are shown in Table 4.3; van Geems concluded: "the mean vector difference for
reaching a lesion marker is 1.9mm, with a standard deviation of 0.6mm, with the greatest vector
error of 2.6mm" [van Geems, p116].
Marker Difference in X Difference in Y Difference in Z Vector difference
(mm) (mm) (mm) (mm)
Target 1 -0.6 +0.4 -1.4 1.6
Target 2 +1.0 +0.0 -1.6 1.8
Target 3 +0.9 -0.2 -1.8 2.1
Target 4 +0.7 +0.5 -0.7 1.1
Target 5 +1.0 -0.1 -1.5 1.8
Target 6 +1.5 +0.2 -1.0 1.8
Target 7 +1.0 +0.5 -1.3 1.7
Target 8 +0.9 +0.9 -1.3 1.8
Target 9 +0.7 -0.7 -2.3 2.5
Target 10 +0.4 -1.4 -0.9 1.7
Target 11 +1.6 +0.4 -2.0 2.6
Mean values
+0.8 +0.1 -1.4 1.9
Standard deviations
0.6 0.1 0.4 0.6
Table 4.3: Differences between the actual position of each target and the tip of the tripod, set for
each target using the 3D phantom [from van Geems, p1161.
These results indicate the accuracy of the CTSP under the best possible circumstances- patient
movement during scanning is not a factor and there is no possibility of the halo moving in relation
to the targets.
Consideration was given to conducting a study using formalin-fixed heads in the manner as
described by others [Dormont, Whittle], but it was felt that this would pose substantial logistic











4.4 Specific factors affecting clinical accuracy using the CTSP
As with all stereotactic systems, the neurosurgeon has to be aware of all potential sources of
inaccuracy, throughout the procedure. Of course, familiarity leads to facility and the more the
system is used, the less likely these avoidable errors will occur.
i. Application of the halo
Patient movement
Patient movement is restricted with conventional stereotactic frames as they are bolted to the
scanner table and operating table. This is not without its own problems, as the weight of the
head is considerable and its position can shift in relation to frame over the period of time from
application, through scanning to surgery [Maciunas_1994  994].
Adams and van Geems' early development of a stereophotogrammetric system to track patient
movement has already been described. This technique was considered overly elaborate for
point stereotaxis where scanning times were short and patients readily understood the need
to lie still and were reminded of this by a single strip of masking tape lightly draped across
their head. Very young patients underwent general anaesthesia for attachment of the halo and
performance of the CT scan.
Scalp movement
Such skin-surface markers do contain an important potential source of error due to movement
of the scalp [Galloway_2001]. This may be normal to the skull surface due to skin swelling (such
as following infiltration) or skin drying, or may be tangential due to traction on the scalp from the
headrest or drapes.
A number of modern "frameless" stereotactic systems use adhesive fiducials attached to the
skin of the face and scalp. The fiducials used here have a fixed relationship with each other as
they are housed in the halo, but great care must still be taken to avoid scalp movement. The
starting point is to mount the halo securely, ideally over the frontal and parietal eminences where
it sits best, and then position the patient appropriately in the scanner and on the operating table.
Trajectory
Selection of halo position in relation to target will determine the trajectory to the lesion. The more











applying the halo. The burr hole (or "entry point") must be within the halo.
ii. CT Scan
Patient movement will be detected by the test of transformation precision, but this will not detect
movement of the halo by scalp deformation. It is best to scan the patient with the head in as close
a position to that planned for surgery. Usually this will be with the halo uppermost; not only does
this diminish traction on the scalp, but also prevents any gravity-induced brain shift from altering
the position of the intracranial target.
The role of slice width has already been alluded to and it is vital that the gantry of the scanner
NOT be tilted.
When the screen cursor is activated, it is important that the centroid of the fiducial be clearly
identified and the most appropriate target selected. Misidentification of fiducials will be detected
by the software but wastes time as the data has to be re-entered.
iii. Data entry and calibration of the tripod
It is i mportant to check that the units of table position and on-screen cursor the same. The data
should be entered by two people and once data has been entered, this should be checked again.
Calibrating the 3D phantom
The target block must be positioned at the correct X-, Y- and Z-co-ordinates; although the scale
is given in millimeters, 0.5 mm increments are feasible.
Setting diagram
Should the setting diagram be used to set the tripod, the 3D phantom can be used to check the
trajectory, but one cannot do the reverse, i.e. use the setting diagram to check the 3D phantom-
determined trajectory.
Setting the tripod
It is absolutely essential that the sequence described is followed:
1. tighten the nut on top of the post, securing the radial arm as this has a tendency to tilt the
long arm upwards and this must be secure before the instrument guide is set
2. tighten the ball and socket joint holding the instrument guide using the Allen key to secure












If done in reverse, there will be a tendency for the radial arm to tilt upwards by 1-2 mm which may
be magnified at the tip given the angular setting; this is usually apparent at the time of setting
the device, and will always be obvious if the tripod is placed on the 3D phantom as a final check
immediately prior to introducing the instrument into the brain.
It is important to remember that even a slight misangulation can translate into a large angular
displacement at the tip [Maciunas 2000].
iv. Surgery
The patient must be draped so as not to displace the halo, which is readily secured with steridrape;
applying the steridrape in the centre and then gently tucking it over the rim of the halo works best.
The importance of burr hole placement in diminishing the effects of scalp retraction have been
mentioned.
Once ready to perform the procedure, the assistant must hold tripod in place carefully without
shifting the halo. Meticulous technique is required in setting of depth stop accurately and using
the biopsy needle correctly.
As previously discussed, the various intraoperative events that may cause brain shift should be
avoided, such as avoiding the ventricle, recognizing tissue displacement and using appropriate
anaesthetic techniques.
v. Components
The production version of the CTSP is manufactured to high standards, compliant with the ISO
90 process and although minimal maintenance is required, deformation of any of the instruments












This laboratory study showed a mean vector difference of 1.8mm with a standard deviation
of 0.3mm using the setting diagram to set the tripod; using the 3D phantom this decreased
marginally to 1.9mm with a standard deviation of 0.6mm, with the greatest vector error of 2.6mm.
This level of accuracy was considered sufficient for clinical application.
When considering accuracy in the clinical context, it is helpful to consider Gildenberg's proposal,
that one ask "How accurate do I need to be today?" [Gildenberg_2001]. There is clearly a
"hierarchy of accuracy" with increasingly elaborate systems [Kitchen 1993], and matching
the complexity of the intervention to the problem at hand is sensible. If one is approaching a
small lesion in a critical or deep location, the answer to Gildenberg's question is obviously "very
accurate", but if one is biopsying a hemispheral tumour, perhaps there is more margin for error.
When using the CTSP, the "test of transformation precision" is an appropriate moment to reflect
on this question; often the "error" between the legs will be below 1 mm, but if it is greater than
1 mm, one needs to give consideration to repeating the scan.
The most useful "real world" reflection of application accuracy is an analysis of results in clinical
practice, which was a major purpose of this dissertation. One way to frame that question is to ask
how often the procedural goal was met, and this will be addressed in the next chapter. Safety,
as reflected by the frequency and severity of complications, is another very important issue that












Overview of Procedures performed
5.1 Overview and Methods
Data was prospectively recorded during the development phase of the Cape Pointer from
June 1994 until June 1998; this comprised 76 patients who underwent a total of 83 stereotactic
operations. The operative logs were subsequently retrospectively reviewed to capture a further
24 patients who underwent stereotactic surgery over the period June 1998 until June 2000,
following the installation of the first commercially manufactured Cape Town Stereotactic Pointer.
This comprised a further 24 patients who underwent a total of 32 stereotactic operations.
As described in Chapter 3.6.2, the evolution of the CTSP over this six year period comprised four
sequential phases, corresponding to four different arrangements for housing the fiducials:
Phase 1 June 1994 - May 1995 adhesive fiducials attached directly to the scalp
Phase 2 June 1995 - June 1996 fiducials in prototype halo, skull-mounted with a
screw in the outer table or scalp-mounted with tape
Phase 3 July 1996 — June 1998 prototype halo, scalp-mounted with sutures
Phase 4 July 1998 — June 2000 production halo, scalp-mounted with sutures
Demographic details were recorded as well as the clinical presentation and course, imaging
findings (characteristics of the intracranial lesions, number, location and size), surgical operation
(hospital, anaesthesia, details of the surgery performed), postoperative course, complications
and outcome. Hospital folders (including microfilmed records where necessary), Radiotherapy
departmental folders, and Radiology departmental records were reviewed for each patient. This
data was entered on an Excel spreadsheet, a summarized version of which may be found in
Appendix I.
A data sheet was used to log details at the time of the stereotactic CT scan; this scan was












The indications for surgery in 100 patients included biopsy or aspiration of a lesion, implantation
of a catheter to decompress a tumour cyst or divert CSF and craniotomy to resect a tumour
(Figure 5.1).
An intracranial mass was biopsied in 65 patients while 14 patients underwent cannulation of
a craniopharyngioma for implantation of an Ommaya reservoir. Fifteen patients underwent
aspiration of a collection, most commonly an abscess (12); and a small number underwent





















A neoplasm was present in 75 patients, most commonly an astrocytoma (36), while 15 patients
harboured a cerebral metastasis and 14 had a craniopharyngioma. CNS infections, most
commonly cerebral abscesses, accounted for 18 cases and hydrocephalus was treated in 3
patients. Two of the remaining 4 patients had infarcts, one had a giant capillary cavernous
angioma and one had basal ganglia calcification due to tuberose sclerosis.
Due largely to challenges in making a histopathological diagnosis, particularly early in the series,
there was a difference between the initial diagnosis and the patient's final diagnosis, and this is
shown in Table 5.1.




Grade III 15 16
Low grade 5 6
Metastasis 16 15
Craniopharyngioma 14 14
Other primary tumour 7 10
Infection 15 18
CSF abnormalities 3 3
Other 1 4





Table 5.1: Initial diagnosis and final diagnosis in 100 patients. Astrocytomas were graded












These 100 patients underwent 115 operations, of which 72 were biopsies (62.6%), while 18
lesions such as abscesses and parasitic cysts were aspirated (15.7%). Intracranial catheters
were introduced under stereotactic guidance in the remaining 21.7% of cases; either to implant
an Ommaya reservoir in a cystic craniopharyngiomas in 18 instances (15.7%), divert CSF in 4
cases (3.5%) or guide stereotactic craniotomies in 3 cases (2.6%).
Thirteen patients underwent more than one stereotactic procedure, with 11 patients having two
operations and 2 having three operations.
Seven patients each underwent two successful operations; three patients with brain abscesses
required a second procedure to tap a new collection (Cases 61, 89 and 93), two patients
underwent a second stereotactic insertion of an Ommaya reservoir (Cases 3 and 71) and repeat
surgery for CSF diversion was required in one child (Case 55). Two biopsies were repeated, in
one case for a new lesion (Case 40) and in the other, for new symptoms (Case 42).
Two patients underwent successful implantation of an Ommaya reservoir following an initial
unsuccessful operation; the first patient required revision of a catheter which had been misplaced
at the first operation (Case 48), while the second experienced a significant haemorrhage
necessitating termination of the first procedure (case 80).
One patient underwent two biopsies that were both non-diagnostic (Case 75), while two patients
each underwent a third biopsy following two biopsies that failed due to incorrect use of the
system. The third biopsy was diagnostic in one patient (Case 77), while in the other it was
partially successful in that histology was abnormal but inconclusive (Case 79). These cases are











No Dates Reason for repeat surgery
3 19940707 New loculated craniopharyngioma cyst Both successful
19950119 developed, separate from previous Ommaya
reservoir
40 19961205 Biopsy of new lesion Both successful
19970825
42 19970116 Re-biopsy of lesion for new symptoms Both successful
19971106
48 19970422 Misplacement of catheter when cannulating 2^d procedure successful
19970429 craniopharyngioma
55 19970728 Revision of ventricular catheter Both successful
19970814
61 19970912 Re-accumulation of abscess Both successful
19970916
71 19980206 Re-siting of catheter in craniopharyngioma to Both successful
19980226 avoid traversing ventricle
75 19980317 No diagnosis Both failed
19980324
77 19980720 No diagnosis 3rd biopsy successful
19980728 No diagnosis
19980817
79 19980921 No diagnosis 3rd biopsy partially
19980929 No diagnosis successful
19981012
80 19981006 First operation to implant Ommaya reservoir 2nd procedure
19981103 in craniopharyngioma terminated because of successful
haemorrhage
89 19990518 Re-accumulation of abscess Both successful
19990603
93 19990806 Re-accumulation of abscess Both successful
19990811











The 100 patients comprised 53 males and 47 females.
Twenty two of the patients were children aged 16 or younger, who underwent a total of 27
stereotactic procedures (23.5% of the total).
Five of the patients were adults aged 70 or older.
The median age of the cohort was 36 years, as was the mean age.
5.6 Clinical presentation
Details of each patient's presenting symptoms and signs were documented.
As all the patients had an intracranial space-occupying lesion, it is not surprising that headache
(53%) and focal deficits (50%) were most commonly noted.
Altered higher mental function (drowsiness or personality change) prompted investigation in 31%
while 30% had seizures.
Visual symptoms, most commonly reduced acuity and diplopia, occurred in 19%, while 14% had











Presenting Astrocytoma Astrocytoma Metastasis Craniopharyngioma Other Infections Other
symptom* I/11 (n=6) III/IV (n=30) (n=15) (n=14) tumour (n=19) (n=6)
(n=10)
Altered 14 4 4 5 5
mental
status
Headache 1 17 8 11 4 10 2
Seizures 3 11 5 4 8
Focal 4 13 11 2 7 12 1
I deficit
Visual 1 3 3 10 2
symptoms
Other 1 6 3 4
Table 5.3: Presenting symptoms of patients sorted by diagnosis.
* a patient may have presented with more than one symptom.
5.7 I maging findings
5.7.1 Enhancement characteristics
A varying degree of enhancement of the lesion on CT scan following administration of IV contrast
was seen in 90 cases. Of these, 13 enhanced uniformly and avidly, 35 enhanced inhomogenously
and 28 showed peripheral "ring enhancement". Fourteen cystic suprasellar tumours showed
enhancement as well as calcification in either the associated solid component or the capsule.
Five low density lesions did not enhance at all and five lesions were CSF density collections.
5.7.2 Location
The targeted lesion was located in the right hemisphere in 51 cases (44.3%), the left hemisphere
in 31 cases (27%) and the midline in 33 cases (28.7%).
The majority of lesions were deep (45.5%), with 19 suprasellar lesions, 13 lesions located in the
genu, rostrum, body or splenium of the corpus callosum, 2 lesions in the midbrain and 1 in the
quadrigeminal cistern. The lateral ventricle was the target in 5 cases (4.3%), 24 lesions were in
















Basal ganglia and thalamus 12 5
Lateral ventricle 3 2
Deep white matter 17 7
Subcortical white matter 10 6
Superficial Cortex 7 11
Total 51 33 31
Table 5.4: Anatomical location of lesions
5.7.3 Volume
As stereotaxis was generally only used when a freehand approach was considered likely to fail,
or had failed, the lesions were generally small.
Volume was estimated as for a spherical structure by multiplying the largest cross-sectional
diameters in three planes, multiplied by ri/6 ({X*Y*Z}*{22/42}) [Bernays].
Lesions ranged in volume from 0.52 ml to 70.7 ml, with a mean volume of 14.5 ml and median
volume of 9.4 ml (interquartile volume 4.2 ml — 18.8m1).
The distribution of lesion volumes is shown in Figure 5.3; the values on the abscissa reflect
lesion volumes based on an average diameter of 10mm (5_0.53m1); 10-20 mm (s4.2m1); 20-30











Figure 5.3: Distribution of lesion volumes (n=113)
5.8 Management
The majority of operations took place at Groote Schuur Hospital (88.7%), while 13 (11.3%) took
place at Red Cross Children's Hospital.
5.8.1 Surgeons
In all, 19 surgeons were involved in these cases with a cumulative number of 200 surgeons/ 115
cases. At least one of the two neurosurgeons (AGF and AGT) involved in developing this system
performed each of the first 32 cases and these two surgeons participated in 44 and 43 operations
respectively. Two fellow registrars (HAE and GAW) subsequently became involved, participating
in 24 and 21 cases, of which they were lead surgeon in 11 and 12 cases respectively.
The first 50 patients in this series underwent a total of 54 operations, of which 49 (90.7%) were
done by AGF and/or AGT, while the second 50 patients underwent 61 operations, of which only
21 (34.4%) were done by AGF or AGT.
Six other colleagues served as lead surgeon in a total of 22 cases (median n=4); all told, 45
cases (39%) were done by surgeons other than AGF and AGT. Although this was desirable
as the purpose was to develop a system that would be widely used, this may also have been
a factor in the delayed recognition of a problem during the transition from the prototype to the












Eighteen patients experienced minor complications, none of which was permanent.
Superficial wound infection occurred in one patient following aspiration of an abscess (Case 33).
This patient had negative HIV serology, but had a past history of pulmonary tuberculosis and
had therefore been commenced on antituberculous drugs, steroids and intravenous antibiotics
two weeks prior to surgery for a ring-enhancing lesion which had gradually enlarged. Three days
after his stereotactic procedure he had evident wound sepsis; however, this was superficial and
required nothing further than local dressings. A second operation was required to re-tap the
abscess.
Transient neurological complications occurred in eight patients. Mild postoperative worsening
a pre-existing motor deficit was noted in three patients (Cases 10, 27 and 59) but this did not
persist. One patient was noted to have new onset of dysphasia (Case 94), curiously enough
after biopsy of a lesion in the right frontal lobe, and this also resolved. Delayed waking from
anaesthesia or transient reduction in their level of consciousness was noted in four patients,
following biopsy (Cases 16 and 34), craniotomy (Case 57) and cannulation of a large cystic
craniopharyngioma (Case 73).
Four patients experienced transient neuro-endocrine complications following insertion of an
Ommaya reservoir into a craniopharyngioma cyst ; three developed diabetes insipidus (Cases
48, 92 and 95), while one experienced hypothalamic dysfunction with an episode of bradycardia
intra-operatively upon puncturing the craniopharyngioma cyst followed by transient postoperative
hypothermia (Case 3).
Adverse effects of drugs occurred in eight patients with seven developing rashes due to
anticonvulsants (Cases 19, 32, 37, 57, 69, 91 and 94) and steroid-induced hyperglycaemia in one
(Case 16). Only four of the seven patients who developed an anticonvulsant-induced skin rash











No Date Complication Outcome
3 19940707 bradycardia when inserting catheter in No sequelae
craniopharyngioma and transient postoperative
hypothermia
10 19941027 Transient weakness left leg Resolved
16 19950131 Transient drowsiness and steroid-induced Resolved
hyperglycaemia
19 19950302 Anticonvulsant rash and DVT No sequelae
27 19960305 Transient weakness left leg Resolved
32 19960516 Anticonvulsant rash No sequelae
33 19960523 Wound sepsis (following abscess tapping) No sequelae
34 19960606 Delayed waking from anaesthesia Resolved
37 19960822 Anticonvulsant rash No sequelae
48 19970429 Transient exacerbation of diabetes insipidus Resolved
57 19970818 Transient confusion & anticonvulsant rash Resolved
59 19970902 Transient weakness right leg Resolved
69 19971212 Anticonvulsant rash No sequelae
73 19980305 Delayed waking from anaesthesia No sequelae
91 19990622 Anticonvulsant rash No sequelae
92 19990707 Transient diabetes insipidus Resolved
94 19991018 Mild dysphasia, anticonvulsant rash Resolved
95 19991116 Transient diabetes insipidus Resolved
Table 5.7: Minor complications
5.9.3 Postoperative CT scan
The majority of patients (104/115; 90.4%) underwent a postoperative CT scan. This was done
in all cases where a catheter was implanted in order to check the position and in most cases
where an abscess was aspirated; although aspiration of pus at the time of surgery convincingly
confirmed the operative objective had been met, 66% of these patients required further CT
scans to monitor their response to antibiotics.
Sixty out of the 71 (84.5%) patients who underwent a stereotactic biopsy had a postoperative
CT scan, most within the first 24 hours (68.3%). The primary purpose of this was to establish
that there was no intracranial haematoma, but often this scan also revealed the site where the
biopsy was taken, as indicated by a small fleck of haemorrhage. Thirteen patients (21.6%) were
scanned more than three days after biopsy, by which time an assessment of intracranial blood











Twenty patients (42.6%) had no blood evident on the postoperative CT scan; of the 27 (56.4%)
in whom a haematoma was seen, this was greater than 1cm in diameter in only four (14.8%).
All but one of these haematomas were intracerebral, the only exception being a small surface
haemorrhage in a patient who underwent biopsy of a cortical lesion (Case 27).
The patient who experienced a substantial intraoperative haemorrhage upon attempted puncture
of a craniopharyngioma underwent scan following craniotomy and this confirmed an extensive
subarachnoid haemorrhage (Case 80). No patient underwent further surgery to evacuate a
clinically silent haematoma disclosed by a routine CT scan. The problem was clinically apparent
in both patients who underwent craniotomy, either manifesting with sudden postoperative
deterioration in GCS (Case 75) or torrential intraoperative bleeding (Case 80).
No Y: <5mm Y: 5-10 mm Y: 10-30 mm Y: 30-40 mm Total
Day 0 1 2 1 0 1 5
Day 1 16 6 11 3 1 36
Day 2 1 0 1 0 0 2
Day 3 2 1 1 0 0 4
Total 20 (42.6%) 9 (19.1%) 14 (29.8%) 3 (6.3%) 2 (4.2%) 47
Table: 5.8: Presence of haemorrhage on the postoperative CT scan
5.10 Outcome of stereotactic biopsy
Histology was obtained in 74 cases, as the three craniotomies were preceded by an initial biopsy.
Of the 71 isolated biopsies, the Backlund spiral biopsy needle was used in the first 14 cases, 2
of which had an additional specimen taken with the Melvill aspiration needle, while the Sedan
side-cutting biopsy needle was used for the remaining 57 cases.
An incidental finding was a difference in diagnostic rates with the two biopsy needles used in
this study. Of the eight biopsies that yielded tissue that was inconclusive, 7 occurred in the first
14 biopsies, a rate of 50%. These biopsies were all taken with the spiral biopsy needle, and the
pathology report usually made reference to the small size of the specimen.
This biopsy needle was replaced with a side-cutting Sedan needle from Case No 22 onwards.
A total of 60 biopsies were performed with the Sedan needle and if one excludes the cases that











inconclusive. Fisher's exact testing revealed this finding to be significant (p<0.001), however
this result needs to be interpreted with caution due to the developmental nature of this project.
Furthermore, patients were not biopsied with both needles, hence this retrospective comparison
may be flawed.
No Date Problem Solution
1 19940606 Abnormal tissue (calcified neuropil) but Biopsy needle
non -diagnostic
6 19941006 ?High grade glioma; GBM at craniotomy Biopsy needle
8 19941020 Abnormal tissue (non-specific necrosis) but Liaison with Pathologist
non -diagnostic
12 19941117 Smear ?GBM; histo uncertain histogenesis Biopsy needle
14 19941201 Abnormal tissue obtained (vessels and Biopsy needle
haemosiderin-laden macrophages) but
non -diagnostic. Subsequent craniotomy
also non-diagnostic
17 19950214 ?Low grade glioma Biopsy needle
20 19950316 AIDS; Nonspecific inflammatory Biopsy needle
79 19981012 Non -diagnostic Calibration data corrected; likely
inflammatory process such as TB
Table 5.9: Inconclusive histology
An intraoperative smear preparation was performed in 60/71 biopsies (81%). The final histological
diagnosis concurred with the smear diagnosis in 43 cases (71.7%) (Table 5.9).
Metastatic lesions were correctly diagnosed on smear in 13 cases (100%), while of the 22
astrocytomas, 19 were correctly identified as glial on smear (86.3%). Astrocytomas were graded
using the WHO classification [Kleihnes] and this proved to be challenging on smear, with an











Astrocy- Astrocy- Astrocy- Metasta- Other 2Non- Total
toma toma Grade toma Grade sis tumour neoplas-
Grade I - II III IV tic
Smear 2 7 4 13 4 7 37
correct




Smear 0 1 2 0 2 2 7
wrong
No smear 4 4 5 0 1 32 16
0 1 0 0 2 2 5
Total 6 17 13 13 9 13 71
Table 5.10: Accuracy of the smear stratified for different pathologies.
'Invalid: the smear was considered invalid for this pathology if there was a sampling error
2 Non-neoplastic: includes infective/ inflammatory conditions and vascular lesions
3 Frozen section rather than smear was done on two cases at Red Cross Hospital
5.11 Outcome of stereotactic cannulation
Fourteen patients underwent a total of 18 stereotactic operations, with four patients requiring
repeat surgery for different reasons in each case. One patient experienced progression of a
separate cyst and required a second reservoir to treat this (Case 3), and in another patient,
a second catheter was inserted in a new trajectory under stereotactic guidance as the initial
catheter traversed the lateral ventricle and a leak was noted on the contrast cystogram (Case
71).
The cyst wall was not penetrated on two occasions. In one instance, clear fluid resembling CSF
was aspirated at the time of surgery and the postoperative CT scan confirmed that the distal tip
of the catheter was in the subarachnoid space alongside the tumour cyst (Case 48), while in the
second case significant haemorrhage was experienced while attempting to penetrate cyst wall,
resulting in the abandonment of the stereotactic procedure (Case 80). Both patients underwent











In one case the lesion was missed altogether due to a system calibration error which was only
recognized postoperatively (Case 78) and this patient subsequently underwent microsurgical
excision.
The cyst was cannulated at the first operation in eleven of the remaining thirteen patients (84.6
3̀/0), but the procedure was considered entirely successful in only 7/11 (60%) as four experienced
catheter-related complications. In two cases the postoperative CT scan showed the tip to be
abutting the distal wall of the cyst; a minor revision was performed in one patient (Case 95)
where the catheter was pulled back one centimeter in order to reduce the risk of perforation
and subsequent leakage of bleomycin, but this was not done in the other patient (Case 90) as
bleomycin was not administered. In two further cases, the cyst was initially aspirated, yielding
fluid typical of a craniopharyngioma but the surgeon did not implant a reservoir as there was
uncertainty as to whether the tip had remained located in the cyst (Figure 5.4.).
Figure 5.4: Failed implantation of Ommaya reservoir following successful cyst cannulation.
Stereotactic planning scans of two patients in whom the catheter tip was not adequately secured
in the tumour cyst. The catheter was withdrawn in the patient on the left (Case 60), whose cyst
in hindsight was clearly too small for this treatment strategy. The catheter was left in situ in
the patient on the right (Case 92) and he subsequently underwent craniotomy and subtotal
resection.
In the first such instance, the cyst was particularly small with a volume of 0.8 ml (Case 60). The
patient was scheduled for craniotomy but the cyst was no longer visible on the preoperative












In the second instance, the cyst was initially entered but the flow of cyst fluid ceased upon
withdrawal of the Seldinger guide-wire and re-insertion of the catheter failed to produce a
convincing restoration of flow of tumour fluid; the preoperative cyst volume in this case was
25.7m1 (Case 92). The postoperative CT scan confirmed decompression of the cyst but the
patient went on to have a craniotomy in view of the residual solid component.
All the cases are summarized in Table 5.11.
No Age Date Comments
3 9 19940707 Tumour diagnosed 3 years previously at a peripheral hospital where a VP
19950119 shunt was inserted; she was referred for management of her progressive
diencephalic syndrome. The first stereotactic operation uncomplicated but
a second catheter was required 6 months later for a new loculated cyst,
not in communication with the existing Ommaya reservoir.
45 15 19970318 Initial craniotomy at age 5; cystic recurrence. Uncomplicated procedure.
48 5 19970422 First catheter misplaced hence second operation required. The Modified
19970429 Seldinger technique used to penetrate cyst at 2 nd operation.
60 16 19970905 Craniotomy and resection at age 14; presented 2 years later with
headache and a small cyst. The stereotactic procedure was successful in
that the cyst was aspirated, but was too small to retain the distal end of the
catheter.
71 49 19980206 Catheter inserted successfully, but revised as noted to be traversing
19980226 ventricle on postoperative CT scan.
73 25 19980305 Uncomplicated procedure.
76 6 19980622 Uncomplicated procedure.
78 6 19980915 Lesion missed (calibration error)
80 13 19981006 Haemorrhage on first attempt; second operation uneventful.
19981103
82 53 19981201 Uncomplicated procedure.
87 14 19990216 Craniotomy and resection at age 10; cystic recurrence. Uncomplicated
procedure.
90 1.5 19990527 Uncomplicated procedure; distal end of catheter in too far on follow-
up scan but not revised as marked clinical improvement with simple
decompression and decision made not to instill bleomycin.
92 6 19990707 Stereotactic procedure successful in that the cyst was aspirated,
but unable to maintain position of distal end within the cyst when
decompressed.
95 8 19991116 Cystic recurrence while undergoing proton therapy 4 months after
craniotomy and subtotal removal; successful insertion but tip in too far on
follow-up scan therefore revised (pulled back 1 cm).













All three stereotactic craniotomies were successfully completed, as were all four of the CSF
diversion procedures.
Apart from one abscess that could not be aspirated stereotactically due to brain shift, all
procedures where the goal was to aspirate an abscess or cyst were successfully concluded (18/
19; 94.7%).
As discussed above, eighteen craniopharyngiomas were to be cannulated and this was achieved
in thirteen (72.2%). Two cases were partially successful in that the cyst was entered, but could
not be completed as the cyst was decompressed to the extent that the tip of the cannula could
not be secured within the cyst (2/18; 11.2%). Three cases failed (3/18: 16.6%), two because of
an error in technique on the part of the surgeon (Cases 48_1 and 80_1) and one because of
incorrect use of the system (Case 79).
Of the 71 stereotactic biopsies performed, 54 were unequivocally successful in yielding
diagnostically accurate pathological tissue (76.1%).
As discussed in Chapter 5.10, abnormal tissue was obtained at biopsy in a further eight cases
(11.3%), but there was some doubt as to the exact diagnosis (Table 5.9); these were considered
to be partially successful and in only two cases (Cases 6 and 79 _3) did this have a significant
clinical impact.
Biopsy failed in eight patients (12.6%); failure was considered to be due to a system error, directly
attributable to development of the system in two cases, with both leading to a fundamental change
to the system (Cases 5 and 28). Three operations in two patients (4.2%) reflected surgeon error,
in attempting to biopsy an intraventricular tumour (Case 67) and failure to biopsy a tumour which
was later found at craniotomy to be a meningioma (Case 75 _1 and 75_2). Four biopsies failed
immediately after the transition from the prototype to the production system, due to incorrect use
of the system (Cases 77 1 and 77_2; Case 79_1 and 79_2).
In total, 13 procedures failed. Two failures revealed deficits in the system that were subsequently
corrected (the configuration of the fiducials and the method of securing the halo) and six reflected
errors in surgical judgment, which perhaps reflects a "learning curve" of decision-making. Failure











system as a consequence of failing to amend the calibration data in the software program. These
six operations were performed by four different lead neurosurgeons, which may have contributed
to the delay in recognizing that there was a problem.
Date Problem Error Solution
No
2 19940630 Brain shift, stereotactic procedure 0 Anaesthetist awareness
abandoned
5 19940906 Fiducials transposed. stereotactic a New configuration (J6)
procedure abandoned
28 19960326 Lesion missed- normal brain tissue a More secure technique for
obtained attaching halo
48 19970325 Unable to penetrate craniopharyngioma 0 Modified Seldinger technique
cyst
67 19971209 Lesion missed- normal brain tissue and 0 Avoid stereotactic biopsy of
choroid plexus obtained intraventricular lesions
75 19980317 Non -diagnostic - li kely lesion not 0 Biopsy technique
19980324 penetrated 0 Biopsy technique
Non -diagnostic - li kely lesion not
penetrated
771 19980720 Non -diagnostic 13 Calibration data
77_2 19980728 Non -diagnostic 13 Calibration data
78 19980915 Lesion missed- stereotactic procedure 13 Calibration data
abandoned
79_1 19980921 Non -diagnostic 13 Calibration data
79_2 19980929 Non -diagnostic 13 Calibration data
80_1 19981006 Intraoperative haemorrhage 0 Modified Seldinger technique
Table 5.12: Failed procedures
Error classification:
a: error due to failure of the stereotactic system
[3: error due to incorrect use of the system




















Each of the cases that failed due to system or surgeon error will be reviewed in detail in order to
highlight the lessons learnt. Cases with inconclusive histology will be reviewed in Chapter 6.10.
The data are summarized in Table 5.9, stratified for success and failure in terms of the four
phases defined previously.
Phase 1 Phase 2 Phase 3 Phase 4 Total
Period June 1994 — June 1995 — July 1996 — July 1998 —
May 1995 June 1996 June 1998 June 2000
Fiducials Applied directly Halo screwed Prototype halo Production halo
to scalp with into outer table sutured onto sutured onto
adhesive or stuck on with scalp scalp
doughnut tape
Number of 21 13 42 24 100
patients
Objective fully 13 12 44 23 92
met
'Partial 7 0 1 2 10
success
Failures due to 1 0 4 1 6
surgeon errors
Failures due to 1 1 0 5 7
system errors
Number of 22 13 49 31 115
procedures
Table 5.13: Results of 115 stereotactic procedures, stratified according to the 4 phases in the
development of the CTSP.
'Partial success was either inconclusive histology (8 cases) or aspirating a cystic
craniopharyngioma but failing to secure a catheter in the cyst (2 cases).
Overall, the procedural objective was unequivocally met in 92/115 cases (80%), but this needs
to be analysed in context. The project described in this thesis started off with a prototype which
underwent 5 major iterations (adhesive doughnut fiducials > tacks > halo screwed on > halo
taped on > halo sutured on) before the production version was introduced, at which time a
further "developmental" problem occurred, in that incorrect calibration data was used for six











Furthermore, targeting was accurate in the ten cases classified as "partial success" in that the
inconclusive biopsies revealed pathological tissue in all eight cases and both craniopharyngiomas
were initially entered upon passage of the cannula.
If one excludes the six cases over the period when the incorrect calibration data was used and
one includes as successes the ten cases in which targeting was correct, the surgical objective
was realized in 101/109 cases (92.7%).
Case Illustrations













A 46 year old female awaiting cardiac transplant for Eisenmenger Syndrome developed sudden right-
sided retro-orbital pain and headache. Head CT scan showed 2 small ring-enhancing lesions in the
right frontal lobe and right parietal lobe.
Stereotactic aspiration was attempted via a right frontal burr-hole under general anaesthesia; when
the dura was incised, a one centimeter space was found between the dura and the brain, most likely
due to over-enthusiastic anaesthetic management of suspected raised intracranial pressure. This
brain shift had altered the position of the lesion, which was clearly deeper and was aspirated freehand
after determining the correct trajectory with the aid of the stereotactic device.
Course: 	Negative culture; patient commenced on intravenous antibiotics and remained under the
care of Cardiology.
Final diagnosis: 	Brain abscess
Figure 5.6: Axial T1 MRI scan (a) and CT scan, both with IV contrast, show a right frontal subcortical
ring-enhancing lesion adjacent to an infarct. Following aspiration, the lesion was smaller on the
postoperative scan (c), which also demonstrated an adjacent locule of subdural air.
Problem: 	Management error. Brain shift due to iatrogenic brain shrinkage













A 25 year old female presented with a 3 week history of headache, neck stiffness and left hemiparesis;
she was on treatment for cervical carcinoma-in-situ and known to be HIV+ with human papilloma virus
infection and condylomata accuminata. Serology for toxoplasmosis, cryptococcus and syphilis was
negative. The fiducials were attached to her scalp in the ward, following which a CT scan was done
to localize the target. The patient was taken to the Operating Theatre while the data was entered and
the setting diagram printed; when the trajectory was checked prior to starting the case it was clearly
incorrect. An attempt was made to biopsy the lesion freehand after placing the burr-hole at the pre-
determined entry point, but this was non-diagnostic.
Course: 	The patient was commenced on 4-drug TB therapy as well as pyramethamine/
sulphadiazine, dexamethazone and phenytoin; despite this, she continued to
deteriorate and treatment was stopped after one month.
Final diagnosis: 	Unknown, most likely Primary CNS Lymphoma
Figure 5.7: Lobulated lesion in the trigone of the right lateral ventricle with extensive low density
throughout the white matter of the hemisphere, enhancing brightly following administration of
intravenous contrast.
Problem: Technical error. Two of the fiducials were transposed when entering data from the CT
scan into the program and the software was unable to detect the error as the fiducials were in an
equilateral triangle configuration, hence two solutions were possible.
Solution: 	Configuration of fiducials changed from equilateral triangle to an isosceles triangle to
ensure there was only one possible position for the pointer to be mounted. This necessitated the












A 43 year old female presented with a 3 month history of stiffness and numbness of the left foot; she
was systemically well with no past medical history of note. CT scan showed seven ring-enhancing
lesions widely distributed though the brain; all other investigations were negative.
Stereotactic biopsy of right parietal lesion after attaching halo with tape showed normal brain.
Course: 	Four drug TB therapy was commenced for a presumptive diagnosis of multiple
tuberculomas and follow-up imaging two months later showed the lesions had resolved; the patient
remained well at long-term follow-up.
Figure 5.8: Axial CT scan showing ring-enhancing lesions with surrounding low density (a). Follow-up
CT one day after biopsy shows a small haematoma in the deep white matter, some distance away from
the planned target.
Problem: Technical error. Technique for securing halo using adhesive tape not reliable enough.












This 5 year old boy from a rural area developed headache and visual loss following a minor head
injury and was referred to the Red Cross Children's Hospital Trauma Unit with a deteriorating level
of consciousness 5 days later. CT scan showed acute hydrocephalus and a suprasellar cyst with a
mineralized wall, highly suggestive of craniopharyngioma. The patient underwent urgent VP shunt
insertion bilaterally and postoperatively his level of consciousness improved promptly but he had
ongoing features of pituitary dysfunction and poor vision, particularly on the left.
A decision was made that he would best be managed by instillation of bleomycin into the cyst and
one week later implantation of an Ommaya reservoir was attempted using stereotactic guidance.
Upon inserting a catheter with the stylet in place, correct placement was suggested by the fact that
firm resistance was felt when the cyst was encountered, but when the catheter was passed to the
predetermined depth, clear fluid resembling CSF was aspirated. Follow-up CT scan showed the
catheter tip to be located in the subarachnoid space adjacent to the tumour, seemingly deflected by
the dome of the cyst.
One week later, the patient was taken back to the Operating Theatre where the halo was applied after
induction of anaesthesia with a laryngeal mask airway and the patient underwent a second stereotactic
planning scan. Following intubation and induction of general anaesthesia, the operative wound was
re-opened and the previously inserted Ommaya reservoir removed and this time a modified Seldinger
technique was used to place the intracranial catheter.
The Backlund spiral biopsy needle was inserted and the spiral tip used to perforate through the firm
capsule into the cyst. Once placement of the outer cannula within the cyst was verified by drainage
of typical craniopharyngioma fluid, a guide wire was inserted into the cyst and the cannula then
withdrawn. A small transverse incision was made in the distal tip of the catheter which was then
passed over the guidewire, which was easily withdrawn once the catheter was positioned within the
cyst.
Course: Postoperatively the patient experienced marked diabetes insipidus requiring regular
DDAVP. He was reviewed by the radiotherapy service who felt him to be a good candidate for
bleomycin; a contrast cystogram showed no evidence of a leak and accordingly he received his first
dose of bleomycin without ill-effect.











four years before showing progression, at which time he underwent radiotherapy. Visual acuity on
the left had been poor at the outset and this gradually deteriorated to blindness; this may have been
a complication of bleomycin as this occurred without any evident increase in the size of the tumour.
Figure 5.9: Initial CT scan showing a suprasellar cystic tumour with a densely calcified wall and
accompanying hydrocephalus (a). Axial (b) and sagittal (c) T1 weighted MRI scans confirming extension
from the sella into the third ventricle. CT scans after each of the two stereotactic operations showing
the catheter alongside the cyst after the 1 5t operation (d) and within the cyst after the 2"d (e), confirmed
on a corona! reconstruction (f) and contrast cystogram (g).
Problem: 	Surgical technique: unable to penetrate thick calcified cyst wall with stylet-containing
catheter alone.
Solution: 	Modified Seldinger technique, using Backlund spiral biopsy needle to penetrate the













A 14 year-old boy presented with headache 6 months after undergoing thoracic laminectomy for
debulking of a spinal cord astrocytoma. CT scan showed hydrocephalus with an enhancing lesion
in the fourth ventricle and a smaller lesion in the left frontal horn. Stereotactic biopsy of the lateral
ventricle mass was attempted via left frontal burr-hole; CSF was aspirated and histology of the small
biopsy fragment showed choroid plexus.
Course: 	The patient underwent insertion of a VP shunt and a posterior fosse craniectomy for
debulking of the tumour, following which he was referred for craniospinal radiotherapy.
Figure 5.10: Axial CT scan showing enhancing lesion in left frontal horn (a); stereotactic biopsy was
non-diagnostic, showing normal brain and choroid plexus (b).
Problem: 	Poor surgical decision, it is technically difficult to target intraventricular lesions using
stereotaxis
Solution: 	Such a lesion is better approached using an endoscopy, which was introduced into our












A 32 year old female presented with right focal seizures of three weeks duration and had a past
history significant for pulmonary tuberculosis treated five years ago. CT scan demonstrated a low-
density ring-enhancing mass adjacent to the falx in the left parietal region; the differential diagnosis
was thought to include an abscess or metastasis.
Stereotactic biopsy was attempted via a left parietal burr-hole; histology showed numerous eosinophils
and neutrophils, which was interpreted as the capsule of an inflammatory lesion. A follow-up CT scan
24 hours after surgery showed an obvious tract leading to the edge of the lesion.
A repeat stereotactic biopsy was performed one week later; a more anterior entry point was selected
and the previous burr-hole enlarged with a small strip craniectomy. Macroscopically the tissue obtained
at biopsy resembled old blood clot and histology showed thrombus but no other pathological tissue.
Following surgery the patient recovered fully and was admitted to the Neurosurgical ICU with GCS
15/15 but she suddenly deteriorated after two hours, at which time CT scan showed a massive
intracerebral haematomas necessitating immediate craniotomy. Copious tissue was sent to the
pathologists but still no diagnosis could be made.
Course: The patient had a dense right hemiparesis which substantially improved over the
course of three months. Follow-up CT scan showed no residual lesion and an angiogram was negative;
a follow-up MRI scan was scheduled for six months and curiously this showed a new enhancing
occipital lesion.











Figure 5.11: Axial CT scan showing the lesion on the first stereotactic planning scan (a); following
a non-diagnostic biopsy, a thin tract is seen leading to the edge of the lesion (b). CT scan obtained
urgently following the patient's abrupt deterioration 2 hours after a second stereotactic biopsy showed
a massive intracerebral haematoma (c)
Problem: 	Poor biopsy technique. Despite the fact that no lesion was found at the time of craniotomy,
it is likely that this was simply missed and non-representative tissue had been obtained at the time of
stereotactic biopsy, due to not penetrating the lesion adequately.












A 29 year-old female presented with right sided weakness of four months duration on a background
of headache for six months. CT scan showed an inhomogenously enhancing lesion in the genu of the
corpus callosum with extensive low density in the frontal lobe.
• Stereotactic biopsy via a left frontal approach simply showed evidence of oedema in the
white matter.
■ A follow-up stereotactic biopsy one week later showed features of a high grade glioma on
smear but this was not confirmed on the paraffin sections.
■ A third stereotactic biopsy was performed and this confirmed a grade III astrocytoma; a
titanium marker was left in place but this was not visible on the postoperative CT scan.
Course: 	The patient was referred to Radiotherapy for further management.
Figure 5.12: Axial CT scan demonstrating the target used for the third stereotactic biopsy.
Problem: 	Avoidable system error, lesion missed on the first biopsy and it is likely that only the edge
was biopsied at the second operation as not all specimens were pathological. Surgical planning for
the third biopsy was appropriate in targeting the centre of the lesion. This was the first case operated
with the production version of the CTSP. In hindsight, it was realized that the calibration data on the
software had not been changed from that of the prototype, hence this data was incorrect for this
particular phantom and tripod.
Solution: 	Check every step of the procedure and all components when failure occurs. The success












A 6 year-old girl presented with a one month history of headache and vomiting on a background of
longstanding polydipsia and short stature. CT scan showed a lesion typical of craniopharyngioma
and a decision was made to treat her with bleomycin and implantation of an Ommaya reservoir was
required.
In view of the patient's young age, the halo was attached under General Anaesthesia and the
stereotactic scan was done under optimal circumstances and therefore highly accurate (maximum
error 0.7mm). The surgical plan was to utilize the modified Seldinger technique we had developed,
approaching the cyst via a right frontal approach avoiding the ventricle. This was challenging as the
cyst was not particularly large (volume = 3.1 ml) and was vertically orientated, occupying the third
ventricle. For the first time in this series, the Image Intensifier was utilized [Duffill], in order to visualize
the tip of the guide wire to ensure that this did not penetrate into the subarachnoid space when
utilizing the modified Seldinger technique.
When the catheter was passed under screening, it was seen to deflect off the shunt catheter, which
quite clearly indicated deviation from the planned trajectory. This was attempted a second time and
on further passage of the catheter, it appeared that the tip of the catheter was anterior to the sella
and hence anterior to the tumour cyst. Clear fluid resembling CSF was obtained on gentle aspiration,
confirming misplacement.
An attempt was made to re-insert the catheter after re-setting the phantom with a new target one
cm more posterior, but this also failed to locate the tumour cyst. A decision was made not to leave a
catheter in situ.
Course: The patient underwent craniotomy and subtotal resection of the tumour two weeks later











Figure 5.13: Corona! MRI showing the typical appearance of a mixed solid-cystic craniopharyngioma
(a) and the stereotactic planning scan (b). Upon inserting the catheter stereotactically with additional
fluoroscopic control, it was clear that the trajectory was incorrect. As can be seen in (c), the catheter
displaced the tip of one of the shunts; the halo and two of the feet of the tripod can just be identified in
this image. Upon reinserting the catheter, the trajectory appeared to be directed anterior to the sella
and therefore anterior to the suprasellar cyst (d).
Problem: Avoidable system error. This was the first case operated at Red Cross Children's
Hospital using the new production version and it was not initially understood why this problem had
arisen.
Solution: 	Prior to doing the next paediatric case (Case No 80), the entire CTSP sequence was
reviewed step by step by two of the Neurosurgeons (AGF and GAW) as it as apparent that there was
a systematic error as similar problems had occurred at Groote Schuur Hospital (Case No 79).
In doing this, it was realized that the calibration data for the phantom and tripod had not been amended












A 52 year old female presented to a peripheral hospital with weight loss, confusion and incontinence
of six months duration on a background of NIDDM and pulmonary tuberculosis. On examination
she was mute with frontal release signs and a mild left hemiparesis. Investigations included HIV
serology (negative) and lumbar puncture (0 polymorphonuclear cells, 3 lymphocytes, protein 0.83,
globulin +). CT scan showed a faintly enhancing lesion in the medial right frontal lobe; the patient was
commenced on 4-drug tuberculosis therapy and referred to Neurosurgery for consideration for biopsy
of the intracranial lesion.
• Stereotactic biopsy via a right frontal approach was non-diagnostic, yielding degenerate
neurons and perivascular gliosis, consistent with a "neighbourhood reaction". A postoperative
CT scan the following day revealed a small haematoma anterior to intended biopsy site.
• A second biopsy one week later showed numerous reactive astrocytes but no inflammatory
cells, necrosis or neoplasm. A follow-up scan showed a small locule of air lateral to the frontal
horn, even further from the region of interest.
■ A third stereotactic biopsy was performed two weeks later (21 days after the first biopsy) and
this was also non-diagnostic, showing oedematous changes only.
Course: As no diagnosis had been made despite three attempts at biopsy, an opinion was sought
from Neurology. Fine needle aspiration biopsy of a small lesion in the left upper lobe of the lung
was recommended and this yielded acid-fast bacilli. The patient was continued on her course of
4-drug tuberculosis treatment and transferred to a convalescent care facility, but her condition did not











Figure 5.14: Axial CT scan showing the faintly enhancing lesion in the medial right frontal lobe (a); the
site of the first stereotactic biopsy was clearly incorrect, as shown by the small haematoma anterolateral
to the mass, and the second biopsy was even more lateral (c). A CT scan was not requested after the
third biopsy.
Problem: Avoidable system error with the first and second attempts.
Possibly this patient had an inflammatory process not amenable to diagnosis by stereotactic biopsy,
as the third biopsy was performed after correcting the calibration data.
Solution: 	With the exception of the third biopsy in this patient, correction of the calibration data













This 13 year old boy was referred to Ophthalmology with a history of headache and visual symptoms
noted at school over the past month. He had a right temporal hemianopia and disc pallor; CT scan
showed a suprasellar predominantly cystic lesion typical of craniopharyngioma but no hydrocephalus.
He had delayed puberty and endocrine workup confirmed hypopituitarism; a decision was made that l
he would best be managed with intracystic bleomycin.
■ The halo was attached and the stereotactic planning scan performed under anaesthesia
with a laryngeal mask airway, following which he was intubated for surgery. Two attempts
were made to introduce the catheter with the thin stylet in place but the tip felt as though it
was being deflected by the mass. The Backlund spiral biopsy needle was then introduced
with the intention of using the modified Seldinger technique but the needle abutted against
the proximal end of the standard instrument guide before it entered the cyst. The needle was
therefore removed and the instrument guide replaced with the cutoff guide to enable deeper
intracranial penetration. A definite "give" was felt when the needle was inserted beyond the
depth of the capsule but torrential arterial bleeding ensued when the stylet was removed,
indicating a significant vascular injury.
A decision was made to proceed immediately with a pterional craniotomy; the needle had been
left in place to enable ongoing decompression of the haemorrhage and this was replaced with
a silicon ventricular catheter when the craniotomy was performed. Upon opening the dura the
brain was not unduly tense and as there was no active bleeding, no further exploration was
attempted.
The bone flap was left out and an urgent CT scan showed extensive subarachnoid
haemorrhage and the patient was admitted to the Neurosurgical ICU for ventilation under
propofol sedation.
He was weaned and extubated after 48 hours at which time he had a dense left hemiparesis.
Angiogram showed no evidence of a false aneurysm or other vascular injury.
■ A decision was made that treatment with bleomycin remained the fist choice for him and
he therefore underwent a second stereotactic procedure, with the catheter being inserted
uneventfully on this occasion. He experienced diabetes insipidus after this operation and











Course: 	The patient received a total of 32 mg of bleomycin, following which the cyst remained
stable for 3 years, at which time progression was treated with Radiotherapy. Further enlargement of
the intrasellar cyst was managed by transsphenoidal surgery and later subfrontal decompression.
Figure 5.15: Initial axial CT (a) and reconstructed corona! CT (b) showing the enhancing thick tumour cyst wall;
immediate postoperative CT showing extensive subarachnoid haemorrhage (c). CT Scan following 2" operation,
confirming intracystic placement (d). Follow-up CT five months later, showing low density change along catheter as
well as right frontal porencephaly underlying the cranial defect (e).
Problem: 	Surgeon error in attempting to penetrate cyst wall using the blunt tip of the biopsy needle
and not the spiral.












The results reported here reflect two simultaneous processes- a new stereotactic system was
being developed, by surgeons who were also learning the principles of stereotaxis. Other authors
have commented on the increased rate of errors when using a prototype [Gumprecht] and in the
early phases of introducing a production version into practice [Heilbrun_1983]. It is also clear that
there is a learning curve in introducing stereotactic techniques [Barnett 1999].
Very few publications reporting a series of stereotactic procedures specifically present the
distribution of volumes, but the lesions operated on in this series tended to be small as large
lesions were operated on "freehand".
Apart from two targeting errors early in the series, both of which led to fundamental changes,
most of the errors represented incorrect surgical decisions, while the high number of inconclusive
biopsies early in the series could be ascribed to a number of reasons, as will be discussed in
the next chapter. The sequence of failed procedures spanning the transition from the prototype
to the production version was due in a sense to the CTSP becoming a victim of its own success
in that a number of surgeons were using the system independently by that stage and it therefore
took time for the developers to realize that there was a problem.
The 115 operations reviewed in this chapter will now be reviewed in terms of the procedures
performed, encompassing stereotactic biopsy in the next chapter, stereotactic chemotherapy in














By far the commonest indication for morphological stereotactic surgery is retrieval of tissue
specimens for diagnostic purposes. An oft-cited study found that 12% of patients undergoing
stereotactic biopsy at a major academic institution were found to have diagnoses that were not
considered prior to surgery [Friedman_1989]. While the greatest experience with stereotactic
tumour biopsy has emanated from such centres, the value of this technique to all neurosurgeons
in practice is borne out by a series in which stereotactic biopsy led to a change in management
in 40% of cases in a community hospital setting [Plunkett].
Early applications of stereotaxis were directed at the treatment of tumours by implanting various
isotopes, while the use of this approach for biopsy alone appears to have lagged [Dagi]. This
was due largely to deficiencies in the methods available for delineating such lesions and then
retrieving pathological tissue. An atlas could be used to guide functional procedures, but was of
little help in dealing with conditions such as intracerebral tumours where normal anatomy was
inevitably altered. The presence of a lesion had to be deduced indirectly from features such
as ventricular displacement or a vascular blush; Talairach's group tackled this problem with
particular vigour, utilizing angiography to devise the system of repérage [Kelly 2004i].
A technique for tissue retrieval from deep brain structures at the time of functional stereotactic
surgery was described in 1964 [Kalyanaraman]; the authors demonstrated that this could be done
safely, in performing 155 biopsies in 65 patients. They speculated that their method could be
applied to deep-seated brain tumours and this was confirmed nine years later when 28 patients,
out of a series of 31 reported, had a diagnosis made with this technique using the Todd-Wells
stereotactic apparatus [Conway]. The challenges of preoperative imaging were immense at that
ti me- patients underwent a selection of skull x-rays, angiography, pneumoencephalography,
positive contrast ventriculography and radioisotope scans!
The advent of CT scanning the same year [Hounsfield] had an immediate impact on neurosurgery.
An ingenious technique for CT-guided biopsy of intracranial lesions was reported as early as
1977 [Maroon]; the original EMI scanner required the patient's head to be immersed in a water











There was however another reason for the limited application of stereotactic techniques to brain
tumours during the pre-CT era. As many intracranial tumours presented only once they exerted
mass effect, needle biopsy in these patients with critically raised intracranial pressure carried a
high mortality as a minor degree of haemorrhage could prove critical. Biopsy could also provoke
brain swelling which was very difficult to control prior to the availability of steroids. The outlook
for glioblastoma was dreadful, with operative mortality as high as 40% following needle biopsy
[Frankel].
In light of these concerns, craniotomy was preferred for diagnostic purposes in North America,
while needle biopsy was often used in Britain. Prior to using a stereotactic technique, needle
biopsy was performed "freehand" with a diagnostic yield that varied between 33% and 88%; this
was dictated in part by the diameter: depth ratio of the lesion [Lee]. Following the introduction of
CT-guided stereotactic biopsy at two British centres, the diagnostic yield increased from 64.9%
for freehand biopsy to 92.1% for stereotactic biopsy, accompanied by an improvement in the
operative mortality from 5.5% to 1.3% [Lee]. Although some centres reported disappointing
results with stereotactic approaches compared with freehand CT-guided techniques [Wen],
cumulative experience eventually settled this debate.
In the current era of "frameless stereotaxy", it is worth remembering that stereotactic frames
didn't only bring a new level of accuracy, but also a novel degree of stability in that the needle was
passed along a single trajectory. The instrument was therefore prevented from moving erratically
from side to side and this may well have been an important factor in reducing morbidity.
At the other end of the resource spectrum, it is salutary to reflect that freehand approaches to
such lesions are still practiced by neurosurgeons who do not have access to any stereotactic
equipment at all. Although this may still be a reasonable therapeutic strategy when approaching
a large lesion such as an abscess, it is not at all ideal for retrieving a diagnostic sample.
6.2 Aims of stereotactic biopsy
The aim of stereotactic biopsy is to retrieve a sample of abnormal brain tissue for analysis by the
pathologist in order to make a definitive diagnosis; this specimen must be representative of the
pathological process and sufficient to allow adequate histopathological examination. As this is












Before embarking on a stereotactic biopsy, certain requirements must be met:
i. A lesion can be seen on imaging
As the essence of stereotactic surgery is the careful selection of a target, there must be
a focal lesion that can be defined in three-dimensional space, not only on the patient's
initial imaging study but also on the imaging to be used to plan the biopsy. Intravenous
contrast may need to be administered in order to define the lesion, or to refine the choice
of target.
ii. The diagnosis cannot be established non-invasively
A time-honoured dictum in neurosurgery is that one cannot make a diagnosis of an
intracranial mass without examining part of that lesion under the microscope. However,
with the ever-improving diagnostic capabilities of modern imaging, ranging from MRI,
including MR spectroscopy, though to PET, one may well be able to make a diagnosis
without recourse to an invasive procedure. An example of this is the relatively common
paediatric entity of a pontine glioma, where there is now common agreement that the
characteristic low-intensity expansion of the upper brainstem together with encasement
of the basilar artery make any other diagnosis so unlikely as to render a tissue diagnosis
unnecessary for routine clinical practice.
Other scenarios include patients with systemic conditions such as HIV, where serological
tests or even a trial of therapy may point to the nature of the intracranial lesion, or the
patient who presents with an intracranial mass that appears most likely to be a metastasis
with lesions elsewhere; in this case, less invasive strategies, such as bronchoscopic
biopsy should there be a lung lesion, may be sufficient.
iii. A more definitive option is not available
Stereotactic biopsy is ideal for small lesions in eloquent areas, or for multiple lesions,
but may well be contra-indicated in the patient with a very large tumour with raised
intracranial pressure. Such patients are very susceptible to even minor procedures;
although the volume of the needle is negligible and does not itself cause a problem,
its passage through the brain may cause additional swelling or the biopsy may result
in a haemorrhage which critically increases intracranial pressure. In such a patient it











goal is not total excision. An exception may be a patient who is too unwell to tolerate a
craniotomy but a diagnosis is nonetheless considered mandatory.
The emergence of other minimally invasive techniques has also impacted on surgical
decision-making, such as the use of neuro-endoscopy for lesions such as colloid cysts
and pineal tumours.
iv. A vascular lesion is excluded
Haemorrhage is the most feared complication of stereotactic biopsy and lesions such as
giant aneurysms, arteriovenous malformations (AVM) or cavernous angiomas are absolute
contra-indications to this technique. Suggestive features would include the pattern of
enhancement and the location, hence adequate imaging should deter stereotactic biopsy
in such cases; cavernous angiomas usually have a characteristic appearance on MRI
and angiography should identify aneurysms and AVMs. Some of the pre-MRI stereotactic
series reported attempts to biopsy these with adverse consequences.
In a similar vein, in planning any stereotactic biopsy it is vitally important to be able to
access the lesion without having to traverse areas of high vascularity such as the Sylvian
fissure.
v. There is no contra - indication to surgery
All the usual standard considerations apply:
■ Coagulopathy
The issue of intracranial haemorrhage after stereotactic biopsy is addressed below,
but two factors that significantly increase the risk of a haemorrhage complicating
needle biopsy of the brain are a bleeding diathesis or uncontrolled hypertension.
Stereotactic biopsy should be avoided in patients who have been using aspirin,
although it is less clear that the same risk attends the use of other non-steroidal anti-
inflammatory agents.
■ Local sepsis
Any infection involving the scalp, skull or subdural space in the vicinity of the surgical












Patients who are critically ill or have very advanced disease with a poor performance
status (e.g. low Karnofsky score) may not benefit from histological confirmation that
they do indeed have a high grade glioma.
In summary, stereotactic biopsy is most commonly indicated for lesions which are:
■ Deep
■ In eloquent brain regions
■ Multiple
■ High risk for another approach
Stereotactic approaches are not indicated when a large tissue sample is required, such as with
diagnostic brain biopsy for elusive neurological conditions [Kaufman].
6.4 Biopsy instruments
Just about every different type of stereotactic frame that has been manufactured has been used
to perform a biopsy.
The main area of contention is the instrument used to retrieve the specimen. The first needle
used for this purpose was a hollow cannula with a hole at the distal end and a central stylet.
To the dismay of the neuropathologist, brain samples aspirated using such needles are usually
somewhat disrupted and a variety of other instruments have been devised. These entailed either
guillotine-like excision of a piece of the lesion or grasping a specimen with a cup forceps.
i. guillotine-type action
■ end - on Backlund spiral needle
■ side -cutting Sedan, Nashold needle
ii. small cupped forceps











Figure 6.1: Stereotactic biopsy needles; various modifications of each of these have been introduced. The
spiral or coil needle (a) should be introduced into the lesion with gentle rotation and the biopsy is then
taken by sliding an outer cannula over the corkscrew. Perhaps the most popular is the side-cutting needle
which consists of two cannulae, one inside the other, each with a window 10mm in length (b). The needle
is introduced with the outer window "closed" and this is opened with a simple rotatory action, a sample
is aspirated with gentle suction at the proximal end and retained by closing the window (c). Some prefer
using microcup forceps as this may give more refined haptic feedback from the lesion (d). (Figures from
[Cosman], with permission from Wolters Kluwer)
The inventive Swedish neurosurgeon Erik-Olof Backlund, frustrated by the difficulty of
biopsying craniopharyngiomas, designed a spiral biopsy needle which has been widely used
[Backlund_1971]. The principle entails rotating the tip into the tumour in a corkscrew fashion
and then sliding the outer cannula over the spiral, coring out a specimen 10 mm by 1-2 mm.
Paradoxically this was found to be good for soft tumours such as gliomas but less effective when
there was a firm capsule.
The most commonly cited choice however is a side-cutting needle; this is essentially a suction
biopsy device. There are different sizes available, but it seems most authors favour a needle
2.1 to 2.5mm in outer diameter that produces a core that is 5 to 10 mm by 1.5 to 2 mm in size.
Lunsford credits Professor Sedan in Marseilles with the introduction of this instrument, although
others have subsequently described modifications; in his view, use of this needle cuts the risk of











Other workers advocate the use of a small cupped biopsy forceps such as used for bronchoscopic
biopsies, because there is more refined haptic feedback or "feel"; it has been suggested that this
enables the surgeon to know when s/he has grasped a vessel as this imparts greater resistance
[Cook]. The specimens are usually significantly smaller than with other instruments, usually
around 1.5mm 3 in size.
Some authors have voiced strong opinions as to the relative merits of the different instruments
and there also appear to be regional preferences, but it has been pointed out that there is no
evidence upon which to base claims on this matter as no prospective study has been conducted
to determine the best technique [Kulkarni_1999]. Some surgeons who have used a variety of
different biopsy instruments have concluded that complications are equivalent [Thomas_1989].
As with most surgical nuances, the best strategy is for the neurosurgeon to use whichever
technique s/he is comfortable with.
6.5 Medical management
■ Antibiotics
In this series, prophylactic antibiotics were administered in 67.8% of the procedures
overall but in only 52.1% of the biopsies. Following local practice guidelines, the antibiotic
given was as a single dose at induction of anaesthesia, most commonly 1g intravenous
cefazolin in adults or 50mg/kg intravenous cloxacillin in children. Of the two surgeons
who performed the majority of the procedures, one favoured the use of prophylactic
antibiotics while the other did not, with no discernible difference in the risk of surgical site
infection.
Only one septic complication occurred in this series, with local wound sepsis developing in
a patient in whom a brain abscess was tapped; this patient had already been commenced
on therapeutic doses of intravenous antibiotics one week prior to surgery.
■ Steroids
Use of steroids such as dexamethazone in the setting of perilesional cerebral oedema
is advisable; of patients undergoing stereotactic biopsy in this series, 82% received
intravenous dexamethazone prior to surgery and the usual practice was to continue this











The patient whose death 4 days after biopsy was considered to be a consequence
of exacerbating pre-existing raised intracranial pressure (Case 72), had been on an
adequate course of steroids before and after surgery. All of the patients who manifested
a transient worsening of their neurological status, either leg weakness or dysphasia, had
also received steroids.
■ Anticonvulsants
lntraoperative seizures are uncommon during stereotactic biopsy and did not occur in
our series, probably because 96.5% of patients received general anaesthesia. Seizures
had been a presenting symptom in 30% of the patients in this series and consequently
a number of patients had been commenced on therapeutic anticonvulsants. The place
of prophylactic anticonvulsants is less clear; 57.4% of patients in this series received
anticonvulsants while 66% of those undergoing biopsy did so. Local practice was to use
phenytoin for this purpose and it is noteworthy that the commonest minor complication in
this series was skin reactions to this drug, which occurred in seven cases.
6.6 Anaesthetic management
Stereotactic biopsy can be performed without general anaesthesia, provided the patient is
able to cooperate fully and effective local anaesthesia is used. Local preferences certainly
play a role- it has been noted that most procedures in the UK were performed under general
anaesthesia, while in Australia, Europe and North America local anaesthesia was preferred
[Bradburn]. Some patients, in particular young children and confused or frightened adults, and
certain operative interventions, such as posterior fossa procedures in the prone position, require
general anaesthesia.
In all adult cases in this series, the CTSP halo was applied without recourse to general
anaesthesia; oral analgesia and sedation was typically administered in the ward prior to infiltrating
local anaesthesia with a vasoconstrictor (usually 1% lignocaine with 1:100,000 adrenaline, using
a dental syringe).
Most children underwent general anaesthesia, often with insertion of a laryngeal mask airway
(LMA), prior to applying the halo. The disadvantage of applying the halo in the Operating Theatre
is that portable monitoring has to be available for safe transfer to and from the CT scanner. With
many conventional stereotactic frames, there is potential for the frame itself to hinder access to











As with colleagues in the United Kingdom [Wild], Brazil [Ferreira] and Turkey [Calisaneller], our
practice was to use general anaesthesia unless there was a particular contra-indication. One
of the reasons for this was the fact that performing stereotactic surgery was a new experience
for both the neurosurgeons and the anaesthetists, and seldom was the same anaesthetist in
attendance. The small number of adults who underwent their stereotactic operation without
requiring general anaesthesia (4.3%) tolerated this well and none of these cases had to be
aborted.
If the case is done without general anaesthesia, it is important that this be borne in mind by
everyone in Theatre, especially in discussing the provisional pathological diagnosis within
the room and over an intercom. There was no better illustration of this than one of our cases
where the patient undergoing biopsy of an intracranial metastatic adenocarcinoma was a retired
technologist from our own Pathology laboratory.
6.7 Biopsy procedure
By convention, all intracranial access in our department has been via a burr-hole and a twist
drill has not been used; naturally this was also our approach to performing stereotactic biopsies,
but it is clear that many experienced neurosurgeons prefer using a twist drill. Although a burr-
hole has the theoretical advantage of enabling visualization of the cortex, and therefore enables
the surgeon to avoid any surface vessels, in reality the complication rate with a twist drill is
remarkably low [Maartens].
As previously discussed, various different biopsy needles are available. Taking more than one
biopsy sample increases the yield [Aker], but limiting the number of needle passes though the
brain reduces morbidity. Most biopsy needles are designed such that they have an outer sheath
that can be left in place while an inner cannula containing the tissue sample is withdrawn. Should
one use the side-cutting needle, taking biopsies with the window facing in different directions is
recommended [Fritsch].
Often pathological tissue has an abnormal appearance in terms of colour and consistency, but if
there is any doubt the neurosurgeon is well advised to await an intraoperative smear. In the course
of this series the pathologist was seldom present in the operating theatre; biopsy specimens
were placed on a glass slide which was immediately transported to the pathology laboratory in
an airtight container without any fixative. A smear was done in the majority of cases; tissue for











(H&E), with further studies such as immunohistochemistry or other special stains performed as
indicated.
If there was any suspicion of infection, separation of specimens for routine microscopy, culture
and sensitivity, Ziehl-Neelsen stain and TB culture and fungal culture is best done sterile in the
operating theatre, rather than in the pathology lab.
6.8 Postoperative management
The main objective in caring for these patients after surgery is to detect the onset of a neurological
deficit as a manifestation of haemorrhage or swelling. The major controversies relate to two
issues:
■ should patients undergo routine imaging immediately after surgery?
■ should patients should undergo postoperative observation in an Intensive Care Unit
(ICU), and for how long?
The one patient in this series who developed a significant intracerebral haematoma that required
craniotomy for evacuation deteriorated abruptly two hours after surgery; this complication
manifested with deterioration in the patient's level of consciousness, as assessed by the Glasgow
Coma Score (GCS) [Jennet]. Neurological observations in the ICU sufficed to detect the problem
in this instance and this was confirmed by a CT scan (Figure 6.2).
Figure 6.2: Postoperative haematoma. An abrupt deterioration in the patient's level of consciousness, as












The main reason to scan patients postoperatively is to detect a silent haemorrhage that may
lead to sudden clinical deterioration. This complication will be looked at in greater detail later,
but it is important to bear in mind that most haemorrhages occur at the time of surgery; although
delayed haemorrhage has been described, occurring in 0,4% of cases in one large prospective
series where patients had all undergone an intraoperative CT scan within 15 minutes of biopsy
[Field], this is rare enough to not inform routine care. A study from the Cleveland Clinic noted that
all haematomas manifested within 6 hours [Kaakaji], as is the case with neurosurgery in general
[Taylor].
Our routine practice was to admit patients to ICU after stereotactic biopsy, but recent literature
suggests that this may not be necessary. This is a very important consideration in our setting,
where access to ICU is limited and procedures are often cancelled due to space not being
available. The Cleveland Clinic study suggested that patients could be discharged home safely 8
hours after biopsy, provided the CT scan was reassuring [Kaakaji]. A further helpful study in this
regard emanates from Toronto, where 73 patients out of a consecutive series of 75 ambulatory
patients were safely discharged on the same day, after 4 hours of observation [Bhardwaj]. The
sophisticated environment in which these colleagues practice certainly helped in that all patients
were visited at home by a home care nurse that evening, a service that would be hard to imagine
in our setting, but significantly, confidence in clinical parameters was demonstrated in that routine
postoperative imaging was not part of the management protocol. This article was accompanied
by seven editorial comments, ranging from enthusiastic to skeptical, suggesting that there is a
wide range of opinions on this matter.
In order to ascertain the national practice pattern in the USA, Warnick surveyed active members
of the AANS/CNS Joint Section on Tumors and found that 59% performed routine CT scans
after stereotactic biopsy, particularly those surgeons not practicing in academic settings and
also those surgeons who had been in practice for more than a decade [Warnick]. The authors
developed an algorithm which was then validated by prospective implementation; this called for
CT scanning and ICU admission only for patients who experienced intraoperative haemorrhage
or manifest new neurological deficits. All other patients were monitored for 2 hours in the recovery











6.9 Stereotactic biopsy in Special locations
The deeper, less accessible areas of the brain present particular challenges to the neurosurgeon
and stereotaxis has much to offer in biopsy of lesions in the brainstem and pineal region.
6.9.1 Brainstem
The brainstem is perhaps the region where a stereotactic approach is most helpful, given the
fact that intrinsic lesions are seldom amenable to radical resection. Extreme levels of accuracy
are required, given the proximity of critical neural structures and the distance from the cranial
surface coupled with the fact that these lesions are usually relatively small. Although the majority
of brainstem masses are neoplastic, a wide array of other pathological conditions may also
be encountered, particularly in developing countries where infectious lesions such as TB may
present as isolated brainstem masses [Rajshekar 1997].
Case illustrations
Two patients who underwent biopsy of lesions in the upper midbrain, via a transfrontal approach,












This 4 year old boy presented with left sided weakness which had progressed over one month. CT
scan showed a mixed solid-cystic mass in the midbrain, extending into the right cerebral peduncle;
the solid component enhanced avidly following intravenous contrast. As resection was indicated
should this be a low grade neoplasm, a stereotactic biopsy was performed.
Following induction of anaesthesia and insertion of a laryngeal mask airway, the halo was attached in
the Operating Theatre, positioned in the right frontal area to enable the burr-hole to be positioned just
behind the corona! suture, two centimeters off the midline. The patient was transferred for the planning
CT scan, breathing spontaneously with the AMA in place and once back in the Operating Theatre, he
was intubated and ventilated. Two specimens were taken with a target in the solid component, using
the side-cutting needle with the window directed medially and then laterally. In view of the depth of the
lesion, the outer cannula was left in place between biopsies with only the inner cannula withdrawn to
remove the specimen. The tripod was then reset for a second target within the cyst and 2m1 of deeply
xanthochromic fluid was aspirated.
Course: 	Histology showed a pilocytic astrocytoma hence the patient underwent craniotomy and
resection of the tumour via a right subtemporal approach. In view of the low grade histology he was
not referred for radiotherapy but he presented one year later with hydrocephalus following tumour
progression. A ventriculo-peritoneal shunt was inserted and he subsequently underwent two further
resections, ultimately resulting in cure.
Comment: The initial biopsy was very helpful in that it demonstrated that this was a lesion











Figure 6.3: This mixed density lesion visible in the midbrain on CT scan prior to administration of
intravenous contrast (a) enhanced avidly following contrast, well seen on axial Ti MRI (b). The patient
underwent the planning CT scan breathing spontaneously with a laryngeal mask airway in place (c).
A target was selected to the right of the midline (d) and a small haematoma is evident at the site of the
biopsy on CT scan one day after surgery (e). H&E stain showed bipolar astrocytic cells and moderate












This 16 year old girl presented with left sided weakness of two weeks duration, accompanied by
swallowing difficulty and voice changes. Examination confirmed a mild hemiparesis with bulbar signs
and nystagmus. Imaging showed a poorly defined lesion in the rostal midbrain and posterior thalamus
on the right. As the lesion had a wide differential diagnosis, a stereotactic biopsy was performed.
This was performed in a similar fashion to the previous case, with initial insertion of an laryngeal
mask airway for the duration of halo attachment and planning CT scan in view of the patient's young
age, followed by intubation and ventilation for surgery. Two biopsies were taken at the same target,
oriented in opposite directions with clearly abnormal mucoid tissue obtained.
Course: Histology disclosed an anaplastic astrocytoma hence the patient underwent a full course
of craniospinal radiation. She returned 8 months later with worsening of her neurological status and
was found to have a ring-enhancing lesion in the inferior right frontal lobe. A second stereotactic
biopsy confirmed this lesion was also an anaplastic astrocytoma and the patient was referred back to
the Radiotherapy service for further management.
Figure 6.4: Axial CT scan demonstrating an indistinct lesion in the upper midbrain on the right, showing
faint ring-enhancement (a); follow-up scan one day after surgery shows a very small haematoma at the
site of the biopsy (b). Histology was characteristic for an anaplastic astrocytoma (c).
Comment: Stereotaxis enabled the focal brainstem lesion in this young patient to be diagnosed with
certainty at presentation, facilitating appropriate management. When she experienced a recurrence,












Prior to the advent of CT scanning, the diagnosis of a brainstem tumour was usually made on
clinical grounds, occasionally supported by ventriculography. Surgical exploration was attempted
in a minority of cases, but carried a dreadful mortality of up to 60% in this setting [Villani]. The
first report of CT-guided stereotactic biopsy of a brainstem lesion was published 30 years ago;
a Leksell stereotactic frame was used but no specific details of the approach were provided
[Riegel 1979]. Following this, a number of neurosurgeons reported their experience, either as
part of a larger series [Ostertag, Apuzzo 1983], or as a smaller series with a specific focus on
the brainstem [Hood, Thomas_1988, Kratimenos].
A consensus developed that infratentorial lesions such as lesions in the rostra! brainstem could
be approached safely via a supratentorial transfrontal stereotactic approach, allowing a trajectory
directed thought the tentorial hiatus along the axis of the brainstem, while conversely the use of
a supratentorial approach to the cerebellum, traversing the dura of the tentorium cerebelli, was
fraught with hazard.
■ lpsilateral transfrontal
Following Riegel's series, a case report described the successful management of
a midbrain haematoma in a young medical student from Boston, utilizing transfrontal
aspiration [Beatty]. Venes's group at Ann Arbor published a detailed account of their
technique using intravenous contrast and reformatted coronal and sagittal images to plan
the angle of the trajectory, as well as using stimulation at the target site prior to taking a
biopsy in awake patients [Hood]. Apuzzo's landmark series contained 129 patients who
underwent stereotactic biopsy of diencephalic-mesencephalic lesions [Apuzzo 1987].
The early experience from Queen's Square using a precoronal burrhole [Thomas_1988]
was followed up with a series of 72 patients [Kratimenos]. The entry point was typically
just behind the coronal suture and 1-2 cm off the midline; a burrhole was recommended in
order to visualize any bridging veins. Avoiding puncture of the tentorium was considered
essential in view of the high risk of cranial nerve and vascular injury, but traversing the
lateral ventricle appeared to have few complications.
■ Suboccipital transcerebellar
As mentioned, the tentorium precluded access to the cerebellum from a supratentorial











Following an initial report from Pittsburgh [Coffey], an approach traversing the middle
cerebellar peduncle was described in a series of 26 patients from the Mayo Clinic who
underwent biopsy of a pontine lesion via a suboccipital approach [Abernathey]. This
yielded a diagnosis in all patients with no complications, but a disadvantage was the
need for general anaesthesia as the patient was prone.
■ Contralateral transfrontal
The inner margin of the tentorium may hinder the ipsilateral transfrontal approach to
the midline via the incisura; a novel contralateral approach enables biopsy of lesions in
the lateral pons and lateral cerebellar peduncle (Figure 6.5) [Amundson]. The burrhole
is located about 4cm off the midline and a completely intraparenchymal trajectory is
planned, avoiding the lateral ventricle and aqueduct, veins, arteries and tentorium. These
cases are ideally operated on awake as this enables early detection of a neurological
deficit [Shad]. Should the configuration of the target demand a transventricular route, this
may be used without ill-effect [Pereira_2008].
Figure 6.5: The contralateral transfrontal approach to the brainstem, illustrating the trajectory through the












The present series included two cases where lesions in the rostra! midbrain were biopsied
via transfrontal approach; a firm histological diagnosis was achieved in all cases without any
complications. Great care was taken to limit the number of needle passes, leaving the outer
cannula of the Sedan needle in place while removing the tissue sample from the inner cannula.
The postoperative scans in these cases were particularly significant as they indicated that the
biopsy had been taken at the target site, indicating a reassuring degree of accuracy in vivo.
Although the halo had been sutured to the scalp for these operations, in cases where an extreme
degree of accuracy is required, it is certainly an option to anchor the halo more firmly with a
screw in the outer table of the skull.
6.9.2 Pineal
A bewildering array of different neoplasms occurs in the pineal region, and making a firm
diagnosis on imaging coupled with assay of tumour markers is seldom possible. Although most
lesions in this region require microsurgical resection, with the notable exception of germinomas,
which respond very well to radiotherapy, establishing the histology preoperatively facilitates
operative planning.
No pineal region tumours were biopsied in this series. Pineal tumours show marked geographical
variation and are remarkably uncommon in our practice; no suitable cases were seen during the
period over which this study was conducted. Many of these tumours present with hydrocephalus
so with the introduction of neuroendoscopy in our service in 2000, this has become an attractive
option as it allows definitive treatment by third ventriculostomy as well as biopsy at the same
operation.
In planning a stereotactic approach to the pineal region, it is critical to consider the various
vascular structures situated above and behind the gland. Another consideration is the diagnostic
difficulty posed by the histological heterogeneity of tumours in this location. For these reasons,
many neurosurgeons avoided stereotactic biopsy of pineal lesions, but a large retrospective
French series of 370 cases from 15 neurosurgical centres reported a very acceptable diagnostic
yield of 94%, with the majority of the tumours being germinomas (27%), astrocytomas (26%)
and pineocytomas / pineoblastomas (24%) [Regis]. This was achieved with a low rate of
complications- mortality was 1.6% and serious morbidity occurred in 0.8%. All five patients
who died had haematomas evident on the postoperative scan and three had pineoblastomas, a
notoriously vascular tumour. Most of the serious morbidity occurred in patients with firm tumours











Although the surgical approach appeared not to influence the outcome, it seems sensible to
approach these tumours from a frontal trajectory, using an entry point 2 cm lateral to the midline
and 2-3 cm anterior to the corona! suture [Pell_1994ii]. The Pittsburgh group recommend an
even more frontal approach in order to ensure that the internal cerebral veins and roof of the third
ventricle are not violated [Dempsey].
610 Results
The major advantage of stereotactic brain biopsy over freehand techniques is a higher rate
of diagnosis, coupled with a lower rate of morbidity and mortality; although this technique
may represent "the ultimate in terms of efficiency in pathological diagnosis" [Chandrasoma], it
also presents a number of challenges at the outset. As one of Chandrasoma's neurosurgical
colleagues in Los Angeles has written, "the small quantities of tissue .... may stress a pathology
service that is not experienced in processing such material" [Apuzzo 1983].
In evaluating the results of stereotactic biopsy, two separate but related questions should be
asked:
■ Diagnostic yield i.e. was abnormal tissue obtained, allowing a diagnosis to be made?
■ Pathologic accuracy i. e. is this tissue representative of the lesion as a whole, allowing
the most appropriate treatment plan to be implemented?
6.10.1 Diagnostic yield
Given the heterogeneity that exists within tumours such as astrocytomas, coupled with the limited
sample size of a stereotactic biopsy, it has been suggested that the term "diagnostic yield" is
more helpful than "diagnostic accuracy"; in reviewing 17 of the largest stereotactic biopsy series
published, which encompassed a total of 7,741 procedures, an overall diagnostic yield of 91%
with a range of 80% to 99% was found. [Hall]
The various factors that may conspire to diminish the accuracy of a stereotactic procedure were
considered in chapter 4 and the role of the biopsy instrument has been discussed earlier in
this chapter. Selection of an appropriate intracranial target is also central to the success of a











■ Regional heterogeneity within a lesion; different regions may need to be targeted in order
to ensure representative tissue is obtained
■ Non-enhancing lesions may have a lower diagnostic yield
■ A specific diagnosis may be more difficult to attain in non-neoplastic lesions
The heterogeneity within a lesion was well demonstrated in a study which defined three
zones from which stereotactic biopsies were taken in a series of 29 patients with malignant
astrocytomas [Greene]. The highest diagnostic yield (67%) was from the enhancing margin,
while the hypodense (and likely necrotic) centre yielded 56%. The lowest yield at 36% was from
the hypodense periphery, but notably tumour cells were identified as far as 15mm beyond the
enhancing margin. This zone may be characterized by various host reactive phenomena such
as inflammation, reactive astrogliosis, neovascularization and oedema.
Although a number of authors suggest that a definitive diagnosis may be more elusive in non-
enhancing lesions, Rajshekar's group analysed 29 non-diagnostic biopsies out of their series of
407 cases and found no significant difference between non-enhancing and enhancing lesions
[Ranjan].
It appears to be widely agreed that non-neoplastic lesions present a greater challenge than
neoplasms, with even the leading centres often finding it difficult to make a specific diagnosis in
inflammatory conditions [Revesz].
While careful interpretation of the imaging is arguably the most important factor in locating the
lesion, ancillary investigations may be of help. An intraoperative strategy that was proposed
some years ago was the use of impedance monitoring to define the margin of a lesion [Gorecki]
or the wall of a cyst [Rajshekar 1992]. Directing the biopsy at "hot spots" revealed on metabolic
imaging such as MR Spectroscopy and PET scanning may also increase the diagnostic yield in
selected cases [Messing-Jünger].
6.10.2 Pathological accuracy
Most series reporting stereotactic biopsies confine their focus to the first question, as the only
way to confirm that the neuropathological diagnosis was indeed accurate is to resect the tumour.
One of the first authors to address this question was de Divitiis, who reported that a correct
diagnosis had been made in 92.2% of cases overall, but found that neuroglial tumours were











Chandrasoma and colleagues addressed this question in reporting the pathologic accuracy of
CT-guided stereotactic biopsy in 30 patients with mass lesions who subsequently underwent
craniotomy and resection, allowing a detailed comparison. The histologic diagnosis led to an
appropriate management strategy in 28 (93.3%) of the patients, and was incorrect in 2 (one was
a glioblastoma where only necrotic tissue had been obtained and the other a pineal germinoma
with a significant granulomatous component, which had been the target for the biopsy).
The key observation however was the fact that correlation between the stereotactic and open
biopsy was exact in only 19 (63.3%) cases, which included 11 of 12 non-astrocytic neoplasms
and 8 of 13 astrocytic neoplasms; of the 9 cases in whom the correlation was imperfect, 2
glioblastomas had been undergraded as anaplastic astrocytomas, 2 astrocytomas had a
significant oligodendroglial component that had been missed and 5 non-neoplastic lesions had
simply shown "nonspecific changes" [Chandrasoma]. This series predated widespread use of
MRI which may have improved matters somewhat, but nonetheless this remains an important
concern.
Although non-neoplastic lesions such as infections, inflammatory conditions and developmental
disorders (as in Cases 1 and 14) are particularly challenging for the neuropathologist, glial
tumours present an array of challenges too. Great difficulty may be encountered in making the
following distinctions, particularly on the intraoperative smear:
■ poorly differentiated intrinsic tumour vs. metastasis (Case 12)
■ assigning a grade to a glial tumour (Cases 6, 8, 19 and 22)
■ well-differentiated astrocytoma vs. glial reaction (Case 50)
Various authors have addressed these challenges [Apuzzo_1987, Revesz, Taratuto]. The finding
in this series that 31.6% of astrocytomas were assigned an incorrect grade on smear when
compared to the paraffin section was striking. Furthermore, it is clear that the grade assigned
to an astrocytoma on the basis of a stereotactic biopsy may need to be reviewed should the











6.10.3 The role of the Neuropathologist
Stereotactic biopsy has been referred to as a multidisciplinary procedure that requires a
neurosurgeon, a neuroradiologist and a neuropathologist [Aker]. In our experience, many general
pathologists express dismay at the small size of a stereotactic biopsy, but this has only been
compounded by the advent of neuroendoscopic biopsy, where the samples may be even smaller!
As has been stated, a resourceful and interested pathologist is pivotal to the successful application
of stereotactic biopsy, particularly when a microforceps is used for sampling [Apuzzo_1987].
The first point of contact with the neuropathologist is typically the intraoperative examination.
Although some centres persist in using frozen section [Kim], the small specimens are usually not
suitable for this technique and consequently the smear technique has really come into its own.
Initially advocated by Cushing and Eisenhardt and refined by Russell in 1937 [Marshall 1973],
this technique was more readily accepted in the UK than the USA, until needle biopsy became
more widely accepted [Marshall 1974]. With stereotactic biopsy, the surgeon's main concern
is not what the exact diagnosis is, but whether tissue sufficiently abnormal to be potentially
diagnostic has been obtained, and the smear technique is an excellent way to settle this, quickly.
A smear was performed in 81% of cases in this study, with marked variability in accuracy
depending on the diagnosis. All metastases were correctly identified on smear, but this was less
reliable for astrocytomas, with 13.7% misdiagnosed; the concomitant difficulties of assigning a
grade based on smear have already been mentioned.
It is worth remembering that the smear technique was first introduced by neurosurgeons as
a technique to be performed in the Operating Theatre. It is a straightforward matter to gently
smear a small specimen between two glass slides and immediately fix the specimen with 50%
ether and 50% alcohol (or even spray fixative); this prevents the small specimen from drying,
which obliterates any chance of getting a histopathological diagnosis. Should there not be a
neuropathologist on site, or even a pathologist with an interest in neuropathology, the slides
can then be mailed to a centre where a diagnosis can be made [Maureen Duffield, personal
communication]. This may be a very helpful strategy for users of the CTSP working in under-
resourced settings.
Sometimes the pathologist, however experienced they may be, simply gets it wrong and it may be













A 19 year-old man was referred to Groote Schuur Hospital by a senior colleague in Private Practice,
having presented with an 18 month history of a left sided thalamic pain syndrome and recent onset
of a mild hemiparesis. He had nothing of note in his past medical history or family history; a gaze
palsy and mild left hemiparesis were present but systemic examination was unremarkable. MRI scan
had been performed and this showed a small rim-enhancing lesion in the right thalamus. As the
lesion could also be seen on a contrast enhanced CT scan, a stereotactic biopsy with the CTSP was
proposed.
Following attachment of the halo in the right frontal region, a stereotactic planning scan was performed.
The biopsy was performed under general anaesthesia; the burr-hole was made 5 cm off the midline
and after inserting the biopsy needle, 3 specimens were taken, each time withdrawing the inner
cannula and leaving the outer cannula in situ in order to avoid repeated passes through the brain.
Histology was interpreted as an epithelial malignancy, possibly a metastatic carcinoma. An extensive











Figure 6.6: Initial gadolinium-enhanced T1 MRI scan (a) showing a rim-enhancing tumour in the right
thalamus, also visible on an enhanced axial CT scan (b). CT scan following stereotactic biopsy,
demonstrating a new small hyperdensity in the right thalamus, likely a small haematoma at the biopsy
site (c). H&E stain showed large cells with prominent nuclei and nucleoli typical of germinoma, adjacent
to normal brain, with lymphocytes at the interface; this had been interpreted initially as a metastatic
epithelial malignancy (d) and he received proton therapy. Corona! T2 weighted MRI 6 months later
shows a hyperintense signal in the right thalamus following proton therapy; the tract of the biopsy
needle is also clearly visible (e). In view of symptom recurrence, a repeat stereotactic biopsy was
performed (f) and this showed no evidence of malignancy.
Course: 	The patient was treated with proton therapy and chemotherapy (cisplatinum) with some
improvement in his motor deficit and pain syndrome. He experienced worsening of his symptoms 10
months later however and a repeat stereotactic biopsy was performed; this showed no evidence of
malignancy and he has remained free of recurrence for the past 12 years.
Comment: The long-term cure achieved with local irradiation (proton therapy) and systemic
chemotherapy makes a metastatic carcinoma unlikely and the diagnosis was changed to germinoma











6.10.4 What about non-diagnostic biopsies?
As the Toronto group has stated, a failed biopsy poses a real management dilemma [Soo]. Non-
diagnostic biopsies may be classified as:






If the biopsy contains nothing but normal brain, there has clearly been a targeting error. Usually,
the biopsy will need to be repeated, although clinical review may occasionally suggest otherwise,
as in Case 28 in this series.
Should no tissue be obtained, the technique of biopsy must be reviewed. A related technical
problem that has been reported has been the occasional case where the lesion was too firm to
penetrate [Muhlbauer]. We encountered this situation in Cases 1 and 14 in this series, where the
rather flimsy spiral biopsy needle was unable to penetrate a mineralized lesion.
In a recent series from Brazil, 93% of patients demonstrated histopathological changes on biopsy
but a clinical diagnosis was only made in 83.6%; of the inconclusive biopsies, 12 showed normal
brain and 14 showed features such as gliosis or necrosis [Teixeira].
It has been pointed out that an inconclusive biopsy may still be helpful [Reigel 1982]. In areas
with a high incidence of inflammatory masses such as tuberculosis, it may be very difficult to
make a specific diagnosis, but excluding a neoplastic process has definite value. Furthermore,
it has been suggested that in some cases it seemed that biopsy had encouraged a response to
antituberculous drugs that had previously been ineffective [Rajshekar 1997]!
Before repeating the biopsy, it is important to consider whether obtaining more tissue will
necessarily lead to a diagnosis. Having excluded a malignant neoplasm, it may be sufficient to












Cases illustrating the challenges encountered in introducing stereotactic biopsy in our centre will












A 6 year old girl presented with a one month history of headache, neck pain and vomiting; no systemic
abnormalities or neurological deficit noted. CT scan demonstrated multiple mineralized lesions in the
basal ganglia, particularly on the right, with low density change in the adjacent hemisphere.
The patient was transferred to Groote Schuur Hospital for the stereotactic planning CT scan after
attachment of the four fiducials to her scalp in the right frontal region. The lesions in the right
caudate nucleus were chosen as the target and following satisfactory completion of the imaging and
calculations, the patient was transferred back to Red Cross Children's Hospital where the operation
was performed under general anaesthesia. The burr hole was made at the pre-determined location
and seven specimens taken using the spiral biopsy needle. Histology showed dense calcification but
was otherwise considered non-diagnostic.
Course: 	No specific treatment was offered but her symptoms subsided on follow-up. She remained
well and subsequently manifested cutaneous features of Tuberose Sclerosis.
Figure 6.7: Axial CT scan shows mineralized lesions in the basal ganglia bilaterally with low density
adjacent to the lesions on the right side (a). Histology showed widespread calcification in the neuropil
(b). Follow-up CT scan (five) years later showed resolution of the low density with no progression of
the lesions (c).
Final diagnosis: 	Tuberose Sclerosis, non-neoplastic lesion
Inconclusive biopsy
Problem: 	Unable to penetrate mineralized lesion












A 51 year old man presented with sudden onset of left sided weakness on a background of drowsiness for
2 months. Examination disclosed left hemiplegia and CT scan showed an inhomogenously enhancing
mass in the right thalamus with marked surrounding low density and midline shift. Stereotactic biopsy
with the spiral biopsy needle via a right parietal approach yielded four small fragments which on
smear were considered suggestive of a high grade glioma, but a definitive diagnosis was not possible
due to the sample size and extensive necrosis.
Course: In view of the inconclusive histology report, the patient underwent a pterional craniotomy.
A total resection was attempted via a transsylvian transinsular approach as the initial frozen section
diagnosis was a low grade glioma, but final histology was glioblastoma multiforme. The patient was
referred for Radiotherapy but died two months after surgery.
Figure 6.8: Axial CT scan shows the lesion in the basal ganglia (a); the smear preparation shows a
tangle of blood vessels with a massively necrotic background (b), making precise identification of the
tumour challenging. The specimen was considered insufficient for paraffin sections and the tumour
was reported as "suggestive but not diagnostic of a (high grade) glioma".
Comment: Small sample size presents a challenge to the Neuropathologist, particularly early in the
introduction of stereotactic techniques
Inconclusive biopsy
Problem: 	Inadequate specimen due to consistency of necrotic tumour
Solution: 	Careful selection of biopsy site, avoid biopsying necrotic region












A 53 year old female presented with headache and confusion following a one week history of left leg
weakness which had progressed to a hemiparesis. CT scan showed an inhomogenously enhancing
lesion in the right basal ganglia.
Stereotactic biopsy via a right frontal burr-hole disclosed inflammation and necrosis, thought to be
infective in origin as no neoplasm was identified. The patient was commenced on 4-drug TB therapy
as well as intravenous penicillin, chloramphenicol and metronidazole but continued to deteriorate,
leading to a second freehand biopsy five days later. This was reported as showing "a large number of
vascular channels" but no diagnosis was made. The patient deteriorated markedly three weeks after
presentation and died four days after an external ventricular drain was inserted for hydrocephalus.
Postmortem examination revealed an extensively necrotic high grade astrocytoma.
Final diagnosis: 	Glioblastoma multiforme
Figure 6.9: CT scan following second freehand needle biopsy and insertion of ventricular drain (initial
scans missing)
Problem: 	Difficulty establishing a diagnosis in the presence of extensive necrosis
Inconclusive biopsy
Solution: 	Careful selection of biopsy site, avoiding biopsy of necrotic region












A 27 year old man presented with clinical features of raised intracranial pressure. CT scan showed a
lobulated mass in the left frontal lobe, extending into the corpus callosum and demonstrating peripheral
enhancement. Stereotactic biopsy with a spiral biopsy needle yielded disintegrating fragments of
tissue which disclosed a malignant neoplasm of uncertain histogenesis.
Course: 	The patient was referred for Radiotherapy but did not tolerate this. He died 3 months
later following readmission to Radiotherapy for palliative care and post mortem disclosed a grade IV
astrocytoma.
Final diagnosis: 	Glioblastoma multiforme
Figure 6.10: Enhancing mass in corpus callosum on CT scan (a); histological review disclosed
pleomorphic large cells with prominent nucleoli but no background structure (b), hence this was
reported as "a malignant neoplasm of uncertain histogenesis, due to the small amount of material
available".
Comment: With a small biopsy specimen, an ambiguous appearance on smear can make it very
difficult to distinguish a glioblastoma from a metastatic adenocarcinoma. The imaging appearance
was considered to be more in keeping with a glioblastoma of the corpus callosum.
Inconclusive biopsy
Problem:	Sample size












A one month old boy was referred for CT scan for asymptomatic macrocrania; this disclosed a
mineralized multiloculated mass in the left thalamus, showing minimal enhancement following
administration of intravenous contrast, with a small cyst posterior to the mass.
At three months of age, the patient was anaesthetized and underwent a stereotactic planning CT
scan at Red Cross Children's Hospital. The biopsy was performed via a left parietal burr-hole; frozen
section of the first specimen showed gliosis and two further biopsies demonstrated haemosiderin
-
laden macrophages and thin-walled proliferating capillaries. No specific diagnosis could be made
however.
Course: 	The patient remained asymptomatic but a follow-up MRI six months later showed the lesion
had enlarged. A craniotomy was performed at which time a diagnosis of arteriovenous malformation
(AVM) was made on frozen section and the operation was terminated so an angiogram could be
obtained. The angiogram showed no evidence of an AVM but was otherwise non-diagnostic; new
onset of hydrocephalus necessitated insertion of a left sided ventriculo-peritoneal shunt six months
later.
Final diagnosis: 	Giant capillary cavernous angioma
Figure 6.11: left thalamic lesion (a) showing a lobulated mineralized lesion in the right thalamus.
Histology demonstrated abnormal vessels and haemosiderin-laden macrophages (b). Follow-up CT
scan 2 years later showed enlargement of both the solid component as well as the adjacent cyst (c).
Problem: 	Failure to consider a vascular aetiology
Inconclusive biopsy












A 21 year old man presented with a 4 month history of headache and mild right hemiparesis having
been treated for recent onset seizures at a rural hospital. CT and MRI scans showed a mixed density
lesion in the left parieto-temporal region. Stereotactic biopsy with the spiral needle yielded 3 small
fragments thought to show features of a grade II astrocytoma.
Course: 	The patient was referred for Radiotherapy but he became confused and treatment was
therefore terminated after 10 Gy. His course was also complicated by a deep vein thrombosis in the
calf.
Figure 6.12: Mixed density lesion on CT (a) and MRI (b) scans. Histological review disclosed a cellular
tumour with early vascular proliferation (c), making distinction between Grade II and Ill difficult.
Comment: Concern may arise about under-grading an astrocytoma following a stereotactic biopsy,
but in this case the lack of contrast enhancement was in keeping with a Grade II tumour.
Problem:	lower diagnostic yield with non-enhancing lesions
Inconclusive biopsy













An 11 year old girl with Neurofibromatosis Type 1 was referred from Ophthalmology with a history of
progressive visual deterioration over the preceding three years together with a worsening hemiparesis.
CT scan showed a hypodense lesion in the posterior left thalamus with peripheral enhancement and
marked central enhancement on MRI scan. A stereotactic biopsy was recommended in view of her
progressive neurological signs.
At the time of biopsy the needle was felt to enter a firm lesion but the initial histopathology diagnosis
was "normal brain". Subsequent review by a Paediatric Neuropathologist noted the presence of a
number of Rosenthal bodies, indicative of a Grade I Astrocytoma.
Course: 	No progression of lesion on initial follow-up, but subsequently lost to Neurosurgical
follow-up.
Figure 6.14: Initial MRI showed an avidly enhancing lesion in the posterior left thalamus (a), biopsied via
a parietal approach following administration of intravenous contrast for the planning CT (b). Histology
revealed a Grade I Astrocytoma with a number of Rosenthal Bodies (c).
Comment: In hindsight, this lesion was typical of a Pilocytic Astrocytoma in the setting of
Neurofibromatosis Type 1.
Problem:	Difficulty establishing a diagnosis in low grade tumours
Initially negative biopsy












The forgoing discussion demonstrates that stereotactic biopsy is an effective and accurate
procedure, but it is also important that the surgical objective be achieved at low risk to the
patient. Mortality should be very low as this is not a therapeutic procedure. A review of 7,471
biopsies suggests that this is indeed the case- the overall diagnostic yield of 91% was achieved
with 3.5% morbidity and 0.7% mortality. [Hall]
Given the developmental nature of this series, and the heterogeneity of the procedures, it is
difficult to compare our data, but there was only one death, giving an operative mortality of 0.8%
(1 patient/115 procedures) and two patients suffered major morbidity (1.7%).
A recent publication from Pittsburgh sought to establish a benchmark for the complications of
frame-based stereotactic surgery through analyzing a 28-year experience encompassing 2,651
cases, most of which were performed in a specially constructed operating room containing
a dedicated CT scanner [Lunsford 2008]. Immediate postoperative CT scan detected blood
products in only 43 of 1,664 biopsies (2.6%), six of whom required craniotomy for haematoma
evacuation. Two patients, early in the series, died as a direct result of their stereotactic surgery,
a mortality of 0.075%.
The complications that require particular consideration are:
■ Haemorrhage
■ Swelling




■ Systemic, such as DVT
One of the important tasks has been to identify which patients are at particular risk for
complications. The Toronto group noted that markedly raised intracranial pressure increased the
risk of death due to herniation [Bernstein_ 1994]. Preoperative use of antiplatelet agents, chronic
corticosteroid use, biopsy of deep-seated lesions and malignant gliomas and a greater number











confirmed that biopsy of thalamic and basal ganglia lesions carried a higher risk of complications,
particularly if more than one needle pass was required, and also found that diabetes with a blood
glucose level >200mg/dI had 100% predictive value for biopsy-related morbidity [McGirt].
One study reported a high diagnostic yield taking a median of 14 biopsies per patient with
remarkably low complication rate of 1.5% [Fritsch]. Perhaps the number of needle passes is
more relevant in this regard than the number of biopsies taken.
6.11.1 Haemorrhage
Haemorrhage is the most feared complication of stereotactic brain biopsy. When it does occur it
is usually venous or capillary in origin and arterial bleeding is rare.
Various factors may affect the risk of biopsy-related haemorrhage:
i. Preoperative factors
■ avoid biopsy of vascular lesions
■ coagulopathy or taking aspirin
■ uncontrolled hypertension
ii. Intraoperative factors
■ the site of biopsy, avoiding major surface vessels
■ a burr hole enables the neurosurgeon to avoid lacerating a surface vessel
■ trajectory selected to avoid crossing more than one pial surface, regions of vessels such
as the Sylvian fissure and the supratentorial midline
■ technique of biopsy (haptic feedback or "feel")
■ avoiding multiple passes
iii. Postoperative factors
■ blood pressure control
A small fleck of blood on the postoperative scan is common in our experience, and can be quite
helpful (as can a small locule of gas) in indicating the site of the biopsy and certainly is no cause











Figure 6.15: Haematomas following stereotactic biopsy. Minor haemorrhage <5mm in diameter
(a); moderate haemorrhage which was managed expectantly (b) and large haematoma which
required urgent craniotomy for evacuation (c).
As already discussed, many neurosurgeons routinely obtain postoperative CT scans to establish
whether there has been intracranial bleeding; in an effort to establish the true incidence of this,
Kulkarni and colleagues conducted a prospective study in which 102 consecutive patients who
underwent stereotactic biopsy over a two year period underwent a CT scan within 24 hours of
surgery [Kulkarni]. Nine patients (8.8%) experienced an early postoperative deficit, of whom
threehad no blood evident on their scan and the deficit was attributed to increased tumour
oedema. Although six patients who had a deficit also had blood evident on CT scan, a further
56 patients had haemorrhage but no deficit i.e. the haemorrhage was clinically silent. In the
majority of cases the haemorrhage was minor; the authors utilized a helpful classification based
on maximum diameter which has also been used in this study, with a fairly similar spread (Table
6.1)
Type of haemorrhage No of patients
Kulkarni et al This series
Intracerebral < 5mm 22.5% 19.1%
Intracerebral 5-10 mm 20.6% 29.8%
Intracerebral 10-30mm 6.9% 4.3%

















While the main recommendation of this publication, namely that routine CT scanning after
stereotactic biopsy doesn't add significantly to patient outcome, was indisputable, the incidence
figures quoted stimulated a spirited debate and spurred other groups into conducting prospective
studies examining this issue. The group from Munich argued that use of a dedicated workstation
to plan the surgery and a 1mm biopsy forceps to take the biopsy reduced the risk of bleeding
[Kreth 1999] and followed this up with a prospective study where the senior author performed
345 biopsies over a two year period [Kreth 2001]. This study reported an incidence of silent
bleeds of 9.6% and haemorrhage-related morbidity of 0.9%.
In the rare event that bleeding is apparent at the time of biopsy, this may be from a surface
vessel, which may be readily controlled, or from the biopsy site, which cannot be controlled. It
is strongly recommended that the surgeon leave the biopsy needle in place to try to prevent a
large intracerebral haematoma forming. Should the bleeding not abate, an external ventricular
drainage catheter with large fenestrations may be inserted in order to allow the blood to continue
draining and a decision made whether to proceed to craniotomy or obtain an urgent CT scan or
angiogram.
6.11.2 Swelling
The one death in this series that appears to be linked to a stereotactic procedure was a 44
year old woman who died five days after biopsy of a large right parietal anaplastic astrocytoma.
The patient had been referred following initial management elsewhere; a CT scan reportedly
showed a large inhomogenously enhancing tumour with considerable mass effect. Unfortunately
the scan could not be traced for review. The patient had been transferred to the Radiotherapy
ward three days after an uneventful biopsy but was still receiving dexamethazone. Her level
of consciousness deteriorated on postoperative day 5; a CT scan showed no haematoma and
she was continued on a high dose of intravenous dexamethazone but continued to deteriorate
and died the same day. An autopsy was not performed, but it is highly likely that she died from
herniation due to raised intracranial pressure, possibly provoked by the stereotactic biopsy.
Many patients harbouring intracranial lesions which require biopsy will have raised ICP to some
degree so this is not in itself a contra-indication to needle biopsy, but great caution is required
for the patient with critically raised pressure for whom the smallest volume increment may prove
fatal. Of the five patients who died in a series reported from Toronto, all had a glioblastoma
multiforme and three died from transtentorial herniation with no evidence of haemorrhage at











or even the volume of the biopsy instrument itself could precipitate herniation in this situation.
6.11.3 Increased neurological deficit
There is no question that patients who already have a focal deficit at the time of biopsy are
at increased risk for that to worsen. Another consideration is the site of the biopsy; this has
been convincingly shown by a study reported by Cook and Guthrie, comparing the neurological
complications of biopsy in eloquent vs non-eloquent areas [Cook] (Table 6.2).
Postoperative clinical All patients Non-eloquent region Eloquent region
status
No change 171 (93%) 149 (99%) 22 (68%)
Transient deficit 7 (4%) 2 (1%) 5 (16%)
Permanent deficit 5 (3%) 0 5 (16%)
Table 6.2: The influence of biopsy site in determining whether a patient suffers a postoperative
neurological deficit (from [Cook])
6.11.4 Seizures
Anticonvulsants are often commenced in patients presenting with seizures, but stereotactic
surgery may itself provoke a seizure. This has been reported in 1-2% of cases in some series
[Teixeira] [Blaauw], but given the high incidence of potentially serious drug-induced side-effects
we encountered, the use of prophylactic anticonvulsants does not seem justified.
6.11.5 Infection
A single dose of prophylactic antibiotic was usually given to prevent a surgical site infection,
as with any other neurosurgical procedure. Of the two surgeons performing the majority of the
operations described in this thesis, one gave prophylactic antibiotics routinely while the other
did not, which appeared to make no difference in this small series. Shaving the head is not
necessary, provided the hair is washed and the surgical site properly cleaned [Blaauw]. The
only septic complication was a patient who developed a superficial wound infection 3 days after












Implantation along the biopsy tract is a rare complication, but it is striking and has been described
following biopsy of the following tumours:
■ pineoblastoma, in an 18- month old boy, 3 months after biopsy despite having received
chemotherapy [Rosenfeld]
■ metastasis, in two adults, 6 months and 3 months after biopsy, following treatment with
radiosurgery [Karlsson]
■ glioblastoma multiforme, 3 months after biopsy [Pierallini, Steinmetz]
■ anaplastic astrocytoma, 2 months after biopsy [Kim]
This complication typically presents relatively early after the biopsy and may be reduced by
li miting the number of passes of the biopsy needle.
Case reports of various rare complications following stereotactic biopsy include
■ traumatic false aneurysm in a 3 year old child following biopsy of a supratentorial
astrocytoma, discovered at craniotomy for resection of the tumour; most likely a cortical
vessel was injured at the time of the initial biopsy as bleeding occurred at the time of
durotomy, although this was easily controlled [Sahrakar]
■ pneumocephalus following inadvertent premature removal of the single skin staple
following biopsy of an anaplastic astrocytoma in a 79 year old man; this was complicated
by acute pulmonary oedema necessitating ventilation [Roth]
Systemic complications such as deep venous thrombosis may also occur, systemic consequences












Lunsford stated [Lunsford 1993] that there are at least five reasons for failure to obtain a correct
histological diagnosis using a stereotactic technique:
■ Choosing the wrong patient
■ Choosing the wrong technique
■ Choosing the wrong imaging tool
■ Choosing the wrong surgeon
■ Choosing the wrong pathologist
Stereotactic biopsy may appear to carry a long list of potential complications, but it is important
to bear in mind the fact that many these procedures are done for lesions that are usually located
deep within the brain or in eloquent cortex and often have abnormal vasculature. In that context
this really is a remarkably effective and safe procedure.
Performing a biopsy is almost invariably a diagnostic procedure which leads to further interventions.
Stereotaxis can however be used for therapeutic purposes as well; the next chapter will describe














7.1 Craniopharyngioma: the questions
The benign histological appearance of craniopharyngioma belies a malevolent nature, with many
patients paying a high price in complications of both the disease and its treatment. This is largely
due to the location of the tumour, adjacent to critical neuronal regions, such as the hypothalamus,
pituitary stalk and pituitary gland, optic nerves and chiasm, and vascular structures such as the
branches of the internal carotid arteries.
The evolution of neurological surgery over the past century is reflected in enormous strides in
the management of craniopharyngioma. In reviewing this history, Di Patri observed that Harvey
Cushing had coined the term "craniopharyngioma" on the basis that "this admittedly cumbersome
term has been employed for want of something more brief to include the kaleidoscopic tumors,
solid and cystic, which take origin from epithelial rests ascribable to an imperfect closure of
the hypophysis or craniopharyngeal duct." Notably, Cushing himself found this to be "the most
forbidding of all intracranial tumors" [Di Patri]
The 1950s brought two major advances in the management of these tumours- the use of
corticosteroids and the introduction of the operating microscope. The use of cortisone and
adrenocorticotrophin (ACTH) was first reported from Boston Children's Hospital [Ingraham] and
this led to a marked improvement in postoperative survival. Not only could potentially lethal
postoperative pituitary insufficiency be treated, but surgeons were now able to attempt more
radical resections. This was greatly facilitated by the use of the operating microscope which was
first used for a neurosurgical operation in 1957 and within a decade, a number of neurosurgeons
had reported microsurgical complete resection of craniopharyngiomas [Di Patri].
Among the most ardent exponents of radical resection was Harold Hoffman at the Hospital
for Sick Children in Toronto, who in 1977 maintained that total excision could be carried out
almost invariably, without mortality or even morbidity [Hoffman]. Another landmark was reached
in 1990 when Yasargil reported a series of 144 cases, 93% of whom underwent a total resection
[Yasargil]. Radical resection, usually via a pterional or subfrontal craniotomy had become
accepted as the standard of care, particularly among experienced surgeons [Sanford]. Ongoing











as transphenoidal resection [Laws 1994] and other applications of endoscope-assisted surgery
[Teo], widened the range of options available to the neurosurgeon in striving for this goal.
Another important strategy in managing these tumours has been the use of radiotherapy, delivered
in various ways. It has been noted that "one of the longest lasting debates in neurosurgical practice
... (is) ... what is the role of radical surgery, and what is the place of radiotherapy in the treatment
of craniopharyngioma?" [Di Patri]. Long-term studies have demonstrated that conventional
external beam radiotherapy does indeed improve long term tumour control, especially following
subtotal resection, while more sophisticated forms of treatment such as fractionated stereotactic
radiotherapy, radiosurgery (either with the linear accelerator (LINAC) or Gamma Knife), proton
therapy and intracavitary beta-irradiation have also been extensively investigated [Kalapurakal].
Although craniopharyngioma may be seen in adults, it is more common in paediatric practice,
accounting for approximately 6-9% of CNS tumours in children, and this has obvious implications
for management in general and the use of radiotherapy in particular. Determining the optimal
treatment for craniopharyngioma has therefore been a source of controversy, notwithstanding
Fred Epstein's 1992 symposium entitled "Craniopharyngioma- The Answer"!
There is no question that radical surgery has led to a marked reduction in mortality, but long-term
morbidity has emerged as a major concern, particularly in children who almost invariably manifest
endocrinopathies and severe postsurgical obesity as well as visual deterioration and have a high
prevalence of neurocognitive sequelae as well as seizures and motor deficits [Hukin_2007].
In response to these concerns, many neurosurgeons have adopted a more cautious surgical
approach, which has been characterized as a pendulum swinging from aggressive to more
conservative management [Sainte Rose]. A central tenet of the modern approach is management
by an experienced multi-disciplinary team [Hargrave], with the principle goal of treatment being












As craniopharyngiomas arise from epithelial cell rests of Rathke's pouch (the craniopharyngeal
duct) or squamous metaplasia, they are of epithelial origin, hence drugs known to be
effective against epithelial neoplasms have been utilized in their management. As many
craniopharyngiomas, particularly those found in children, have a large cystic component,
treatment by instilling such drugs directly into the cyst is an appealing strategy; the agents used
most often for this purpose have been B-emitting radionuclides and chemotherapeutic drugs
such as bleomycin.
Ayub K Ommaya designed a subcutaneous reservoir attached to a ventricular catheter, which
enabled percutaneous access to the ventricles for repeated CSF sampling or direct administration
of drugs such as antineoplastic agents and antimicrobials [Ommaya]. This was subsequently
manufactured by the Heyer-Schulte Corporation and came to be known as an "Ommaya
reservoir". Following a report describing the use of this device for regular decompression of a
cystic craniopharyngioma in a patient who had already undergone five craniotomies [Fox], such
reservoirs have found application in treating a wide array of neurosurgical conditions are now
manufactured in different configurations by various companies.
7.2.1 Radionuclides
The use of intracavitary irradiation in craniopharyngioma was pioneered by the Swedish
neurosurgeons Herbert Olivecrona and Lars Leksell, with the latter reporting a case treated by
stereotactic puncture of the cyst and injection of phosphorus-32 (32p) in 1952 [Backlund_1994].
Typically, the radiopharmaceutical is stereotactically injected into the cyst as a single dose,
without any need for an implanted catheter, which some authorities believe stimulates production
of tumour fluid [Lunsford 1994]. This is a relatively simple treatment to administer as it can be
accomplished with only local anaesthesia to the scalp.
Building on the work of his predecessors at the Karolinska, Backlund developed an approach
to treating craniopharyngioma, the Multimodality Protocol (MMP), in which the choice of
microsurgery, intracavitary irradiation, radiotherapy or radiosurgery was guided by a simple











Table 7.1: The Multimodality protocol (MMP): treatment options based on a morphological
classification of craniopharyngioma. IC: intracavitary irradiation; MS: microsurgery; RS:
radiosurgery; RT: radiotherapy [from Backlund 1994]
This well-reasoned approach advocated microsurgery for small lesions, even if cystic, as well
as solid lesions of any size, but emphasized the role of intracystic therapy for the commonly
encountered scenario where the cyst volume was greater than 10m1. Although the various forms
of external beam radiotherapy were not first-line treatment options, their role was quite clearly
recognized.
The ideal situation for intracystic radiotherapy is to utilize a B-emitting agent of high energy
that has limited tissue penetration together with even dose distribution; those used include
32 P, yttrium-90 (90Y), rhenium-186 (186,-%he, and aurum-198 ("Au). In view of the complex issues
pertaining to the manufacture and handling of these isotopes, they are seldom a realistic option












Bleomycin is an antineoplastic antibiotic secreted by Streptomyces verticillus, composed of 2 main
glycopeptides, Bleomycin A2 and B2 which bind to DNA and causes strand scissions [Umezawa].
It is widely used to treat malignant disease, although most tissues, with the exception of lung
and skin, are capable of enzymic degradation of bleomycin. It was first used by Umezawa for the
treatment of squamous cell carcinoma in 1966 but CNS application was impeded by poor blood-
brain barrier penetration. Various investigators reported using bleomycin for malignant gliomas,
delivered via an Ommaya reservoir; craniopharyngioma, given its epithelial nature, was also an
attractive target and this was first reported in 1976 by Takeuchi, who noted that production of cyst
fluid decreased with "no complication worth mentioning" [Takeuchi].
Takahashi and colleagues injected bleomycin labeled with cobalt-57 into the tumour cyst and
reported that the radioactivity decreases rapidly with a half-life of 3 hours; by 24 hours, levels
had dropped to around 10% of the initial activity [Takahashi]. These authors reported long-
term tumour control and this was followed by other positive results from Milan [Broggi], Lyon
[Mottolese 1996] and Sao Paulo [Cavalheiro]. There was consequently general enthusiasm
within the Paediatric Neurosurgery community about the potential benefits of this approach [JC
Peter, personal communication].
Although the treatment outlined above is often referred to as "stereotactic brachytherapy",
this applies specifically to the use of radiopharmaceuticals, hence the term "stereotactic
chemotherapy" is used here.
7.3 Case series
As craniopharyngioma is a benign tumour, arrest of further tumour growth coupled with
decompression of the cyst to reduce intracranial pressure and optic pathway compromise are
important therapeutic goals. Following the initial optimistic reports of tumour control by intracystic
bleomycin, delaying the use of radiotherapy in children as well as sparing the hypothalamus
and therefore preserving endocrine function, this was considered an option worth pursuing.
This was particularly appealing in a developing country context, where preservation of function
is rendered even more important given the limited access to endocrine replacement therapy
and the difficulty of returning to central hospitals in an emergency. A Brazilian colleague has
emphasized the important influence environmental factors such as these have on neurosurgical












All patients presenting to Red Cross Children's Hospital and Groote Schuur Hospital with a
largely cystic craniopharyngioma from January 1997 to December 1999 were considered for
insertion of an Ommaya reservoir and bleomycin treatment. A protocol for treatment was drawn
up by colleagues in Radiotherapy in consultation with Neurosurgery (Figure 7.1).
Initial decision-making:
Predominantly solid tumour: craniotomy and debulking
Predominantly cystic tumour: insertion of Ommaya reservoir into cyst (craniotomy or stereotactic)
Permeability test:
2 weeks after insertion
2m1 fluid withdrawn from reservoir
2m1 Omnipaque injected
Patient position rotated to ensure adequate contrast distribution
CT scan 15 minutes after injection; 5 mm thick slices from one centimeter below tumour to one cm above
tumour
Injection of bleomycin:
Schedule: weekly for 6 weeks
Oral analgesia and topical anaesthesia (EMLA) to scalp; mild sedation with oral chloral hydrate as indicated
Repeat CT scan prior to first dose of bleomycin, calculate volume of cyst
Dose 4-6 mg depending on volume of cyst
Mixed with 0.9% saline to a dose of 1U/ ml
Butterfly needle inserted into reservoir
Withdraw cyst fluid equal to volume of bleomycin to be injected + 2m1, stop immediately if significant headache
Inject bleomycin solution and flush reservoir with 2m1 0.9% saline
Fluid to be sent for biochemical analysis (LDH and cholesterol)
Completion of therapy:
Repeat CT scan after 6 weeks
o If significant reduction: follow-up CT in 6 weeks
o If multiloculated, repeat contrast cystogram to establish whether another Ommaya reservoir is required
o If progression of solid component, progress to localized radiotherapy
Figure 7.1: Protocol for the use of bleomycin at Groote Schuur Hospital and Red Cross Children's
Hospital
7.3.1.1 Insertion of Ommaya reservoir
The intracranial catheter for the Ommaya reservoir was implanted stereotactically in all cases
considered here; one patient who received bleomycin following insertion of an Ommaya reservoir
at craniotomy was not included in this analysis. As difficulty was experienced in penetrating the
calcified cyst wall with the relatively soft silastic catheter in some cases, even with the wire stylet
in place, a modified Seldinger technique was devised. This entailed puncture of the cyst with the











cyst using a rotatory action should there be resistance, and then pulled back to make a small
perforation though which the could then be inserted with ease. The inner spiral needle was then
withdrawn and if fluid typical of a craniopharyngioma was aspirated, a J-tipped vascular guide-
wire was passed into the cyst. The outer cannula was then withdrawn and the silicon catheter
passed into the cyst along the wire.
After verifying flow from the distal tip, the proximal end of the catheter was attached to a reservoir
which was secured to the pericranium in a subgaleal pocket. At the outset of this series the only
configuration type of reservoir available for use had a "T" configuration with the inlet port on the
undersurface, but a side-inlet reservoir was subsequently obtained.
7.3.1.2 Analysis of response
Details concerning the clinical presentation, management decision-making, treatment given,
complications and outcome were prospectively recorded. Hospital records (hospital folders and
radiotherapy departmental charts) and neuro-imaging studies were reviewed in preparing this
chapter. The response to therapy was classified according to the degree of best response in the
standard fashion [Hukin_2005]:
o >90% reduction in volume compared to prior to therapy= Complete Response (CR)
o >50% = Partial response (PR)
o >25% = Minor response (MR)
o Progression defined as at least a 40% increase in tumour size or a clinical deterioration
that required intervention
7.3.2 Results of intracystic bleomycin treatment
The results of stereotactic cannulation of craniopharyngiomas were described in Chapter 5.11;
this chapter will consider the response to bleomycin in these patients.
Six of the eight children who had an Ommaya reservoir implanted received bleomycin; the first
patient (Case 3) was treated with Yttrium and was subsequently lost to follow-up while another
1.5 year old patient experienced such marked improvement with simple decompression of the











Case Presentation Type Total Response and Bleomycin Outcome
dose duration Complications
45 Headache in 15 A 34 mg CR Temporal lobe Stable for 12
yo girl, surgery low density years
and RT for cra-
niopharyngioma
11 years ago
48 Rapid visual A 44 mg MR, stable for 4 Deterioration in RT after 5
deterioration and years, then re- visual impair- years, stable for
decreased level quired aspiration ment to blind- 7 years
of conscious- ness on L de-




76 Headache andBcyst 	24 mg PR Diencephalic low Died at nine
deteriorating vi- density months
sion in 6yo girl
80 Headache, de- A 32 mg MR, stable for 4 Panhypopituita- Surgery (trans-
teriorating vision years rism sphenoidal and
and delayed pu- subfrontal) fol-
berty in 13yo boy lowed by RT,
stable for 5
years
87 Headache and Ccyst 20 mg CR Nil Died 3 months
mild right hemi- (2 courses after 2nd recur-





95 New onset left Cyst 25 mg CR first course, Low density left Died 10 years
hemiparesis af- (2 courses PR second frontal lobe after later, after 3rd
ter commencing of 10mg course, died 3 1s1 course recurrence
proton therapy and 15mg) months later
Table 7.2: Children receiving intracystic bleomycin. Type: Backlund classification (see Table 7.1).











Of the three adults that were considered for bleomycin (Table 7.3), one experienced such
marked improvement in her vision following decompression of the cyst that bleomycin was not
administered initially, despite her having had the catheter revised due to a leak on the initial
contrast cystogram; she was subsequently lost to follow-up (Case 71). A further patient (Case
73) suffered a major complication with deterioration in her level of consciousness together with
a new onset left hemiparesis and CT scan suggested that this was iatrogenic due to inadvertent
intracranial penetration of the needle in that there was a new tract haematoma. This patient was
also from a rural area and was lost to follow-up after returning home.
A third patient experienced transient drowsiness following her first dose of bleomycin and
although she recovered and received six doses of bleomycin, she subsequently manifested a
relentless deterioration and died three months after starting treatment (Case 82). No autopsy
was performed but her deterioration was ascribed to bleomycin by the treating clinicians.
Case Presentation Type Total Response Bleomycin Outcome
dose and duration Complications
71 49 yo female; HA A 0 N/A N/A Returned
and deteriorating to referring
vision; from rural hospital, lost to
area follow-up
73 25 yo female A 25 mg PR Confusion while Returned
with headache (5 x 5mg) instilling blm, to referring
and reduced bloodstained fluid hospital, lost to
level of aspirated. New L follow-up
consciousness; hemiplegia with




82 53 yo female A 30 mg MR Drowsy one Died 3 months
with deteriorating (6 x 5mg) day after first after starting
vision, blm instillation, bleomycin
headache, poor recovered
memory and well, then
personality subsequent severe
change over one deterioration
year
Table 7.3: Adults considered for intracystic bleomycin. Type: Backlund classification (see Table













This 15 year old girl was first referred from a rural area 11 years previously, having presented with
features of raised intracranial pressure. A large suprasellar tumour and marked hydrocephalus were
present on CT scan and she underwent bilateral VP shunt insertion, pterional craniotomy and subtotal
resection and radiotherapy (total dose 60cGy). She returned with recurrent symptoms of raised
intracranial pressure and a large cystic suprasellar mass was evident on CT scan (Figure 7.2)
Course:An Ommaya reservoir was inserted via a right frontal approach and she received 34 mg of
bleomycin over a 5 week period. The excellent response (>90% reduction in cyst volume) has been
sustained for twelve years.
Figure 7.2: Axial T2 MRI at time of tumour recurrence (a) and follow-up image at 6 months demonstrating
a CR (b and c); a further follow-up scan at one year showed new hyperintense signal changes in right
temporal lobe (d) which had initially been normal in appearance; this was more marked 4 years later (e)












This 6 year old girl had been managed by Ophthalmology for a squint since birth and presented with
deteriorating visual acuity; examination disclosed pale chronically swollen discs. CT scan showed
hydrocephalus and a cystic mass within the third ventricle with a small suprasellar enhancing mass,
typical of craniopharyngioma. Bilateral VP shunts were inserted and within three days of shunt
insertion the patient reported improved vision.
As she was considered a good candidate for bleomycin, she underwent stereotactic insertion of
an Ommaya reservoir three weeks later. This was accomplished successfully with the blunt-tipped
catheter with the stylet in place easily entering the cyst on first pass, following which it was secured
to the straight connector of the reservoir. Two weeks later a contrast cystogram demonstrated no leak
and the first dose of bleomyin was instilled uneventfully the same day.
Course: 	Three further doses of 5mg were instilled over the following ten days and she remained
clinically well; as the cyst appeared smaller on CT at the time of the fourth instillation, a contrast
cystogram was performed at the time of the fifth instillation. Three milliliters of cyst fluid was aspirated
following which 4mg bleomycin was injected, mixed with 1 ml of Omnipaque. The patient immediately
complained of headache, felt sleepy and then vomited, following which her headache resolved. No
leak was evident on the CT scan. Two days later she was found to have mild hyponatremia (131mmo1/1)
but she was otherwise well; ten days after instillation of the fifth dose she was drowsy and somnolent
and CT scan showed extensive low density in the diencephalon. She was commenced on high doses
of intravenous hydrocortisone and ceftriaxone. Her level of arousal fluctuated over the following two
weeks but she was eventually fit to go home on a maintenance dose of hydrocortisone.
One month after the event she was readmitted with a reduced level of consciousness and although
she had episodes of improvement, she required readmission to the Paediatric Endocrine service on
a number of occasions over the following months. Follow up neuroimaging showed atrophy and MR
angiography showed diffuse vascular changes.
Overall, her course was one of relentless deterioration with prolonged episodes of hypersomnolence











Figure 7.3: Axial CT at presentation (a), sagittal (b) and corona! (c) T1 weighted MRI with gadolinium
following shunt insertion, showing the tumour cyst located within the third ventricle. Following the
stereotactic planning scan (d), the catheter was implanted successfully in the cyst. Follow-up CT ten
days following the last dose of bleomycin showing low density changes in the thalami and midbrain
bilaterally (e). Axial T2 MRI 15 days after bleomycin showing extensive hyperintensities in the
diencephalon (f) while CT scan 2 months later showed marked cerebral atrophy (g). MR angiogram at
9 months (h) showed diffuse narrowing of both middle cerebral arteries and anterior cerebral arteries
bilaterally with a moya-moya blush.
Problem: As a Backlund Type Bcyst , perhaps the cyst was too small for bleomycin treatment, although
she responded well initially. The apparent absence of leakage may have been falsely reassuring,












The purpose of treating these patients with bleomycin was to control tumour growth while
preserving endocrine and neurological function. The technical challenges presented by this
strategy will be considered before reviewing the efficacy of bleomycin in this series, together
with and the complications of its use.
7.4.1 Technical issues
7.4.1.1 Implantation of the reservoir
Various methods of implantation of the catheter for the Ommaya reservoir have been reported,
including craniotomy, stereotaxis and endoscopy. The Canadian Pediatric Brain Tumor
Consortium study reported that intracystic bleomycin was utilized in 6 of 17 centres; of the 19
patients selected for this treatment, seven (36.8%) experienced complications related to catheter
insertion, with no technique noted to be optimal [Hukin 2007].
Craniotomy is favoured by some as it enables placement of the catheter under direct vision, but
even this does not guarantee accurate placement- the first patient in whom we implanted an
Ommaya reservoir at the time of craniotomy had a suboptimal position as the tip of the catheter
appeared to extrude beyond the wall of the cyst, although no leak was evident on the contrast
cystogram. This patient was not included in the present series.
Conversely, some authors have recommended stereotactic placement as a safer option than
craniotomy, using a Gordis® tube with only 2 holes at the distal end to avoid leakage, inserted
directly with the stylet in place [Mottolese_2001]. This group reported two technical problems
early in their series due to misplacement as a result of cyst shrinkage due to tapping first with a
Sedan needle.
Ommaya's original design was a T-shaped construct positioned over a burr-hole with the
ventricular catheter connecting to an inlet which was perpendicular to the base of the reservoir
[Ommaya]. This type of reservoir, manufactured by Codman®, was used at the outset of the
study but the design presented a problem as the catheter had to be withdrawn by about 1-2 cm
in order to secure the proximal end to inlet of the reservoir, risking inadvertent withdrawal of the
tip of the catheter from the intracranial cyst. Later in the series, a reservoir with a side inlet was











connected to the inlet of the reservoir which was easily secured in a subgaleal pocket.
The Verona group advocated a protocol they termed the multimodality stereotactic approach
(MSA) which enabled insertion of the Ommaya reservoir catheter under visual control following
the introduction of an endoscope under stereotactic guidance [Nicolato 2004]. These authors
contended that direct visualization facilitated perforation of the cyst wall which they often found to
be firm and elastic and, in their experience, this technique reduced the risk of deviation from the
stereotactic track, which was clearly a problem in two of the cases reported here (Case 48 and
Case 80). A further advantage of the endoscope is the ability to fenestrate septa, converting a
multilocular tumour into one that is more readily treated with a single Ommaya reservoir system.
In this centre, bleomycin instillation was followed by radiosurgery to the residual solid component,
utilizing the Gamma Knife.
A technique for inserting an Ommaya reservoir via "two burr hole technique" using the endoscope
has been described from Tokyo [Joki]. Using this approach inevitably requires the catheter to
pass through the ventricle which may be more hazardous should there be a leak.
7.4.1.2 Contrast cystogram
This is an essential step in order to ensure there is no leak from reservoir, catheter or cyst
prior to instilling bleomycin. In general, 1-2 ml of intravenous contrast is injected into the reservoir
and the patient scanned 15-60 minutes later. This procedure is referred to by various other
names (permeability test/ water tightness test/ dye test) and has been performed anywhere from
7 days to 5 weeks after insertion of the Ommaya.













7.4.2.1 Efficacy of bleomycin
On the whole, these results were not very encouraging. Of the six children treated, three showed
a complete response with marked reduction in size of the cyst treated, although two of these
patients experienced subsequent cystic recurrences together with growth of the solid component
and eventually died, following a decision not to continue pursuing active treatment in view of their
generally poor functional state. These three patients had all undergone microsurgical resection
and radiotherapy previously. The child whose death was likely due to bleomycin-induced
diencephalic injury (Case 76), had shown a prompt response to therapy and may well have had a
complete response had therapy not been discontinued in view of this complication. Two children
showed a minor response in that the cyst did not shrink to any great extent but there was no
progression for four years in both cases.
Both adults who received bleomycin fared poorly, although it is not clear whether this can be
ascribed to the drug alone. One patient clearly had an iatrogenic complication in that a new
hemiplegia was noted after instillation of bleomycin and CT scan showed a haemorrhagic tract,
suggestive of needle penetration, while documentation in the patient who died was insufficient to
make a definitive assessment.
The published experience with the use of intracystic bleomycin was reviewed in depth in writing
this chapter. The variation in the dosage schedule is quite remarkable, both in terms of the
frequency of instillation and the dose administered [Caceres, Hargrave]. Some argue for daily
instillation given the half life of 3 hours, but most administer the drug every other day on a
Monday / Wednesday / Friday basis; the protocol reported here was at the conservative end
of the spectrum in using a weekly dosage schedule. It appears as though daily instillation may
increase the risk of severe side-effects [Savas_2000, Jiang].
Most centres administer a dose of 3-5 mg, determining the optimal dose according to the volume
of the cyst and often escalating this over time. There may be a correlation between the dose
received and the response rate- the Canadian series noted that 4 out of the 5 patients who
had a complete response had received a dose of bleomycin that was above the median for the
group overall, while 66% of their patients who received a lower dose progressed within one year
[Hukin 2007]. Despite this trend, the authors noted that this tumour behaves in a heterogeneous
manner in that some cysts will disappear with a small dose of bleomycin and smaller cysts may











doses >15mg /week were associated with a higher rate of toxicity in their series.
The variation in efficacy of intracystic bleomycin is perhaps not too surprising given the variation
in treatment protocols. The three largest series published reported complete response rate
ranging from 29.4% (Canada) [Hukin_2007] through 37.5% (Lyon) [Mottolese 2001] to 50%
(Milan) [Broggi 1989]. Of the patients reported in the Canadian multi-centre study, 58.8%
required no other treatment and this was the case for 71% of those from Lyon. The combined
French/Brazilian series reported a 62% "good outcome" result, although this wasn't defined
[Zanon]. In a review published in 2006, the overall results were calculated at CR 23%, PR 51%
and MR 26% at a median follow-up of 28 months [Hargrave].
It is striking that the 3 patients (42.9%) who enjoyed an initial complete response, had all received
prior radiotherapy. This is not commented on by other authors and from the details provided in
the various reports it is not clear whether this was the case in other series.
A theoretical advantage of having an Ommaya reservoir in place is the ability to monitor biological
activity through laboratory analysis of the fluid. Takahashi reported that lactate dehydrogenase
levels not only fell over the course of treatment, but over time there was also a reversal in the
isozyme pattern with a fall in the L5 fraction and a rise in L1. Some authors however have not
found this to be reliable [Mottolese 2001].
One of the theoretical concerns about the use of bleomycin is the possibility that this may make
later surgery more difficult, but the experience of the Lyon group has been the converse of
this, reporting that the tumour was easier to remove as it was firmer with a clear cleavage
plane [Mottolese_2005]. The histopathology appears to be unremarkable in tumours resected
following a course of bleomycin [Hukin 2007].
Some authors have used bleomycin in combination with radiotherapy, either with intracystic
32p [Jiang] or with radiosurgery [Nicolato 2004]. The complete response observed in the three
patients who had undergone radiotherapy some time prior to receiving bleomycin suggests there












7.4.2.2 Complications of bleomycin
The use of intravenous bleomycin may be complicated by various systemic side-effects such
as interstitial pneumonia, pulmonary fibrosis, fever, scleroderma-like skin changes and alopecia
[Savas]. It is hardly surprising that this agent may have serious sequelae if it leaks into the brain.
Acute complications
It appears from the literature that minor side-effects such as fever and headache are to be
expected following intracystic bleomycin; vomiting occurs infrequently and may have more
ominous significance. The major acute side-effects relate to neural injury, the most significant of
which is peritumoural oedema in the brain adjacent to the cyst.
The first series published describing the use of intracystic bleomycin in craniopharyngioma
commented on the low rate of complications, limited to mild fever in two patients [Takahashi]. A
subsequent series reported two serious complications- one patient suffered a middle cerebral
artery infarct and another bilateral sensorineural deafness [Broggi 1989]. Another case of
deafness was reported from Bologna [Frank] and the Lyon group reported a case of blindness
following an incorrect toxic dose [Mottolese 2001]. A case report in 1994 described the onset
of hypersomnia, personality changes, memory impairment and thermal dysfunction in an adult
shortly after a dose of 5mg had been administered; the patient had commenced on a dose of
0.5mg and tolerated a gradually increasing dose up to that point, with the only adverse effect
being a short-lived pyrexia of 38.5° after each dose [Haisa]. Although follow-up imaging showed
reduction in the size of the tumour at 9 months, with no accompanying abnormalities in the brain,
his hypothalamic dysfunction persisted.
The first death attributed to intracystic bleomycin was reported nine years ago [Savas]; this
patient suffered extensive damage to the diencephalon and upper midbrain. CT cystogram had
revealed a leak at one month and treatment was therefore deferred and only commenced when
she became symptomatic at 5 months. Since then a number of similar cases have been reported
(Table 7.5). Four cases with similar imaging findings were reported from Canadian centres. One
case from Vancouver [Hader] and three patients out of a series of eight who received a total
of 13 courses of intracystic bleomycin at the Hospital for Sick Children in Toronto, developed
hyperintense signal change in the brain adjacent to the cyst. This was thought to represent
peritumoural vasogenic oedema and was treated with high-dose steroids [Lafay-Cousin]; none











In our case as well as those reported by Savas [2000] and Hader [2000], no leak was visible on
a CT scan performed immediately after the event. Possible explanations could include diffusion
of the drug through the wall of the cyst if it is particularly thin or a reaction within the wall of the
cyst which causes a reaction in the adjacent brain or a leak more proximally, directly into the
parenchyma of the brain which might not be visible on CT scan [Hader]. The initial signs of this
complication may be subtle but progressive and it is worth noting that the Toronto group used
high-dose steroids on the basis that this strategy is used to good effect in systemic bleomycin-
induced alveolitis and fibrosis [Lafay-Cousin].
Two deaths occurred due to thalamic infarcts in patients three months after treatment with
bleomycin and 32 P; although they did not have immediate scans, they reasoned that there had
been no dislodgement of the catheter as no CSF was ever aspirated. It may be that there was
a synergistic effect from 32 P being administered simultaneously and interestingly, both these











Patient/ Tumour Surgery/ Complication Outcome
Dose
Author
Savas 47 yo female pre- Stereotactic. Confusion 5 days after complet- Death 45 days after
2000 sented with hydro- 56 mg over 8 ing course; CT showed diffuse symptom onset
Ankara cephalus. days signal change in the diencepha-
Small cyst (10cm 3 ) Ion and mesencephalon
Hader 7 yo female. NS Lethagy and panhypopituitarism Patient underwent
2000 NS 2mg x15 after completing course. Imaging  surgery; persistent en-
Vancou- doses (total showed collapse of the catheter- docrine deficit although
ver 30mg) containing cyst but enlargement CT changes improved
of a new cyst with peritumoural over time
oedema.
Lafay - 5.5 yo female. Endoscopic Persistent headache and vomit- Partial L III palsy and
Cousin Predominantly 3mg x13 ing; T2 and FLAIR hyperintensity mild hemiparesis devel-
2007 cystic, partially doses oped which responded
Toronto calcified tumour (total 39 mg) to high dose steroids.
extending into the I maging improved but
third ventricle long-term weight gain.
9 yo male. NS. Fatigue and deterioration in Hypothalamic dysfunc-
Large suprasellar 3mg x11 memory. Extensive oedema on tion. High dose ste-
tumour with rim (total 33mg) MRI roids; long-term weight
calcification gain but improvement
in changes on scan;
required surgery for
progression.
12 yo male, devel- NS. Asymptomatic- routine imaging No specific treat-
oped cystic recur- 3mg x 25 at completion of course. Oe- ment given as patient
rence frontally (total 75 mg) dema noted in right frontal lobe remained asymptom-
and in temporal and left temporal lobe atic. Follow-up imag-
lobe 4 years after ing showed persistent
initial diagnosis. signal change in frontal
lobe.
Table 7.4: Published cases where patients have been found to have peritumoural signal change
following intracystic bleomycin. NS: not stated.
Changes in other regions of the brain are more difficult to explain- we had two patients who
developed new signal changes in the frontal lobe and temporal lobe, remote from the catheter.
A remote cerebellar infarct has also been reported [Park].
While some centres have indeed reported poor results [Frank], it may well be the case that
serious bleomycin-related complications have occurred more frequently as many of these may











to complications, citing these as "personal communications" [Hader] while another commented
in 2004 that "evidence for mortality related to intracavitary bleomycin treatment is anecdotal"
[Nicolato_2004] but it appears as though there are now a number of such anecdotes.
Chronic complications
An occlusive arteriopathy has been found in children with slowly growing basal tumours [Mori] and
radiation is known to induce vascular abnormalities such as moya-moya syndrome, cavernous
angiomas and stroke [Liu]. A few such cases have been described in patients who received
bleomycin and radiation. A patient was reported to have complete occlusion of the clinoidal
portion of the internal carotid artery as well as stenosis of the ipsilateral posterior cerebral artery
19 years after treatment of a cystic craniopharyngioma with intracavitary 198Au and bleomycin
[Sagoh].
Two patients in the Canadian series developed moya-moya syndrome 4 - 5 years after radiation,
one of whom died from a massive middle cerebral artery infarct [Hukin_2007]. A patient who
was initially treated with bleomycin and then underwent surgery and radiosurgery developed
a moya-moya syndrome manifesting with multiple strokes and frequent transient ischaemic
attacks, necessitating bilateral pial synangiosis procedures [Scott, RM]. Six out of a cohort of 20
children treated with radiation therapy were found to have some type of vasculopathy; two had
received bleomycin prior to undergoing subtotal resection and radiotherapy. One of these patients
developed a moya-moya syndrome with right internal carotid occlusion and the other developed
an aneurysm on the right internal carotid along with narrowing of the left internal carotid artery
[Liu]. The authors suggest that there may have been an interaction between bleomycin and
radiation in these patients. The MR angiogram shown in Figure 7.3 is certainly consistent with a
moya-moya syndrome.
7.4.3 New approaches
Systemic chemotherapy has been used with little success in this condition [Hargrave], but the
benign and predominantly cystic nature of this tumour makes local chemotherapy much more
appealing. Local chemotherapy in the form of carmustine wafers (Gliadel®) applied to residual
tumour at the time of surgery has been found to be effective in glial tumours and has also been
used in treating a craniopharyngioma [Laws_ 2003].
Interferon alpha (IFN-a) is also effective against squamous carcinoma; the first report of its use











[Jackaki]. A recent series from São Paulo described impressive results after intracystic
administration in 21 patients, with 11 (52.4%) achieving a complete response [lerardi], which
thus far has been sustained on long-term follow-up [Cavalheiro, personal communication, 2008].
7.5 Perspective
The essence of modern management of craniopharyngioma is to individualize treatment.
I mplanting a catheter into the tumour cyst to enable decompression or intracystic therapy is a
relatively simple strategy and may be associated with better long-term endocrine function than
microsurgical resection. This is particularly relevant in developing countries where access to
microsurgery is limited and adequate endocrine replacement therapy precarious.
Although intracystic therapy remains an appealing option in cystic tumours, we now reserve the
use of bleomycin for recurrences following microsurgical excision and radiotherapy, on the basis
of the experience reported here. A possible synergy between bleomycin and radiotherapy may
warrant further investigation.
A number of technical challenges were encountered in implanting the catheter stereotactically
but once these were addressed, the Cape Town Stereotactic Pointer was highly effective for
this purpose. The majority of patients reported in this series were children; the next chapter will













The major indications for which the CTSP was used were for biopsy of intracranial lesions for
histological diagnosis and cannulation of tumour cysts but there were various other applications
that are worth noting.
As shunt insertion in children was the first application considered at the outset of this project,
as described in Chapter 3.4, meeting the challenges posed by operating on children was an
important requirement.
8.1 Paediatric Neurosurgery
While working at Red Cross Children's Hospital as the Paediatric Neurosurgery registrar, the
author's interest in stereotactic techniques was stimulated by an editorial in Archives of Disease
in Childhood written by Thomas and Kitchen [1993], calling for wider utilization of stereotaxis
in diagnosing and treating various conditions in children. In view of this paediatric context, it is
not surprising that the first presentation of the CTSP in a neurosurgical forum was at the annual
meeting of the International Society for Pediatric Neurosurgery in Santiago in 1995 [Peter].
As has been described, the first case in this series was a six year-old girl with lesions in the basal
ganglia bilaterally. A total of 27 stereotactic operations were performed in 22 children (Table
8.1); this group therefore accounted for 23.5% of all the procedures. There were 13 girls and
10 boys and their ages ranged from 0.2 months to 16 years with a median age of 6; the most
frequent indications were therapeutic in that 11 children underwent insertion of an Ommaya
reservoir in a craniopharyngioma (14 operations) and 3 children underwent insertion of a shunt
(4 operations). Biopsy of a suspected tumour was performed in 8 children (9 biopsies). As can











Case Age/ Procedure Diagnosis Comments
Gender
1 6 F Biopsy R basal ganglia Inconclusive histology Likely tuberose sclerosis
3* 10 F Cannulation (Ommaya) Craniopharyngioma Treated with yttrium
11 F Cannulation (Ommaya) Craniopharyngioma Lost to follow-up
14 0.3 M Biopsy L basal ganglia Inconclusive histology Giant capillary cavernous an-
gioma
15 0.2 F Cannulation (shunt) Arachnoid cyst Normal development
21 2.5 F Cannulation (shunt) Isolated ventricle Normal development
39 4 M Biopsy R midbrain Pilocytic astrocytoma Cured following resection
40* 15 F Biopsy R midbrain Anaplastic astrocytoma Recurrence 9 months later
15 F Biopsy R inferior frontal Anaplastic astrocytoma Died following palliative radio-
therapy
45 15 F Cannulation (Ommaya) Craniopharyngioma Bleomycin- good response
48* 5 M Cannulation (Ommaya) Craniopharyngioma Surgeon error- cyst not pen-
etrated
5 M Cannulation (Ommaya) Craniopharyngioma Bleomycin- partial response
50 11 F Biopsy L thalamus Pilocytic astrocytoma Neurofibromatosis Type 1
55* 14 F Cannulation (drain) Hydrocephalus Infection cleared
14 F Cannulation (shunt) Hydrocephalus Normal development
60 16 F Cannulation (Ommaya) Craniopharyngioma Cyst collapsed so catheter re-
moved
67 14 M Biopsy L frontal horn Anaplastic astrocytoma Non-diagnostic
76 6 F Cannulation (Ommaya) Craniopharyngioma Bleomycin- fatal complication
78 6F Cannulation (Ommaya) Craniopharyngioma System error- cyst not cannu-
lated
80* 13 M Cannulation (Ommaya) Craniopharyngioma Surgeon error- haemorrhage
13 M Cannulation (Ommaya) Craniopharyngioma Bleomycin- partial response
86 8 M Biopsy R basal ganglia Tuberculosis Initial response, lost to follow-up
87 14 F Cannulation (Ommaya) Craniopharyngioma Bleomycin- good response ini-
tially
88 4 M Biopsy R thalamus Pilocytic astrocytoma Marked developmental delay
95 8 M Cannulation (Ommaya) Craniopharyngioma Bleomycin- good response ini-
ti ally
Table 8.1: Patients 16 years of age or younger who underwent surgery with the CTSP




















In the 1980s, recognition of the adverse effects of radiotherapy and chemotherapy on young
children turned the tide against the practice of empirically treating lesions found on imaging,
without recourse to biopsy. As various centres reported their experience with stereotactic
biopsy, children comprised a significant proportion of many large series and a number of reports
specifically addressed the issues pertaining to stereotactic neurosurgery in children.
The most frequently cited stereotactic biopsy series utilized the Riechert-Mundinger apparatus
to perform 302 stereotactic biopsies, of which 26% were in children under the age of 14
[Ostertag]. A very large series which began with a prototype BRW frame also included children
[Apuzzo_1987]; in both of these the youngest child was 18 months of age.
In addition to the publications referred to previously addressing specifically the issue of brainstem
tumours in children, a number of more general descriptions of experience with stereotactic surgery
in children have been published and these are summarized in Table 8.1. As the paediatric skull
has attained 80% of size of an adult by two years of age, size alone is seldom a disincentive to
use a stereotactic frame, but one needs to pay particular attention to areas of thinning of the skull
due to chronically raised intracranial pressure or previous interventions [Pattisapu].
Some of the challenges that have arisen with the use of conventional stereotactic frames in
children include:
■ General anaesthesia has been used almost invariably, necessitating particular attention
to ensure access to the precarious paediatric airway
■ Their smaller head requires longer pins
■ Their less rigid skull makes standard pin fixation in the outer table less secure; great care
must be taken not to apply too much pressure when drilling the burr hole.
Various inventive strategies to create a firmer construct have been suggested, such as
■ Manufacture of a custom-made helmet [Uematsu]
■ Application of Plaster of Paris [Thomas 1993, Muzumder]











Author No and System Results Comments
Age range
Broggi 1983 17 cases; Riechert Histological diagnosis in all, Following CT scan and
Milan 2-16 years 7 were candidates for more angiography, metrizamide
aggressive therapy ventriculography was done to
confirm tumour location
'Storrs 1985 10 cases; BRW Wide range of cases, CT-guided stereotaxic frame
Salt Lake City 10 mo — 16 including stereotaxy-guided provides a level of operative
years excision of an abscess guidance not available with
any other technique
Nauta 1986 9 cases; BRW Repeated successfully in 2 Recommended angiography
Galveston 9 mo — 16 patients following initial non- and arterial contrast CT to
years diagnostic biopsy avoid vascular injury, as
well as burr hole to visualize
cortical surface
Godano 1987 34 cases; 1 Riechert Biopsy successful in 88.2%, Therapeutic interventions
Bologna — 7 years no complications such as draining cysts and 125 1
implants
Davis 1988 30 cases; Kelly 90% diagnosis rate; biopsy One death following biopsy
Rochester MN 5 mo - 16 followed by craniotomy in 13 of a small hypothalamic
years cases lesion. Integration of MRI
and angiography in planning
approach.
'Pattisapu 66 cases; BRW 92% diagnosis rate with 2% Conclusively demonstrated
1989 5mo — 18 complications that frame-based stereotactic
Philadelphia years surgery is safe and efficacious
and Salt Lake in children
City
Munari 1989 134 cases; Talairach 98.6% diagnosis rate; took Sedan Vallicioni needle;
Buenos Aires 2-16 years 4.01 biopsy specimens/ high degree of Pathology
needle track and 5.39 involvement. 20 cases had
specimens/ procedure unexpected non-tumoral
pathology
Black 1993 16 cases; BRW/ CRW Biopsy, craniotomy and Used side-biting Nashold
Boston 4-18 years radiosurgery cases; 125 1 needle but found cup forceps
implants better for firmer lesions
'Walker 1994 110; 4mo — BRW 96.4% diagnosis rate; As attempted resection
Salt Lake City 18 years comprehensive assessment  more common in paediatric
of use of BRW frame in tumours, needle biopsy
children required less often than in
adults
Herrera 1999 24 cases; Riechert 100% diagnosis rate in 22/24 paediatric cases done
C6rdoba 4 mo — 18 biopsies; ' 25 1 i mplants under sedation with local
years anaesthesia
St George 15 cases; Leksell G 83% successful biopsies Difficulty penetrating firm
2004 4-15 years frame capsule of a pineal tumour
Birmingham












The CTSP was found to be well suited to children as the halo is light and small. The two youngest
children, both under 4 months of age, were operated during the first phase, when fiducials were
attached directly to the scalp. The youngest child in whom the halo was used was 1.5 years old,
but there is no reason why this couldn't be used in a younger child.
Two decades ago, Rorke argued that the vast majority of paediatric central nervous system
tumours require resection, not needle biopsy [Rorke]. There are indeed few indications for
stereotactic biopsy in infants and young children and our practice has been to perform definitive
surgery rather than simply a stereotactic biopsy, whenever this has been an option. Furthermore,
ever-improving instrumentation makes neuroendoscopy an increasingly popular strategy for
biopsying lesions such as thalamic gliomas, not least because of the reassurance of directly
visualizing the biopsy site.
There are a number of conditions in childhood that are somewhat controversial, such as the
approach to a solitary granuloma and the role of biopsy in diffuse brainstem tumours.
Solitary granulomas are typically found in a child presenting with a focal seizure who is otherwise
well. Some have advocated stereotactic biopsy of such a "target lesion" in order to distinguish
tuberculomas from neurocysticercosis but our approach has been to treat these symptomatically,
reserving biopsy for those in whom a tumour features prominently in the differential diagnosis
[Domingo]. If a biopsy is performed, it may be very difficult to identify the aetiological agent;
Rajshekar reported that tuberculomas could only be definitively diagnosed in 18% of patients
with a preoperative CT diagnosis of intracranial tuberculoma who underwent a stereotactic
biopsy [Rajshekar 1993].
Following the advent of MRI, it became possible to diagnose diffuse brainstem gliomas with
confidence in children; although Epstein championed an aggressive surgical approach to focal
brainstem tumours, he deplored the use of stereotactic biopsy in diffuse lesions [Epstein]. This
position was subsequently supported by a study from the Children's Cancer Study Group, which
showed that MRI was highly specific for diagnosing brain stem glioma [Albright]. There may
however be a case for biopsy of such lesions in adults [Selvapandian]. Recently there have been
a number of reports recommending biopsy sampling in order to direct new therapeutic regimens;
use of PET guidance may help to refine the choice of target [Pirotte]. Until clear symptomatic or












- An early report from Toronto endorsed the usefulness of frameless stereotaxy in children [Drake],
but an ongoing challenge has been the need to immobilize the head during surgery as rigidly
fixing the skull in the Mayfield clamp is usually not an option in children under 2-3 years of age.
Other groups have addressed this problem [Reavey-Cantwell] and our own experience with
electromagnetic tracking with a small adhesive sensor (AxIEM®) has suggested that this is a very
promising strategy for navigation during open surgery. For point stereotaxis such as biopsy or
insertion of a catheter, our practice is still to use the CTSP, owing to the extreme cost attached
to the single-use biopsy kit that is required should one use the navigation system.
8.2 Hydrocephalus
Stereotaxis is seldom required in the modern treatment of hydrocephalus as the ventricles are
almost invariably larger than normal and consequently relatively easy to locate "freehand", with
the help of external landmarks. Indeed, a skilled neurosurgeon is able to achieve satisfactory
catheter placement in over 90% of cases [Pang]. In view of the increased risk of shunt infection
due to the additional "fiddle" entailed in using stereotaxis for this purpose, stereotaxis was only
used in exceptional cases. It proved helpful in one infant with a quadrigeminal arachnoid cyst
(Case 15 as illustrated in this chapter) and two children with abnormal loculated ventricles (Case
21 and 55).
Discussion
One significant advantage of the CTSP over a conventional stereotactic frame is the ease with
which the halo can be removed after insertion of the ventricular catheter, facilitating tunneling of
the distal catheter.
Stereotaxis has been used to place the proximal catheter of shunt in a variety of different
conditions. These include a cystoperitoneal shunt in a prepontine arachnoid cyst [Sweasey],
cystoventricular shunts in Sylvian arachnoid cysts [D'Angelo] and a ventriculo-peritoneal shunt
in a sequestered fourth ventricle [Montes].
Although the performance of stereotactic third ventriculostomy [Poblete] is now thankfully of
historical interest only, stereotactic guidance may be a very helpful adjunct to neuroendoscopy













This 2 month female infant was referred to Red Cross Children's Hospital by a General Practitioner
following an increase in her head circumference. A quadrigeminal cistern arachnoid cyst had been
diagnosed on an antenatal ultrasound; CT scan showed this had enlarged and was causing brainstem
compression and there was early ventricular dilatation.
Course: After induction of General Anaesthesia, the fiducials were attached and a stereotactic
planning scan performed. Upon returning to the Operating Theatre, the patient was prepared for
a shunt with the distal catheter tunneled prior to inserting the proximal catheter into the cyst under
stereotactic guidance. Clear fluid with a protein level of 1.59/1 was obtained. Follow-up CT scan
confirmed a satisfactory position with decompression of the cyst and at follow-up 16 years later the
patient had a normal neurological examination.
Figure 8.2: Initial axial CT scan (a) demonstrating the cyst located in the quadrigeminal cistern; the












Brain abscess carried a high mortality until recent decades, but since the advent of CT scanning,
earlier diagnosis has improved the outlook immensely [Moorthy]; improved microbiological
techniques and better therapy have also contributed [Shahzadi]. Among the important therapeutic
advances has been the use of stereotactic aspiration for abscesses that are small, deep or
in critical locations. Although such abscesses can sometimes be successfully managed with
intravenous antibiotics alone, failure to respond adequately may mandate drainage in order to
isolate an organism.
In this series, 12 adult patients underwent stereotactic drainage of an abscess; 3 patients required
two operations each, and one of these went on to require a posterior fossa craniectomy for
excision of a separate cerebellar Nocardia abscess. The stereotactic procedure was successful
in all but the first patient, in whom brain shrinkage sabotaged the stereotactic procedure; this
case has been described in detail in Chapter 5 (Case 2). The only septic complication in the
series occurred in a patient who underwent aspiration of an abscess (Case 33). Details of these











Case No Predisposing Single/ Location Size Organism Treatment
Factors multiple
02 Cyanotic heart Multiple R frontal 20x20x20 No growth IV clox/ ctx/ metro;
disease cortical no longer a trans-
plant candidate
10 Nil Single R centrum 20x20x25 No growth IV clox/ ctx/ metro
26 AIDS Single R trigone 20x25x20 Amoebiasis Pyrimethamine and
Sulfadiazine
31 Dental Single L FP deep 20x35x30 Small Gram IV clox/ ctx/ metro;
WM positive ba- required re-tap
cilli once
32 Previous PTB Single L FP sub- 25x12x15 No growth 4-drug T Rx; IV clox
cortical for one week, fol-
lowed by IV pen and
chloramphenicol
33 Previous PTB Single R FP sub- 20x20x20 Bacteroides IV clox/ ctx/metro;
and empyema cortical re-tap twice
49 Dental surgery Single R deep WM 25x20x20 Strep milleri IV pen/ ctx/ metro
51 Trauma, ante- Single R frontal 10x10x10 Haemophi- IV ampicillin/ ctx.
rior fossa frac- deep WM lus influnzae Anterior fossa repair
ture one month later
52 Bronchiectasis Multiple R frontal 25x25x20 No growth IV clox/ ctx/ metro
deep WM
61* COAD; referred Multiple R thalamus 20x25x20 Strep faeca- IV ctx/ metro/ van-
following 4 as- li s/ Entero- comycin. Re-tap 4
pirations in the cooccus days later
private sector
Re -tap R thalamus 20x25x20 - Cured
89* Nil Multiple R temporal 20x15x15 Strep milleri IV pen/ metro. Re-
deep WM tap 16 days later
Different ab - - R temporal 15x15x10 - Cured
scess deep WM
93* SLE on high- Multiple R frontal 15x15x20 Nocardia IV co-trimoxazole/
dose steroids, cortical ctx
Renal failure
Different ab - L frontal cor- 15x15x20 - Craniectomy for ex-
scess tical cision of cerebellar
abscess one month
later
Table 8.3: patients undergoing stereotactic drainage of an abscess

















This 32 year-old woman developed severe headache one week after dental surgery; her background
history was significant for a liver abscess following uterine perforation. She had no neurological
deficit but CT scan disclosed a 2cm diameter ring-enhancing lesion in the inferior left frontal lobe.
An extensive medical work-up was negative and she was commenced on intravenous antibiotics
(penicillin, chloramphenicol and metronidazole). Follow-up scan 5 days later showed the lesion was
slightly larger; her treating neurosurgeon in private practice was reluctant to tap this freehand due to
the depth of the lesion and she was referred to our hospital for stereotactic drainage.
At surgery, 5m1 of brown malodorous pus was aspirated and Streptococcus milleri sensitive to penicillin
was cultured; she remained on appropriate doses of this agent and subsequently recovered fully.
Figure 8.3: Stereotactic CT scan showing a ring-enhancing lesion in the inferior left frontal












Although brain abscesses have diminished in frequency in developed countries, they are
still common in developing countries, comprising up to 8% of intracranial masses [Moorthy].
Stereotactic drainage is seldom required for abscesses that present as an emergency and
require immediate drainage as these are typically large; for those abscesses that are small or
deep, there is usually time to plan stereotactic drainage on the next elective list.
All the case reported here simply underwent needle aspiration without leaving a catheter in situ,
but some authors have advocated insertion of a catheter in order to administer antibiotics directly,
particularly in patients who are immunosuppressed, have large abscesses or have not responded
adequately [Kondziolka_1994]. Aspergillus is an important organism in immunocompromised
patients and although our experience has been that these require craniotomy for excision,
stereotactic catheter drainage has been reported to be effective [Goodman].
The value of stereotactic drainage is underscored by a review of published literature which
found that 82/107 cases (76.6%) had a good outcome [Shahzadi]. As many of these patients will
require more than one surgical procedure, there is little question that stereotaxy may reduce the
"leucotomy effect" of multiple freehand passes of a brain needle [Moorthy].
Stereotactic approaches may be particularly helpful with an abscess in deep location, such as
the case illustrated above; other authors have reported stereotactic aspiration of abscesses
located in the brain stem [Rajshekar 1994].
Five patients in this series (41.6%) had multiple abscesses and this also constitutes a good
indication for stereotactic drainage [Franzini]. Strategies for decision-making in this context have
been proposed [Mamelak] and repeat procedures may be necessary [Chacko], as was the case
in 60% of the cases with multiple abscesses reported here.
Steroids are often administered to patients with brain abscesses in order to diminish mass effect
from oedema but were only used in 59% of cases reported here; the most likely reason for this
is the fact that most of these abscesses were small, ranging in volume from 1.2 — 11 cm 3 , with a











8.4 Biopsy of intracranial lesions in HIV+ patients
The Human Immunodeficiency Virus pandemic has taken a particularly devastating toll in this
country, where the total number of people infected is estimated to be 5.7 million, or 18, 1% of
the population, of whom 280,000 are children [UNAIDS]. Data from the first decade of the HIV
pandemic indicated that the CNS was affected in nearly one-third of patients with AIDS and 10%
of these patients had intracranial mass lesions [Rosenow]. With this background, it is perhaps
surprising that only 4% of the patients in this series were referred for biopsy of intracranial lesions
in the setting of HIV.
Discussion
Within the first decade of the HIV pandemic, it was established that CNS lymphoma (PCNSL),
toxoplasmosis and progressive multifocal leucoencephalopathy (PML) were the most common
HIV-related focal brain lesions [Chappel; Levy_1992].
A study from upstate New York reported that HIV-infected patients constituted 11.3% of their
stereotactic biopsies; of the 16 patients, 8 had toxoplasmosis and 8 had lymphoma [Plunkett].
The patients with lymphoma had all been treated for toxoplasmosis for 4-6 weeks prior to biopsy.
Making a specific diagnosis in these patients may be challenging for the neuropathologist.
A high rate of non-diagnostic biopsies was reported in HIV [Chappel] and it soon became clear
that thorough histopathological evaluation with microbiological backup was required in these
cases [Levy_1992, Zimmer]. It is worth emphasizing the fact that the diagnosis in Case 26 was
made by the rnicrobiologists on the wet preparation, enabling prompt institution of therapy.
This detailed neuropathological workup does however require considerable expertise and
investigations that may not be available in a developing country. In a recent series from Brazil,
15,9% of patients undergoing stereotactic biopsy were known to be HIV-infected; of the 28
patients HIV* patients, toxoplasmosis was diagnosed in 8, lymphoma in 2 and 17 (60,7%)
had a diagnosis of "non-specific chronic inflammatory changes". Despite this high rate of non-
specific diagnoses, the procedure was considered helpful in that 25% of HIV+ patients had a
histopathological diagnosis that differed from the preoperative diagnosis, compared with 14.6%
of HIV- patients [Teixeira].











difference in terms of complications [Nicolato 1997] but one centre reported introducing a
coagulopathy protocol in patients with AIDS after experiencing a 12% incidence of intracranial
bleeding, 9% of which were fatal [Gildenberg 2000ii]; their complication rate fell to 3% with
this measure. Until recently, this report encompassing 243 patients was the largest series of
stereotactic biopsies in AIDS and 6.4% of cases had more than one diagnosis.
Survival was dismal prior to the advent of effective therapy, with mean survival 4.4 months after
neurological presentation [Levy 1984]. Following the introduction of antiretroviral drugs (ARVs)
in 1996, the incidence of PML, PCNSL and toxoplasmosis was halved and the rate of stereotactic
biopsies fell steeply [Rosenow]. Of particular interest in this latter study is the finding that no
patient who underwent lesion biopsy because of negative toxoplasmosis serology (such as Case
20 above) or atypical neuroimaging findings was diagnosed with toxoplasmosis, emphasizing













A 20 year old man with AIDS, tuberculosis and pneumocystis pneumonia developed a left hemiplegia.
Initial CT scan showed multiple ring-enhancing lesions in the basal ganglia and the patient was started
empirically on pyrimethamine and sulphadiazine, although toxoplasmosis serology was negative. A
follow-up CT scan two week later showed a larger lobulated inhomogenously enhancing mass in the
right basal ganglia with widespread low density change in the surrounding hemisphere. In view of
the failure to respond to a course of toxoplasmosis therapy, a biopsy was indicated. The specimen
was reported as showing chronic inflammatory changes in keeping with toxoplasmosis, although no
organisms were identified.
Course: 	The patient was discharged back to the referring hospital for further management but was
lost to follow-up.
Figure 8.4: CT scan demonstrating a hyperdense mass in the basal ganglia (a), which enhances
inhomogenously following intravenous contrast (b). On review of the histology, features of chronic
non-specific inflammation were noted (c), rather than the acute vasculitis typically described in
Toxoplasmosis. In hindsight, these histological features and the absence of organisms, together with












A 28 year old man with AIDS and a low CD4 count (<10) presented to a referral hospital with
headache and a left hemiparesis following the onset of generalized tonic-clonic seizures. Initial CT
scan showed a ring-enhancing lesion in the right parietal lobe and the patient was stared empirically
on pyrimethamine and sulphadiazine for presumed toxoplasmosis. Follow-up CT scan after two
weeks showed progression of the lesion which appeared to be located within the trigone of the lateral
ventricle, hence he was referred for a biopsy.
At surgery, adequate biopsy specimens were obtained despite the fact that CSF was also aspirated.
Frozen section was reported as showing an inflammatory process and the Microbiologists identified
amoebic organisms.
Course: 	The patient was commenced on appropriate therapy and a follow-up scan one month
later showed a satisfactory response.
Figure 8.5: Preoperative CT scan showed a ring-enhancing lesion in the right lateral ventricle with
marked oedema in the adjacent parieto-occipital lobe (a); postoperative CT scan showed a satisfactory
decrease in size of the lesion (b). Definitive histology was reported as showing a necrotizing vasculitis
with gitter cells, but on review the latter were thought to be amoebic organisms containing ingested












One of the more beguiling attractions of modern image-guided surgery is the possibility achieving
better outcomes in the radical resection of intrinsic tumours. Having coined the term "stereotactic
volumetric resection", Kelly recently suggested that "modern surgical techniques simply allow
us to make glioma lumpectomies bigger and safer" [Kelly_2004ii]. However debatable the
oncological merits of such an approach for gliomas, being able to accurately locate a small
lesion such as a subcortical metastasis, hamartoma or abscess may be helpful.
The evolution of the use of stereotactic guidance at the time of craniotomy has been summarized
elsewhere [Ross]. It contended that determining the site and size of the craniotomy preoperatively,
based on the optimal trajectory to the lesion, reduces operating time as well as diminishing the
risks of wound complications and neurological morbidity [Barnett_1993].
Discussion
For those who do not have a neuronavigation system, a number of simpler techniques for doing
this with the aid of a conventional stereotactic frame have been described. Two such approaches
were described in a helpful publication from the Cleveland Clinic, one utilizing micro patties and
the other a silicone elastomer catheter [Hassenbusch]. The first technique entails placement of
2-3 micro patties at the margins of a tumour, inserting them with the aid of a 4.6mm diameter
biopsy needle; after doing so, the stereotactic frame was removed and a conventional craniotomy
performed, with the "stereomarkers" providing a degree of resection guidance at the selected
margins.
The other technique is somewhat simpler- a catheter is passed into the brain to the predetermined
depth adjacent to the tumour and a circumferential suture placed at the level of the cortical surface
in order to recognize any migration that may occur. The stereotactic frame is then removed,
a craniotomy performed around the burrhole and the catheter followed to locate the tumour.
The merits of this strategy have been debated; some consider this a cumbersome approach
[Barnett_1993], while in another's experience, once the catheter has been cut off flush with the
brain surface, "a subsequent fully sterile and unencumbered microcraniotomy can follow the line
of the tube (which moves with the brain) to the target" [Torrens]. This approach was utilized in












Another option that was explored was the "split" halo, which was designed as a two-piece
construct with two thirds of the circumference separated from the remaining third, held firmly
together by two screws so that it could be easily dismantled.
This was designed with the intention that the smaller section would be secured with two screws
(Figure 8.7), enabling the larger section to be removed and then replaced once a craniotomy
had been performed. The tripod could then be mounted on the intact halo and used to locate the
intracranial lesion.
Figure 8.7: The prototype split halo, showing one of the two screws that enabled the halo to be













This 54 year old man presented with right sided seizures and a hemiparesis, having had a
pneumonectomy for stage II adenocarcinoma of the lung 6 months previously. CT scan disclosed
a small enhancing lesion in the postcentral gyrus; excision was considered the optimal therapy and
stereotactic guidance was used as the lesion was small and located in eloquent cortex.
The CTSP was used to place a burrhole directly over the lesion; the halo was then removed and
a small craniotomy performed after re-opening and extending the linear incision made for the burr
hole. Postoperatively he experienced no worsening of his neurological deficit and he was referred to
Radiotherapy for further management.
Figure 8.6: Axial CT scan showing the 20x 30 mm enhancing lesion (a) which was removed in its













9.1 Performance of the CTSP
This dissertation has described the evolution of a novel stereotactic system from the first clinical
application of the concept through a succession of iterations. These successive changes could
broadly be divided into four successive phases of refinement which took place over a six year
period, encompassing one hundred patients.
Experiments to evaluate the application accuracy had shown a vector accuracy of 1.8 +/- 0.3mm
using the setting diagram to set the tripod and 1.9 +/- 0.6mm using the 3D phantom to set the
tripod. The present study comprises the clinical counterpart to this laboratory study.
If one excludes the six cases over the period when the incorrect calibration data was used, and
one includes as successes the ten cases in which histology was inconclusive or catheters were
not implanted but targeting was accurate in retrieving abnormal tissue, the surgical objective was
realized in 101/109 cases (92.7%).
Given the fact that six of the eight failures represented errors of surgical judgment that could not
be ascribed to the stereotactic system, and each of two system errors resulted in a significant
improvement in the system, the Cape Town Stereotactic Pointer demonstrated a satisfactory
level of accuracy in clinical application.
This was accomplished with an acceptable rate of complications. Only one death could be
attributed to a stereotactic procedure, giving a mortality rate in this series of 0.9%. Two patients
experienced major complications (1.7%) and 13 patients experienced minor complications, all of
which proved to be transient (11.3%).
A simple protocol for use of the CTSP evolved over the course of this study, making it easier
for neurosurgeons from varying backgrounds to introduce stereotaxis into their practice with the











9.2 Who is this intended for?
Perhaps the first question to address is, "who should perform stereotactic surgery?" Of course
there are large centres where a small number of neurosurgeons can dedicate their time and
interest to perfecting their stereotactic techniques and they will doubtless be rewarded with
extreme levels of procedural success, but this is a methodology that surely falls within the remit of
just about every neurosurgeon. As was pointed out twenty years ago, "stereotaxis can nowadays
be performed by any neurosurgeon who can make a burr hole and perform simple arithmetic
calculations" [Blaauw].
The author agrees with the view expressed from Cambridge that stereotactic surgery must be
practiced by all neurosurgical registrars (residents) in training [Wild], as this is a technique that
trainees really should be comfortable with by the time they graduate. Although there is an initial
"learning curve", with adequate guidance and supervision this is minimal. One busy neurosurgical
service could find no statistical difference in the negative biopsy rate of the most experienced
surgeon when compared to seven colleagues who performed fewer biopsies [Ranjan].
Although two neurosurgeons pioneered the development of the CTSP, eight neurosurgeons in
all served as the lead surgeon performing operations in this series, with the other six colleagues
serving as lead neurosurgeon in 39% of cases.
As the goal was to develop a stereotactic system that would be of help to the general neurosurgeon,
it is i mportant to evaluate the advantages and disadvantages of the CTSP in such a setting.
9.3 Advantages of the CTSP
Ergonomic
The halo is easily attached using a strategy that all surgeons are comfortable with, namely
insertion of sutures, and this takes no more than 10 minutes. With careful explanation, patients
tolerate this procedure well. There is also the option of cranial fixation with one or two screws
should this be required and these different options for fixation, either scalp or cranial, constitute
a real advantage.
Patient comfort is also enhanced by the fact that the halo is so small and light, with the halo and











stereotactic frames in this respect as they are usually heavy (weighing around 2 kg) and quite
cumbersome and therefore potentially uncomfortable for the patient, with the attendant risk of
shifting if incorrectly applied. Furthermore, these systems often require a special device to attach
the frame to the scanner table.
I maging
The patient can be scanned in a comfortable position, although it is ideal for the patient to
lie with their head in the same position as for surgery; it is critical to avoid patient movement
and adequate explanation helps achieve this. Typically, the scan only takes a few minutes with
modern helical scanners. The CTSP is independent of the type of CT scanner and no special
headrest or holder is required and basic scanner software is used to determine the co-ordinates.
Protocol for use
Each step of the process is intuitive and therefore easy to understand and little additional training
is required for most neurosurgeons, radiographers and nurses.
The Windows-based software is easy to use and can run on any basic personal computer. The
user does not have to understand the mathematics and it is a simple mechanical exercise to set
the device.
All that is required in order to set the trajectory is to set the co-ordinates on the 3D phantom
and then gently apply a depth stop on the surgical instrument. Should the selected trajectory be
unsuitable for the position of the burr hole, this is readily adjusted with the burr hole simulator.
Surgery
The small size of the halo means that access to the airway is unrestricted and this particular
stereotactic system poses no problems for the anaesthetist. Full sterility during surgery may be
ensured by covering the halo with an adhesive drape.
This series has demonstrated that the CTSP is versatile and can be used for various different
applications. Most regions of the cortex and subcortical white matter can be reached with ease,
as can the basal ganglia and the brainstem via transfrontal approach; the temporal lobe can be
accessed if care is taken in positioning the halo.
The halo is easily removed should this be necessary for the next part of the operation, such as












The instrumentation is mechanically simple and with the tripod manufactured from stainless
steel and the phantom from aluminium, they are durable and readily autoclaved. This is a major
factor in developing countries where there is seldom a dedicated instrument technician to care
for equipment. The halo cannot be autoclaved but is readily sterilized by gassing or soaking
according to local practice.
No routine maintenance is required although damage to the tripod and the phantom, which
would render them inaccurate, should be obvious to the user.
Once the calibration data is loaded, this does not need to be altered, unless a different phantom
is used.
9.4 Disadvantages of the CTSP
Potential sources of inaccuracy
This is without a doubt the major consideration and the neurosurgeon needs to be absolutely
fastidious, but this is true of all stereotactic neurosurgery.
This area has been addressed in Chapter 4, but it bears repeating that the particular steps that
require attention include:
■ secure attachment of the halo, in an appropriate position
■ avoiding scalp movement at the time of scanning and at the time of surgery
• avoiding too great an angle in setting the tripod as this may well magnify inaccuracy
• correct use of the surgical instruments such as the biopsy needle
Neurosurgical insight
Careful planning is fundamental to using this system in that it is not ideal to perform surgery
outside the perimeter of the halo. There are a number of ideal entry points, particularly over
the frontal and parietal prominences as the halo sits most securely and these are best used;












In this series, the CTSP was not used to biopsy lesions in some locations such as the cerebellum
and lower brainstem so it is not possible to comment on such applications on the basis of the
experience reported here.
Occipital placement is possible, but this may present a minor problem for the anaesthetist should
the patient require intubation, which would ideally be performed with the patient turned to the
contralateral side.
Multiple trajectories are possible if they can be reached from the same burrhole, but not if bilateral
or widely separate in the same hemisphere. In this situation, one could consider attaching two
halos. As the halos are manufactured to exactly the same specifications, this is an option.
A burr hole was used for all the cases reported here and it may be difficult to use a twist drill,
unless a specific bushing was introduced.
Repeat surgery
The halo is removed after surgery and is therefore not relocatable.
Software problems
Although the program has been designed for ease of use, it is important that the user familiarize
himself/ herself thoroughly before doing a clinical case.
It is also critical that the correct calibration data be used, and this should not be altered. It is
advisable to check the entered values against the printed values from time to time, and this must
be checked in case of an unsuccessful procedure.
9.5 The real cost of innovation
As mentioned in Chapter 3, our rather simplistic goal at the start of this project was "stereotaxis
for a thousand rand". This was our first venture into the world of invention and innovation and
there were lessons to be learnt.
The initial work on this project was undertaken at the University of Cape Town, by clinicians
employed by the Provincial Administration of the Western Cape (PAWC) as well as Biomedical











ti me, the South African Medical Research Council (MRC) had ownership of the project as they
had provided some of the initial funding to the Biomedical Engineers.
The system was patented (as the "Cape Pointer" with Professor Adams as the Inventor) and the
MRC duly appointed an agent, Technifin to take the project to the marketplace. In this company's
view, patent protection was required in various countries, including the USA, although the
clinicians saw no potential whatsoever for this system to be used in developed countries that
already had access to a wide array of sophisticated stereotactic devices.
Technifin licensed the project to a Pretoria-based company, Fibretek, which commenced
manufacturing and marketing the device as the "Cape Town Stereotactic Pointer", a name
recommended by the clinicians. This company, owned and operated by Mr Peter Mundell,
installed the first commercial system in Sunninghill Hospital in August 1997 and within two
years had established the system in South Africa. Building on this success at home, they have
subsequently sold over sixty CTSP systems in ten countries, with the bulk of the sales being in
India, where the local agents, Indelect, have been particularly supportive of the CTSP.
Although innovation is a crucial driver of neurosurgical progress, it brings risks as well as
unforeseen costs. Taking an idea "from the drawing board to the bedside" is a process that
is unfamiliar to most neurosurgeons [Firlick]. Bringing instrumentation to other neurosurgeons
carries substantial costs- not only must the equipment be manufactured to a high standard with
the accompanying quality control, but the various other parties who invest time and resources
in support require an appropriate return on this. In order to have any impact, money needs to be
spent on sales and marketing. Most prospective buyers will want a demonstration in their own
hospital and will expect back-up to be readily available following purchase.
Not only is the cost of a piece of equipment a minor component of the ultimate selling price, but
the neurosurgical marketplace is small, with approximately 25,000 neurosurgeons worldwide
[Kelly 2000ii]. This is compounded by the fact that most of these neurosurgeons practice in
North America, Europe and Asia, with only a very small proportion of these neurosurgeons
practicing in the developing countries where instruments such as the CTSP have role to play.
The question of the substantial costs incurred through legal protection of the intellectual property












When the CTSP was first launched commercially in South Africa, it was sold for R10,000 which
compared very favorably to the major stereotactic systems which were quoted at over R150,000.
None of the South African neurosurgeons who purchased the CTSP had ever used stereotaxis
before and all required hands-on training, supplemented by brochures, videos and telephonic
support. Many of these neurosurgeons have subsequently gone on to acquire navigation systems
as these have become more widely available, and this is an obvious progression.
9.6 Global impact
Over the years, most of the published literature on the use of stereotaxis has emanated from
developed countries, with the exception of India which has a long tradition of stereotactic
neurosurgery [Ramamurthi_2000]. Recently however, stereotactic articles have been published
from developing countries such as Brazil [Ferreira] and Turkey [Calisaneller].
At the time this project began, no stereotactic neurosurgery was being performed in Cape Town
and this was also the case in virtually all African countries. The first country outside of South
Africa to acquire a CTSP was Kenya, where Mr MM Qureshi started to use the system in Nairobi.
He subsequently presented his experience at the Asian Australasian Congress of Neurological
Surgery in 1999 and has since served as an enthusiastic reference. Elsewhere in Africa, systems
have subsequently been installed in Nigeria, Botswana, Uganda, Libya and Angola.
The country where there has been the greatest impact is without doubt India. Shortly after the
production system became available, the author was invited to present at the inaugural meeting
of the Indian Society for Stereotactic and Functional Neurosurgery ("Stereocon") held in New
Delhi, India in December 1997. There was immediate interest in the CTSP and the first system
was sold in 1998. An enthusiastic local agent, Indelect, was subsequently appointed and a
hands-on workshop was held at the 8th Stereocon in Bangalore in 2004. To date, 38 CTSP
systems have been sold in India (Figure 9.1), one has been sold in Sri Lanka and enquiries have
emanated recently from Iran [PJ Mundell, personal communication].
Interest was expressed by colleagues in Colombia and a similar hands-on workshop was held
in November 2005 at the Colombian Congress of Neurosurgery in Cartagena des Indias and
one system has been sold in South America sofar. The CTSP is currently in use in ten countries
around the world (Figure 9.1); to date, over sixty systems have been sold in a total of nine












Figure 9.1: Global reach of the CTSP. The CTSP has proven to be popular in India, with a total of
37 systems having been sold there (a); at present, the CTSP is in use in 10 countries around the
world, namely, South Africa, Kenya, Nigeria, Botswana, Uganda, Angola, Libya, India, Sri Lanka,
Colombia (b).
As was the case in South Africa, a great deal of support and training has been required. This
has taken the form of repeated visits to a host of hospitals by Fibretek and Indelect, production
of training brochures and videos and conducting hands-on workshops (Figure 9.2)
Figure 9.2: The author conducting a Hands-on Workshop with assistance from Mr Ganapathy
Padmanabhan at the 8th Stereocon in Bangalore.
9.7 Future developments
No stereotactic system is immutable and it has been noted that in this field, "the principles of
survival (are) simplicity of use and utility of function" [Bakay]. Following the initial commercialization
of the CTSP, there has been a continuous process of product development which has been
gratifying to witness. This is testament to the versatility of the system, the ingenuity of the users
and the commitment of the manufacturer and his distributors. Novel applications of the CTSP











i. Posterior fossa approach
Dr Manjunath Prasad of Hosmat Hospital, Bangalore, was able to perform a transcerebellar
approach to biopsy a lesion in the cerebellar hemisphere, with the halo mounted in a suboccipital
position.
ii. Haematoma aspirator
It has not been our practice to aspirate deep intracerebral haematomas, but this is the case at
some centres and various neurosurgeons requested a haematoma aspirator be supplied. An
effective instrument for this purpose, based on the Archimedes water-screw principle, had been
devised by Backlund [Backlund_1978] and modified by Higgins and Nashold, who added an
irrigation port with a distal aperture near the instrument's tip [Coffey] and such a device is now
available with the CTSP.
iii. Functional adaptor
Our intention in developing this system was to facilitate access to point stereotaxis for
morphological applications, such as tumour biopsy, aspiration of abscesses and catheter
implantation. Although we did not advocate its use for functional applications, some users have
suggested that the CTSP could be used to guide implantation of a device such as a Bennett
sphere. Such devices have been used for electrophysiological determination of the optimal site
for creating a lesion [Eljamel].
iv. MRI halo
As the CTSP halo is such a simple construct with just three fiducials, manufacture of an MRI-
compatible halo was a straightforward undertaking and the first MRI halo was manufactured
with the ball bearings replaced by 2 mm3 drops of evening primrose oil. A test phantom was
constructed, similar to that described in Chapter 4.5, except the evening primrose oil was used
for the targets in place of ball bearings. The targets were localized to an accuracy of 2.5 +1- 0.5
mm in a preliminary accuracy study, but the halo was not used clinically by our group due to
a concern that potential distortion due to chemical shifts could not be determined as both the
fiducials and the targets comprised evening primrose oil [Meintjes].
An MRI halo has subsequently been manufactured using dilute copper sulphate for the fiducials












In 1958, Austin and Lee wrote "... it seemed to us that the ideal type of stereotaxic instrument
should be based on simplicity and ease of handling in order not to become confused with the
idea that the more elaborate the instrument the more accurate the subsequent injection or
coagulation" [Austin]. A similar philosophy guided the development of the CTSP.
Having developed a system that was easy to use and well tolerated by patients, and also had an
acceptable degree of accuracy in the laboratory matched by satisfactory clinical performance,
it was important to the developers that this be available to as wide a group of colleagues as
possible. This required the system to be sold at a realistic price in order to be cost-effective, but
this was not something over which the developers had any direct control. The fact that over sixty
of these systems have now been sold, many on the basis of recommendations by current users,
suggests that a need has been met.
The late Dr A Sehgal, one of the pioneers of Indian Neurosurgery and the man who convened the
inaugural meeting of the Indian Society for Stereotactic and Functional Neurosurgery (IndSSFN),
told this author that he believed that the CTSP had played an important role in the growth of
IndSSFN through widening access to stereotaxis in his country [Personal communication,
Marrakech, 2005].
Simple technology such as this is therefore able to play an important role in building neurosurgical
infrastructure and expertise. Doctors progress and patients benefit, and this surely this is a






































































































The Cape Town Stereotactic Pointer: Standard components supplied








o Tripod knob and collar
o Tripod screwdriver (Allen key)
o Tripod support block
o Instrument guide sleeve
o Cut-off instrument guide sleeve
o 2.5 mm perpendicular pointer
o 3.2 mm perpendicular pointer
o Setting Phantom
o Burr-hole indicator arm
o Biopsy and other Instruments
o 2.5mm side-cutting biopsy needle
o 2.5mm aspiration needle













The Cape Town Stereotactic Pointer: Protocol for use
Through repeated use, a simplified technique evolved which entails 4 stages:
2i Application of the Halo
The circular halo serves 2 purposes:
1. it contains the fiducials, which are three radiopaque ball bearings, 2mm in diameter,
which are macroscopically visible and also seen on the CT image
2. it serves as the platform upon which the tripod (stereotactic pointing device) will be
mounted, having three small holes on the upper surface which securely house the three
feet of the tripod.
It is worth noting that the fiducials are not located exactly at the holes occupied by the feet of
the tripod, even though each fiducial is referred to as "leg 1", "leg 2" and "leg 3". As each halo
is manufactured to exactly the same specifications, the calibration data in the software corrects
for this offset. The halo must not be able to move during the CT scan or, even more importantly,
during the surgical procedure. As it also serves as the external reference system, generating co-
ordinates, which are determined using the software intrinsic to the CT scanner, it is absolutely
essential that the halo be securely fixed to the patient's head.
This is achieved by suturing the halo to the scalp using 2/0 silk. The hair need not be shaved
at this point although the scalp and hair is cleaned with the solutions used for preoperative
skin preparation (in our case, chlorhexidine shampoo followed by chlorhexidine in 70% alcohol).
Important considerations in selecting the location for the halo include:
■ it should be situated in the optimal position for a convenient and safe trajectory to the
intracranial target from a burr hole located in the centre
■ it must be positioned so that it is stable and unable to rock from side to side
Three small feet projecting from the inferior surface of the halo help with stabilization and
it is secured with four or five sutures of 2/0 silk distributed more or less evenly around the











achieves a snug fit; an alternative method is to secure the halo with self-tapping screws inserted
into the skull.
With an awake patient, it is necessary to precede suturing with infiltration of local anaesthetic
once one has determined where the sutures should be placed. It is important that sufficient
time be allowed to elapse, not only to enable the anaesthetic to work but also to allow the agent
to dissipate in the tissues so that there is not a large skin bleb that may reduce the stability of
the halo. Needless to say, careful explanation before and constant encouragement during the
procedure go a long way towards helping the patient to tolerate this.
As the three fiducials are indistinguishable on the CT scan image, it is important to take note
of the orientation of the halo and hence the fiducials. It is recommended that one routinely use
a particular convention, for example, our usual practice is to rotate the halo so that the middle
fiducial (termed "leg 2" although this is not strictly speaking correct) is closest to the midline of
the patient's head- this diminishes the chances of misidentification of the fiducials. Other helpful
practices include taking note of the sequence in which the fiducials will be imaged during the
scan and drawing a simple diagram which can be referred to during the scan is also helpful.
Although the prototype halo was manufactured from transparent polycarbonate, European Union
rules required that it be manufactured from a material that complied with the US Pharmacopeia
Class VI standard and since 2002 the halo has been made from Ultem 1000 plastic (polyetherimide)
[PJ Mundell, personal communication]. The fiducials however remain visible and it is essential
that the halo not be autoclaved.












This is the data acquisition stage and is easily adapted to local radiological practice. In essence,
one needs only four axial images, namely those through the three fiducials and one through
the target. In order to optimize the selection of the target however, usually a series of scans is
planned through the region of interest. Most cerebral lesions that require biopsy or aspiration
will enhance and administration of intravenous contrast such as Omnipaque® is very helpful in
delineating the pathological area.
The standard head holder may be used, which is preferable to the patient lying with the head
on the table itself as the holder tends to restrict head movement, which is further discouraged
by placing a strip of masking tape lightly across the brow. The patient is positioned with the
halo uppermost- not only does this reduce scalp distortion, but it also replicates the most likely
operative position and therefore diminishes brain shift should one operate in a different position.
The gantry must not be angled. The scanning protocol then depends on the capabilities of the
particular scanner. The most common practice at present is to plan a helical scan from the
fiducials down to the region of interest taking two mm thick contiguous slices. This is certainly
the quickest technique with most current helical scanners taking no more than a minute or so;
such scanners are not always found in centres where the CTSP is used.
An alternative is to plan the slices from the lateral or anteroposterior surview or "scout" view;
should one plan individual slices, each should be 1 mm thick for optimal accuracy. Using this
approach may be preferable should one want to limit the amount of radiation and is particularly
appealing in children, who for that matter are usually anaesthetized anyway so doing the scan
very rapidly is not that necessary. Should there be any concern, the first fiducial imaged should
be scanned again and this will immediately show if there has been any interval change in position.
An efficient sequence is to scan through the area of interest and then determine which slices are
optimal for selecting a target. A sequence of four consecutive scans is then planned, one through
each fiducial and one through the previously selected "target" area. It is usually straightforward
to obtain these images in a very short time — no more than a couple of minutes. It is almost
always possible to get the patient to lie still for this period and provided these four successive











If more than one intracranial target is required (for example, biopsies from two different regions
of a tumour), the appropriate images must be obtained at this stage.
The fiducials must be clearly seen; simply seeing the edge is not acceptable. The software
intrinsic to the CT scanner enables one to readily obtain x and y co-ordinates for each fiducial by
superimposing the grid and moving the cursor on the display screen.
Movement of the bed on which the patient lies is very precisely calibrated with the bed position
appearing on each slice; this figure serves as the z co-ordinate. Two points are worth emphasizing:
■ do not attempt to move the Cartesian grid on the screen or alter the image size after
scanning as this will render all values meaningless
■ The x and y co-ordinates are usually given in millimeters while the table position is
in centimeters. This necessitates multiplication of the table position by ten as all the
stereotactic co-ordinates must be entered as millimeters.
It is also important to check that both the (table position) Z axis and the X and Y co-ordinates
on the screen are in the same units, as some manufacturers display one in centimeters and the
other in millimeters.
2.3 Calculation of Stereotactic Co-ordinates
Upon completion of the scan, the neurosurgeon should be satisfied that the co-ordinates look
intuitively correct. Invariably the x-axis runs horizontally and the y-axis vertically with the origin
of the axes in the centre of the image and x=0 and y=0 at the intersection of the two axes; x
is negative to the left of the origin and y is negative below the origin. In other words, a fiducial
located in the upper right quadrant has positive values for both x and y, while one located in the
lower left quadrant has negative values for both x and y.
The x-, y- and z- co-ordinates are then obtained for at least one and preferably two intracranial
targets. As previously discussed, there is substantial consensus that the highest diagnostic yield
is from enhancing regions and this is therefore the area to target. These four sets of x-, y- and











The CTSP software has been written in an easily used Windows program, which is licensed, to
FibretekTM. The first step is to enter the salient patient details as a new folder, which is saved with
the suffix ".pha".
The second step is to select "enter co-ordinates" from the drop-down menu and enter these
four sets of three co-ordinates taking great care to do this in the correct order. The importance
of vigilance at this point cannot be over-emphasized and in general it works best to have one
person read out the values, taking care to state which values are negative, with a second person
entering the data. Once completed, this is then read back off the screen.
If the data is correct, click "OK" and a data block is displayed which indicates the differences












Fig A3: Screenshot of the test of transformation precision (Picture credit: Mr PJ Mundell).
This test of transformation precision warrants detailed explanation. As the distances between
the fiducials housed in the halo are fixed, this enables one to establish how accurate the CT data
is. The CTSP software compares the distances from "leg 1 to leg 2", "leg 1 to leg 3" and "leg 2
to leg 3" and reveals whether the data is reliable. This enables the surgeon to make a judgment
call; should the target be deep seated, accepting an error of greater than 1mm would be unwise,
while a slightly greater margin may exist should the target be large or superficial.
If the test of transformation precision shows an unacceptable degree of error, the first step is to
check that the data has been entered correctly. Should that not be the problem, each step of the
procedure is carefully reviewed and the calibration data is checked against the printout supplied
with the unit to ensure that this has not been altered inadvertently. If the problem persists, the
most likely explanation is that there was movement during the scan and this then has to be
repeated.
If this is accepted, click "Yes" and the phantom settings for x, y and z will be displayed in millimeters











Figure A4: Screenshot of the Target co-ordinates for the 3D Phantom (Picture credit: Mr PJ
Mundell).
Once the target co-ordinates have been determined, the tripod is then set on the correct trajectory
using the 3D phantom; a probe or pointing rod is passed through the instrument channel to
enable one to establish this trajectory (Figure A5). It is important to set the trajectory using the
following sequence:
1. loosen the clamping knob on the post as well as the two screws on either side of the
perpendicular plates holding the instrument guide
2. li ghtly tighten the screw on the inferior plate such that it is "finger tight"
3. insert the pointing rod through the instrument guide; once one is happy with the trajectory,
tighten the clamping knob on the post, which will secure the horizontal arm in place
4. lastly, tighten the screw on the superior plate using the Allen key
5. the trajectory is now securely set
6. the depth is set by gently tightening the depth stop at the required position on the pointing
rod or biopsy needle
It is worthwhile doing this prior to moving the patient out of the radiology department as this
enables one to perform an intuitive check by coupling the tripod to the halo as most neurosurgeons
will have a good idea of where they expect the lesion to be. Should the trajectory look to be on











Figure A5: The tripod mounted on the 3D Phantom (Picture credit: Mr PJ Mundell).
The final step entails saving the data set to the ".pha" file created at the outset, to enable later
retrieval in theatre or for audit or research purposes. Although at one time a printout was also
generated in order to set the tripod (Figure A6), this is no longer essential, but it does however
serve as useful documentation.












The phantom, tripod, biopsy needles and other accessories need to be autoclaved but there is
enough time to attend to this while the patient is being anaesthetized; the tripod is mounted on
a small autoclavable platform, which prevents it toppling over. Ideally the screws on the setting
phantom should be loosened prior to autoclaving to avoid possible damage due to the high
temperature and then re-set once the instruments have cooled sufficiently.
The patient may be operated on under general or local anaesthesia. A single dose of antibiotic is
given intravenously at induction and steroids and anticonvulsants administered as appropriate.
The patient's head is positioned with the halo uppermost and great care taken to ensure that
there is no shift due to distortion of the scalp. The surgical site, including the halo, is prepped in
the usual fashion following which the drapes are sited and a sterile adhesive drape then gently
applied once the alcohol has evaporated and the halo is dry. The technique used for this is
important- it is best to first apply the adhesive drape in the centre and then gently tuck it around
the inner circumference before folding it over the edge of the halo and onto the surrounding scalp
and drapes. Done correctly, this greatly diminishes the potential for any movement of the halo
during surgery.
Ideally the surgical site will be in the centre of the halo; the scalp is infiltrated with a mixture of
local anaesthetic and a vasoconstrictor (Marcaine® and Por-8®). Our preference has been to use
a burr-hole so the cortical surface can be inspected to avoid lacerating a vessel, utilizing a self-
retaining retractor positioned to avoid scalp distortion.
Prior to opening the dura, it is helpful to replicate the position of the burr-hole on the setting
phantom in order to ensure that the appropriate trajectory is set- this is easily done with the
help of the burr-hole guide. The tripod is set using the vertical guide and placed on the halo; the
pointing rod is then advanced until the tip is in the centre of the burr-hole and the setting clamp
tightened. The tripod is then placed on the phantom and the burr-hole guide moved into position
such that the tip of the pointing rod is located in the centre of the ring which replicates the burr-
hole.
The correct trajectory can now be set on the tripod and the depth stop clamp applied to the
biopsy needle to determine the depth. If one is using a Sedan-type guillotine biopsy needle, at
this point it is useful to firmly apply a 10m1 syringe to the proximal end needle and ensure that the











the biopsy window is closed prior to insertion. In order to ensure that the biopsy is taken from the
chosen target, the depth stop is moved 5-7 mm proximally so that the target lies at the centre of
the biopsy window.
The dura is now incised and the pia gently coagulated. The surgeon couples the tripod to the
halo and this is securely held in place by the assistant. The biopsy needle is steadily advanced
through the trajectory guide to the required depth with the outer window facing in the most
appropriate direction. Often a definite resistance is felt as the tumour is encountered; the inner
cannula is rotated until the windows are aligned and 4-5 ml of suction is applied to the syringe
for a few seconds prior to closing the window by rotating the inner cannula. The inner cannula is
then withdrawn, leaving the outer cannula in place while the assistant takes great care to avoid
any movement of the tripod/halo complex.
The biopsy specimen is retrieved and placed on a glass slide- visual inspection should give an
indication whether grossly abnormal tissue has been obtained. Further biopsies may be taken,
rotating the outer cannula to sample in different directions. Biopsies may be taken either deeper
or more superficially by making small adjustments in the position of the depth stop, and biopsies
may also be taken from a different selected target by re-setting the tripod.
If clearly abnormal tissue has been obtained, it is not usually necessary to await intra-operative
histological confirmation, but if there is any doubt it is prudent to wait until a provisional diagnosis
has been made. The wound is closed in the usual fashion following which the halo is removed.
Postoperatively the patient should ideally be admitted to the Intensive Care Unit, or at least High
Care for observation for at least 6 hours. As the halo is re-usable, the recommended practice is











Figure A7: Surgery using the CTSP. The drapes should be secured circumferentially outside the
halo, taking care not to exert traction on the scalp (a) following which an adhesive plastic drape
may help to stabilize the halo (b). The burr hole is ideally placed in the centre of the halo (c) and
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